Quarterly Report • Sep 8, 2022
Quarterly Report
Open in ViewerOpens in native device viewer

The Phoenix Holdings Ltd. Consolidated Interim Financial Statements as of June 30, 2022 (Unaudited)
Investments, insurance and finance ופיננסים ביטוח ,השקעות

Benjamin Gabbay - Chairman Ben Langworthy Dr. Ehud Shapira (Independent Director) Eliezer Yones Rachel Levine (External Director) Rick Kaplan Roger Abravanel Zhak Cohen

| Part 1 | Report of the Board of Directors on the State of the Corporation's Affairs |
|---|---|
| Part 2 | Consolidated Interim Financial Statements |
| Part 3 | Standalone Financial Data from the Consolidated Interim Financial Statements Attributed to the Company |
| Part 4 | Report on the Effectiveness of Internal Control over Financial Reporting and Disclosure |
| Part 5 | Statements Regarding Controls and Procedures in respect of Disclosure in the Financial Statements of The Phoenix Insurance Company Ltd. |

Report of the Board of Directors on the State of the Corporation's Affairs


| 1. | The Group's Structure, its Areas of Activity, and Developments Therein………….….2 | |
|---|---|---|
| 2. | Description of the Business Environment……………………………………………………8 | |
| 3. | Developments in the Macroeconomic Environment……………………………………….19 | |
| 4. | Business Targets and Strategy………………………………………………………………21 | |
| 5. | The Board of Directors' Explanations for the State of the Corporation's Business23 | |
| 6. | Disclosure on Exposure to, and Management of, Market risks56 | |
| 7. | Linkage balance………………………………………………………………………………57 | |
| 8. | Corporate Governance Aspects…………………………………………………………60 | |
| 9. | Disclosure Provisions Relating to the Corporation's Financial Reporting…………62 |

The Report of the Board of Directors of The Phoenix Holdings Ltd. (hereinafter, "The Phoenix Holdings" or the "Company" or the Corporation") as of June 30, 2022, outlines the principal changes in the Company's operations in the period from January through June 2022 (hereinafter - the "Reporting Period").
The report was prepared in accordance with the Securities Regulations (Periodic and Immediate Reports), 1970. With regard to the insurance, pension, and provident fund operations of the group, the Report was prepared pursuant to the Supervision of Insurance Business Regulations (Reporting), 1998, and in accordance with the directives issued by the Commissioner of the Capital Market, Insurance and Savings Authority (hereinafter - the "Supervisor" or the "Commissioner"). The report was prepared assuming that the reader also has at his/her disposal the Company's report for first quarter of 2022 as well as the full 2021 periodic report (hereinafter - the "Periodic Report").
The Report of the Board of Directors is an integral part of the quarterly report, and the quarterly report should be read in its entirety, as a single unit (hereinafter - the "Financial Report" or the "Financial Statements").
The Company's controlling shareholder is Belenus Lux S.a.r.l. The controlling shareholders of Belenus Lux S.a.r.l are: CP III Cayman GP Ltd., Matthew Botein, Lewis (Lee).


The group is engaged in the fields of insurance, investment management, holding of insurance agencies, provision of credit and other financial services, including the setting up and sale of alternative products. The group manages approx. NIS 361 billion and is considered to be one of the five largest insurance and finance groups in Israel. The Company operates in the field of insurance through The Phoenix Insurance Company; in the field of asset management, the Company operates through The Phoenix Pension and Provident Fund Ltd., The Phoenix Investments Ltd., and Excellence Investments Ltd.; in the field of holding of insurance agencies, the Company operates through The Phoenix Agencies 1989 Ltd.; in the field of credit provision, the Company operates through Gama Management and Clearing Ltd.
Changes in the risk-free interest rate curve and capital market affect The Phoenix Insurance's assets, liabilities, financial performance, and solvency ratio. The Company manages the interest risks of all of its assets and liabilities.
Interest rates - during the reporting period, the Bank of Israel increased its interest rate from 0.1% to 1.25%. Furthermore, in the reporting period, the shekel yield curve increased. The increase in the shekel yield curve has a positive effect both on the Company's financial results, and on The Phoenix Insurance's solvency ratio.
The capital market - during the reporting period, there were slumps in financial markets in Israel and across the world. These slumps have an adverse effect both on the Company's financial results, and on The Phoenix Insurance's solvency ratio.
Inflation - during the reporting period, the inflation rate increased by 3.1%. Inflation forecasts have also increased. The increase in inflation rates has an adverse effect both on the Company's financial results, and on The Phoenix Insurance's solvency ratio.

For more information regarding the effects of changes in the interest rate curve, the capital markets and inflation rates on the Company's financial results, see Section 3 below, and Notes 8B and 8A to the financial statements. As to the effect of the changes in the shekel yield curve and in capital markets on The Phoenix Insurance's solvency ratio, see Section 2.1.5 below, and sensitivity tests in The Phoenix Insurance's Economic Solvency Ratio Report as of December 31, 2021.
During the period from reporting date through immediately prior to the financial statements publication date, financial markets in Israel and across the world recovered, the Bank of Israel increased the interest rate by further 0.75%, and inflation and inflation expectations in Israel and globally continued to increase.
For the purpose if using its financial results, the Company uses a real return of 3% (see Section 5.4.1); in view of that, the changes in the CPI, as stated above, affects the classification of amounts between underwriting profits and investment profits.
In August 2022, concurrently with the approval of the Company's Financial Statements as of June 30, 2022, which are included in this report, the Company's Board of Directors decided to distribute a dividend in accordance with the Company's dividend distribution policy, which was revised in March 20227, totaling NIS 160 million and NIS 0.64 per share. It shall be clarified that to the extent that options are exercised by employees between the dividend declaration date and the record date, the per-share dividend amount shall be adjusted in accordance with the actual number of outstanding shares on the record date. The Company shall publish, as required, a supplementary report in respect of said adjustment on the record date. The said distribution is based, among other things, on a NIS 115 million dividend distribution from The Phoenix Insurance to the Company. Furthermore, the Board of Directors of The Phoenix Insurance also passed a decision as to a change in the minimum solvency ratio target for purposes of dividend distribution from 108% to 111%; for more information, see Section 2.1.4 below.
In March 2022, the Company updated the targets of the multi-year strategic plan. As part of the implementation of the strategic plan, the Company took the following steps during the reporting period:
7 Please see the immediate report dated March 29, 2022 (Ref. No. 2022 -01-037000).

The Company took steps to holds all alternative investments of The Phoenix group under The Phoenix Advanced Investments Ltd. Accordingly, in the reporting period, various steps were taken in order to achieve the above, including: The distribution, as a dividend in kind from The Phoenix Advanced Investments Ltd. of Quality Pension Insurance Agency (2017) Ltd., and 16% of The Phoenix Pension and Provident's shares it held, and the sale of The Phoenix IEC Central Fund Ltd. (formerly - Halman-Aldubi IEC Gemel Ltd.) to the Company. Concurrently, the Company's holdings in The Phoenix Advanced Investments were transferred to The Phoenix Investments, and the holdings of The Phoenix Investments in The Phoenix Capital Ltd. (hereinafter - the "Phoenix Capital") and the Phoenix Investment Funds Ltd. (which manage the activity of alternative investment funds) were transferred to The Phoenix Advanced Investments.
The Company has an indirect 65% stake in The Phoenix Capital, which is engaged in the establishment, management and distribution of alternative investment funds. The Phoenix Capital's activity constitutes a part of the Company's strategic plan to achieve growth in the area of investment management in general, and in the area of establishing, management and distribution of alternative investment funds in particular.
The remaining holdings in The Phoenix Capital are held by Safra Consultation and Investments Ltd. (hereinafter - "Safra"). The parties have in place a shareholders agreement that regulates the management of The Phoenix Capital; the said agreement stipulates, among other things, that decisions in The Phoenix Capital will be made jointly, despite the fact that the parties' stakes in the company are not equal.
On June 29, 2022, the parties signed an addendum to the agreement, which regulated issues which are not material to the Company; the addendum also regulates the manner by which The Phoenix Capital is managed; among other things, and as part of the implementation of the Company's strategic plan, the addendum made changes to the decision-making processes in The Phoenix Capital, such that decisions are made based on the parties' stake in the company. As a result of the said amendment, the latter changed the recording of its holding in The Phoenix Capital from joint control to control.

In accordance with a valuation of The Phoenix Capital, which was carried out by an independent external appraiser, and which was received on July 27, 2022, the Company recorded in its financial statements as of June 30, 2022, a NIS 86 million one-off post-tax capital gain as a result of assuming control.
For further details, please see immediate report dated July 28, 2022 (Ref. No.: 2022-01-078765).
For further details, please see Section 4 below and Section 4 to the Report of the Board of Directors in the 2021 Periodic Report.
In June 2022, the Capital Market, Insurance and Savings Authority issued a circular amending the provisions of the consolidated circular regarding updating the demographic assumption system and a mortality improvement model for insurance companies and pension funds (hereinafter - the "Circular"). For information regarding the Circular, see Section 2.2 below.
The provisions of the Circular update the assumptions underlying the calculations of liabilities and coefficients in life insurance policies, such that the Circular has an adverse effect on The Phoenix Insurance's financial results and solvency ratio. Following the publication of the Circular, the Company recorded in its financial statements as of June 30, 2022, a NIS 364 million decrease in pre-tax comprehensive income. For further details, including the effect on The Phoenix Insurance's solvency ratio, please see Section 2.1.4 E.(4) and the immediate report dated July 3, 2022 (Ref. No. 2022-01-069297).
As of the report date, the Company completed a study on retirement age and pension uptake rates (hereinafter - the "Study"). Following the Study, the Company recorded in its financial statements as of June 30, 2022, a NIS 462 million gross pre-tax increase in comprehensive income. For further details, including the effect on The Phoenix Insurance's solvency ratio, please see Section 2.1.4 E.(4) and the immediate report dated July 3, 2022 (Ref. No. 2022- 01-069297).
The Company continues to prepare for applying IFRS 17 (hereinafter - the "Standard"), in the Financial Statements of the Company and The Phoenix Insurance as from the quarterly and annual periods beginning on January 1, 2024, in accordance with the roadmap revision paper published in May 2022 by the Capital Market, Insurance and Savings Authority. As part of the implementation of the Standard, during the reporting period, reviews and training sessions were held for the Balance Sheet Committee in connection with the application of the Standard. For further details, please see Note 2(FF) to the 2021 Periodic Report.

In June 2022, the Company published an ESG report for 2021. The report was published on the Company's website and on the websites of the TASE and the Israel Securities Authority. To view the full report, as published on the Company's website, see the Company's website at: https://www.fnx.co.il/sites/docs/genery/for\_new\_site/esg/fnx-full-esg-2021-
Furthermore, the Company revised its investment policy in accordance with the Institutional Entities Circular No. 13-9-2021 of the Capital Market, Insurance and Savings Authority, which requires that the overall investment policy, that is determined by the group, will set an investment policy in relation to ESG considerations, which are relevant for the performances of the investment portfolio and, which might affect them. For more information in connection with the investment policy, see the Company's website at: https://www.fnx.co.il/sites/docs/genery/for\_new\_site/mashkiim/Phoenix-
In July 2022, Maala published its 2021 index, in which the Company's overall rating improved from Gold to Platinum, and it was awarded an A rating in the ESG index published by the TASE.
In August 2022, the Company's 2021 Greeneye ESG rating increased to 77/100, and the Company is ranked first among its direct competitors in the insurance and finance sector. to the work plan for 2023.
On August 23, 2022, the Company published a shelf prospectus, which is dated August 24, 2022. For further details, please see immediate report dated August 23, 2022 (Ref. No.: 2022-01-107443).
In June 2022, a binding agreement was signed for extending a USD 130 million loan (hereinafter - the "Loan") by The Phoenix Insurance to El Al Frequent Flyer Ltd. (hereinafter - the "Borrower") through the nostro funds. As of the report publication date, the Loan was extended and the charges were placed in favor of The Phoenix Insurance.
Furthermore, under the agreement, The Phoenix Insurance has the option to purchase up to 25% of the Borrower's shares; the option may be exercised at any time until the end of the term of the Loan, and subject to other conditions it may even be exercised one year subsequent to the end of the Loan's term. Under certain conditions, the option may also be

exercised by way of offsetting against the Loan's balance or part thereof. For further details, please see the Bank's immediate report dated June 23, 2022 (Ref. No.: 2022-01-077968).
In May 2022, The Phoenix Insurance issued - through The Phoenix Capital Raising (2009) Ltd. (hereinafter - "The Phoenix Capital Raising") - additional bonds of NIS 1 par value each at the total amount of NIS 293 million par value by way of expanding Series K Bonds of The Phoenix Capital Raising. The terms of the bonds are the identical to the terms of the existing Series K bonds. The additional bonds were recognized by the Capital Market, Insurance and Savings Authority as a Tier 2 capital instrument in The Phoenix Insurance. For more information, see the Company's immediate reports dated March 29, 2022, May 3, 2022, and May 8, 2022 (Ref. Nos.: 2022-01-037171, 2022-01-044334 and 2022-01-055336, respectively). The additional bonds were rated ilAA by Ma'alot S&P and Aa3.il by Midroog. In July 2022, The Phoenix Insurance issued - through The Phoenix Capital Raising, by way of issuing the new Series M and expanding Series K of The Phoenix Capital Raising - bonds of NIS 1 par value each at the total amount of NIS 400 million par value. The bonds were recognized by the Capital Market, Insurance and Savings Authority as a Tier 2 capital instrument in The Phoenix Insurance. For more information, see the Company's immediate reports dated June 14, 2022, and July 28, 2022 (Ref. Nos.: 2022-01-073339 and 2022-01- 078840, respectively). The additional bonds were rated ilAA by Ma'alot S&P and Aa3.il by Midroog.
The Phoenix Insurance is subject to the Solvency II-based Economic Solvency Regime in accordance with the provisions of Circular 2020-1-15 of the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") - "Amendment to the Consolidated Circular concerning Implementation of a Solvency II-Based Economic Solvency Regime for Insurance Companies" (hereinafter - the "Economic Solvency Regime"), which was published on October 14, 2020. The Economic Solvency Regime is a regulatory directive that regulates capital requirements and risk management processes among insurance companies. The Economic Solvency Regime sets a standard model for calculating eligible

capital and the regulatory solvency capital requirement, with the aim of bringing insurance companies to hold buffers to absorb losses arising from the materialization of unexpected risks to which they are exposed. The solvency ratio is the ratio between an insurance company's economic shareholders' equity recognized for solvency purposes and the required capital.
The Company opted for the alternative provided by the Economic Solvency Regime regarding the transitional provisions, whereby the economic capital may be increased by gradually deducting from the insurance reserves until 2032 (hereinafter - the "Deduction during the Transitional Period"). With regard to the Deduction during the Transitional Period, a letter was addressed to insurance companies managers titled "Principles for calculating Deduction during the Transitional Period in the Solvency II-based Economic Solvency Regime" (hereinafter - the "Letter of Principles"). Pursuant to the Letter of Principles, the Deduction during the Transitional Period shall be calculated by dividing insurance policies issued through December 31, 2016 into homogeneous risk groups. The aforesaid deduction shall be calculated as the difference between insurance reserves (retention) as per the economic balance sheet, including the risk margin attributed thereto (net of the difference between the fair value and the carrying amount of designated bonds) and the insurance reserves (retention) as per the Financial Statements. This difference shall be deducted on a linear basis until December 31, 2032. The deduction balance at each reporting date (hereinafter - the "Deduction Value During the Transitional Period") shall be proportionate to the expected increase in the solvency ratio calculated excluding expedients during the Transitional Period. In accordance with the provisions of the Economic Solvency Regime, the Deduction during the Transitional Period as of December 31, 2021 was recalculated two years after it was calculated for the first time. The Company obtained the Commissioner's approval to recalculate the Deduction Amount as of December 31, 2021. For more information, see Section 2A(2) to the Company's Economic Solvency Ratio Report as of December 31, 2021.
The Economic Solvency Ratio Report as of December 31, 2021, was published at the same time as the Financial Statements as of the first quarter, on May 31, 2022, and was prepared and presented in accordance with the provisions of Chapter 1, Part 4, Section 5 of the Consolidated Circular, according to Circular 2020-1-17 (hereinafter - the "Disclosure Provisions"). In accordance with the Consolidated Circular, the economic solvency ratio report in respect of the December 31 and June 30 data of each year shall be included in the first periodic report published after the calculation date.

Set forth below are details regarding the economic solvency ratio as published in the latest economic solvency ratio report published by The Phoenix Insurance. The meaning of the terms in this section is the same as in Appendix B to Chapter 2 in Part 2 of Section 5 of the Consolidated Circular - "Economic Solvency Regime".
| As of December 31 | |||
|---|---|---|---|
| 2021 | 2020 | ||
| Audited* | |||
| NIS thousand | |||
| Shareholders equity in respect of SCR** | 14,212,110 | 12,770,842 | |
| Solvency capital requirement (SCR) | 7,666,458 | 6,661,640 | |
| Surplus | 6,545,652 | 6,109,203 | |
| Economic solvency ratio (in %) | 185% | 192% |
| publication date of the solvency ratio report: | ||
|---|---|---|
| Raising of capital instruments*** | 346,133 | - |
| Shareholders equity in respect of SCR | 14,558,243 | 12,770,842 |
| Surplus | 6,891,784 | 6,109,203 |
| Economic solvency ratio (in %) | 190% | 192% |
For explanations about key changes in the capital surplus and in the economic solvency ratio as of December 31, 2020, compared with December 31, 2021, see Section 1(a) to the Company's economic solvency ratio report as of December 31, 2021.
Below is a link to the Economic Solvency Ratio Report on the Company's website.
https://investor-relations.fnx.co.il/about-us/solvency-report/

| As of December 31 | |||
|---|---|---|---|
| 2021 | 2020 | ||
| Audited* | |||
| NIS thousand | |||
| Minimum capital requirement (MCR) | 1,916,615 | 1,665,410 | |
| Shareholders equity for MCR | 11,024,131 | 9,773,104 |
(*) The term "audited" refers to an independent audit held in accordance International Standard on Assurance Engagement (ISAE) 3400 – "The Examination of Prospective Financial Information".
According to the letter published by the Commissioner, in October 2017, (hereinafter - the "Dividend Distribution Letter") an insurance company shall be entitled to distribute a dividend only if, following the distribution, the company has a solvency ratio - according to the provisions of the Economic Solvency Regime - of at least 100%, calculated without taking into account the transitional provisions and subject to the solvency ratio target set by the Company's Board of Directors. The aforesaid ratio shall be calculated without the relief granted in respect of the original difference attributed to the acquisition of the provident funds and management companies. In addition, the letter set out provisions for reporting to the Commissioner.
The Phoenix Insurance's policy is to have a solid capital base to ensure its solvency and ability to meet its liabilities to policyholders, to preserve The Phoenix Insurance's ability to continue its business activity such that it is able to provide returns to its shareholders. The Phoenix Insurance is subject to capital requirements set by the Commissioner.
The Phoenix Insurance's Board of Directors has set a minimum economic solvency ratio target and target range based on Solvency II. The economic solvency ratio target range, within which the Company seeks to be during and at the end of the Transitional Period, taking into account the Deduction during the Transitional Period and its gradual reduction is 150%-170%.
The minimum economic solvency ratio target, taking into account the transitional provisions, was set at 135%, and the minimum solvency ratio target without taking into account the provisions during the Transitional Period is set to reach 135% at the end of the Transitional Period according to the Company's capital plan. On August 24, 2022, the Board of Directors of The Phoenix Insurance increased the minimum economic solvency ratio target by 3 percentage points without taking into account the provisions during the Transitional Period - from a rate of 108% to a rate of 111%, beginning on June 30, 2022.

Therefore, based on the audited results as of December 31, 2021, The Phoenix Insurance meets the minimum capital targets set by the Board of Directors. It is hereby clarified that the aforesaid does not guarantee that The Phoenix Insurance will meet the set capital targets at all times.
The following are data as published in the latest economic solvency ratio report published by The Phoenix Insurance, about the economic solvency ratio calculated without taking into account the transitional provisions and the solvency ratio target set by the Company's Board of Directors, as required in the letter referred to above. As of December 31, 2021, and December 31, 2020, this ratio is higher than the target set by the Board of Directors.
| As of December 31 | |||
|---|---|---|---|
| 2021 | 2020 | ||
| Audited* | |||
| NIS thousand | |||
| Shareholders' equity for SCR (in NIS thousand)** | 11,112,151 | 9,931,007 | |
| Capital required for SCR (in NIS thousand) | 9,818,889 | 8,557,405 | |
| Surplus | 1,293,262 | 1,373,602 | |
| Economic solvency ratio (in %) | 113% | 116% | |
| Effect of material capital-related measures taken in the | |||
| period between the calculation date and the publication | |||
| date of the solvency ratio report: | |||
| Raising of capital instruments*** | 354,205 | - | |
| Shareholders equity in respect of SCR | 11,466,356 | 9,931,007 | |
| Surplus | 1,647,467 | 1,373,602 | |
| Economic solvency ratio (in %) | 117% | 116% | |
| Capital surplus after capital-related actions in relation to | |||
| the Board of Directors' target: | |||
| Minimum economic solvency target without applying the | |||
| Transitional Provisions**** | 108% | 105% | |
| Capital surplus over target | 861,956 | 945,731 | |
(*) The term "audited" refers to an independent audit held in accordance International Standard on Assurance Engagement (ISAE) 3400 – "The Examination of Prospective Financial Information".
** The solvency ratio as of December 31, 2021, includes a NIS 500 million dividend distribution performed between the calculation date and publication date of the solvency ratio report as of that date.
*** Composed of raising of Tier 2 capital at the total amount of NIS 270 million and a capital injection at the total amount of NIS 84 million, which arises from the transfer of Phoeniclass Ltd. from The Phoenix Holdings to The Phoenix Insurance, net of the capital requirements. For further details in connection with the transfer of Phoeniclass Ltd., see immediate report dated May 17, 2022 (Ref. No. 2022-02-048480).
**** Minimum solvency target, net of the transitional provisions in accordance with the calculation date. For more information, see Section C above.


Changes in the linked shekel risk-free yield curve affect the Company's economic solvency ratio, especially in the mid- to long-terms, affect The Phoenix Insurance's economic solvency ratio. During 2022, there was a substantial increase in the risk-free linked interest rate curve, that may have a positive effect on The Phoenix Insurance's solvency ratio. However, the economic solvency ratio is also sensitive to a wide range of other effects, including equity markets in Israel and across the world, which suffered significant slumps in this period, and the Consumer Price Index that increased during this period, and are expected to have a negative effect on The Phoenix Insurance's capital surpluses and solvency ratio.
| Range/years | December 31, 2021 June 30, 2022 |
August 18, 2022 | |||
|---|---|---|---|---|---|
| Short term |
1-3 | Between (2.39) % and Between (1.89)% and (2.55) % (0.75)% |
Between (0.60) % and (0.37) % |
||
| Mid-term | 4-10 | Between (2.23) % and (1.26) % |
Between (0.47)% and 0.23% |
Between (0.30) % and 0.15 % |
|
| Mid-long term |
11-15 | Between (1.11) % and (0.64) % |
Between 0.31% and 0.53% |
Between 0.24 % and 0.52 % |
|
| Long term |
16-25 | Between (0.54) % and 0.01 % |
Between 0.57% and 0.78% |
Between 0.57 % and 0.86 % |
The following table summarizes the positive (negative) risk-free linked interest ("spot") rates:4
The Phoenix Insurance estimated the sensitivity of the economic solvency ratio to a 50 bps increase in the risk-free interest, after applying the transitional provisions, and including adjusting the stock scenario; the estimation was carried out based on the data and results of the calculation of the economic solvency ratio as of December 31, 2021. The estimation resulted in a 20% increase in the economic solvency ratio (after applying the transitional provisions and adjusting the stock scenario).
It should be noted that the sensitivity is not necessarily linear; i.e., sensitivity at other rates is not necessarily a simple extrapolation of the sensitivity test presented.
For the results of the sensitivity tests of the economic solvency ratio to various risk factors, including sensitivity to decrease in interest rates, see Section 8 to The Phoenix Insurance's Economic Solvency Ratio Report as of December 31, 2021.
4 The risk-free linked interest rate curves were taken from Fair Spread Ltd. To calculate the solvency ratio, the Company takes into account other components in addition to the risk -free interest rate.

Set forth below are material regulatory directives published during the reporting period and thereafter, and which are not included in the Report on the Corporation's Business for 2021 and the Report of the Board of Directors for the first quarter of 2022. For further details regarding material regulatory directives published during the reporting period, please see Section 4.1.1 to the 2021 Report on the Corporation's Business and Section 2.2 to the Report of the Board of Directors for the first quarter of 2022.

insurance candidate, unless it first presented alternative insurance plans alongside the default plan, and gave the insurance candidate the option make an active selection of such plan; a temporary order was set whereby the circular's provisions shall not apply to the marketing of time-limited P&C insurance plans, which are purchased without proactive marketing; and with regard to senior citizens - in the event of the marketing of a P&C insurance policy, another alternative was given as to the format of the proposed coverage summary document that should be sent to the senior citizen.

Following are drafts of material regulatory provisions published during the reporting period and thereafter, which are not included in the 2021 Report on the Corporation's Business or in the Report of the Board of Directors for the first quarter of 2022. For further details regarding additional drafts of material regulatory provisions published during the reporting period, please see Section 4.1 to the 2021 Report on the Corporation's Business, as well as Section 2.3 to the Report of the Board of Directors for the first quarter of 2022.

insurer's activity, file an annual actuarial report that will review the implementation of the actuarial aspects of the solvency directives, opine on the underwriting policy and reinsurance arrangements, and report to the management and Board of Directors on the reliability and appropriateness of the calculation of the insurance liabilities.

law the practice generally accepted in the different insurance subsegments, and to prescribe that insurance compensation may be paid in different manners - in value or in kind, as a one-off payment or in installments. It is also suggested to prescribe in the law's general part, that insurance benefits shall be calculated based on one of two principles: the indemnity principle and the compensation principle.
Set forth below is a summary description of trends, events and developments in the group's macroeconomic environment, that have or are expected to have an effect on the group.
During the reporting period, the GDP data for the first quarter were published which reflected a surprising 1.6% contraction of the economy due to the spread of the Omicron variant in Israel and globally during that period, and a significant cut in government spending. Government deficit decreased to 0.6% in April. In June, annual inflation increased by 4.1%, which is higher than the upper end of the inflation target. In view of the high inflation rate, the increase in bonds' yields, and the start of a series of interest rate hikes in the USA, the Bank of Israel also opted to increase interest rates (from 0.1% to 0.75%), which was higher than market expectations. The unemployment rate decreased to 3.5% in April, but increased slightly to 3.7% in May. At the end of June, it was decided to prorogate the Knesset. As from the beginning of May, TA 125 Index joined the slumps of capital markets across the world.
The TA 125 Index has fallen by 10.2% in the reporting period; the 10-year yield shot up from 2.16% to 2.70%. The Tel-Bond 60 Index declined by 3.2%. The Shekel has devalued against most of the currencies. The shekel has devalued to a level of NIS 3.49 per USD 1 and a level of NIS 3.59 per EUR 1.
The Bank of Israel continued to increase its interest rate, reaching a level of 2.00%; according to the Bank of Israel's estimates, its interest rate will reach 2.75% in the second quarter of 2023. Inflation continued to increase in July, reaching annual levels of 5.2%, which is lower than in other countries across the world, due to, among other things, a higher stability in electricity prices. Inflation expectations regarding the forthcoming year decreased sharply to 2.6%, in view of the continued strengthening of the Shekel, the decrease in commodity prices across the world, and the increasing indications of an economic slowdown going forward. ??? The growth rate for the first quarter was reduced to 2.7%, but the growth rate for the first quarter increased by a surprising 6.8%. The Bank of Israel reduced its growth forecast for 2022 from 5.5% to 5.0%, and for 2023 from 4.0% to 3.5%. Since the beginning of July, the Shekel shot up sharply against the currency basket, and especially against the Euro, which has devalued against many currencies across the world. Subsequent to balance sheet date, a military conflict

broke out in the Gaza Strip, which lasted several days; the disruption to the economic activity as a result of the conflict was negligible. The Israeli Consumer Confidence Survey recorded a sharp decline from 99 points to 71 points. The TA 125 Index increased by 11.2% in the period, the yield of 10-year government bonds declined to 2.51%, the TEL-Bond 60 Index increased by 1.1%, and the shekel strengthened against most currencies; against the dollar, the shekel strengthened to levels of NIS 3.26 per one USD, and against the Euro it strengthened to levels of NIS 3.28 per one Euro.
In the first quarter, the US economy contracted by 1.6%, due to the restrictions placed in order to stop the spread of the Omicron variant; however, according to Bloomberg's economists survey, growth in the US economy will resume later this year, with growth figures for 2022 projected to reach 2.7%. Surveys conducted among Chief Procurement Officers in the manufacturing sector in May also reflected continued expansion - 55.4 points, and unemployment in the USA decreased in April to 3.6%. In May, inflation rates in the USA increased to 8.6%. Companies' reports for the first quarter were mostly better than expected; 78% of S&P 500 companies presented results that were better than expected; however, the results of prominent retailers, such as Walmart and Target, were disappointing, and this caused slumps in equity markets. Despite the weakness in equity markets, the Federal Reserve increased the interest to 1.75%. The contracts in respect of the Federal Reserve interest started factoring in hikes of up to 3.00% at the end of the year. In the Eurozone, the central bank is extremely cautious with its interest rate hikes due to the fear that the Eurozone's economies will be adversely affected, and market expectations are that a first hike will only take place in July; the pressure to increase interest rates alongside companies' difficulty to pass on price increases to consumers, and the damage to the economy due to the war between Russia and Ukraine weighed on equity markets for most of the period. However, towards the end of the period, equity markets managed to recover; this recovery was also triggered by dovish indications from the Federal Reserve.
The yield on 10-year bonds in the USA shot up to 3.01%; the S&P 500 slumped by 16.5%, with technology companies leading the trend, and despite increases in energy sector shares. In Europe, the EURO-STOXX slumped by 11.4%; the Euro has weakened against the Dollar, reaching levels of EUR 1.05 per USD 1.
After it contracted in the first quarter, the US economy continued to contract in the second quarter as well (by 0.9%), which meets the criteria for recognizing the US economy in the first half of the year as having fallen into "recession". However, the current macro data have been surprisingly good again and reflected an expansion of the economy. The labor market was characterized by a higher-than-expected number of jobs were created (528 thousand) compared with only 250 thousand jobs that were expected

to be created; factory orders increased by 2%, compared with an expected increase of 1.2%; mortgages given increased by 1.2%, and the survey of procurement managers in the industry (ISM) described a higher-than-expected expansion - 52.8 points. On the other hand, commodity prices continued to decline sharply, inflation in the USA in July was surprisingly static (0.0%) which supported the decrease in yields of bonds in the long tenor of the curve. On the other hand, in the short tenor of the curve, yields continued to increase due to further hikes in the Federal Reserve's interest rate, which reached a level of 2.50%. The opposite trends in yields of short vs. long duration bonds has driven the yield curve deep into negative territory, which indicates that the economy will fall into recession in a time range of a year to two years. The war between Russia and Ukraine has continued, and so did the disruption to the supply of gas from Russia to Europe, which threatens to trigger an even worse slowdown in the Eurozone's economy (which has grown in the second quarter by 0.6% - less than expected). The Euro responded with devaluation, to the extent that its exchange rate was even lower than that of the US Dollar; this was despite the fact that the European Central Bank's hike in interest rate was higher than expected (which moved interest rates away from negative territory), due to the continued hitting up of inflation in the Eurozone - reaching annual levels of 8.9% in July. The IMF reduced its growth forecast for 2022 from 3.6% to 3.2%; 2023 - 2.9%. The geopolitical tensions between China and Taiwan have escalated; this involved threats by the Chinese, which included military drills of the Chinese army around Taiwan, and warnings issued by the west.
The yield on 10-year US bonds declined slightly to 2.97%, the S&P 500 Index increased by 11.7%, the Euro-STOXX increased by 8.0%; and the euro devalued against the USD, reaching an exchange rate of 1.00.
The group's business strategy and targets constitute forward-looking information, as defined in Section 32A of the Securities Law, and are based on the data and information available to the group as of the report date, its plans as a result thereof, the market situation and the group's position. The group's business strategy and targets may change from time to time. In addition, the achievement of the group's targets and strategy is uncertain and is not under the sole control of the group. The group's business strategy and targets may not materialize due to, among other things, changes in the group's priorities, new needs of the group, market developments, macro changes, other business opportunities, etc.

The multi-year strategic plan - which was approved in December 2020 - is based on four fundamental principles: yield-focused growth, technological innovation and efficiency, maximization of the portfolio's value and capital management, all of which are relevant to the group's key areas of activity: insurance, asset management, agencies and credit. Since the publication of the plan, the Company has acted consistently to implement and execute it. The Company reviews its targets from time to time in the light of its achievements and market conditions; accordingly, in March 2022, the Company's Board of Directors adopted an update to the strategic plan (hereinafter - the "Strategic Plan"), as part of which the Company's targets for the plan's period were updated as described in the chart below.

The interim targets are based on (a) multi-year work plans for a 5-year period (from its approval date); (b) an assumption of net return on investment of 3%. Compared to the plan's objective, actual results are based on the actual returns in the financial markets in Israel and around the world, macroeconomic growth, the Company's results and other variables. For the Company's actual results taking into account a real 3% return, see Sections 5.4-5.6.

The group's operations are affected by constant changes in regulations and regulatory reforms. In addition, as the controlling shareholder of institutional entities, the group must also deal with the minimum capital requirements that apply to the activity of the institutional entities, which impose, among other things, restrictions on dividend distribution by the institutional entities.
The group's operations and results are significantly affected by the capital markets, including, among other things, the low-interest environment that has implications for its insurance liabilities and on the returns embodied in the group's financial asset portfolios, and consequently - on the management fees and financial margins from investments as well.

Assets under management as of June 30, 2022
Total assets under management by provident funds, excluding guaranteed return provident fund tracks, pension funds, ETFs, and customers' investment portfolios are not included in the Financial Statements. Proceeds in respect of investment contracts are not included in premiums; rather, they are charged directly to liabilities in respect of insurance contracts and investment contracts.
For further details on the premiums in the various operating segments, please see Note 3 to the Financial Statements.
Premiums, gross, contributions towards benefits and proceeds
in respect of investment contracts for 1-6/2022




Set forth below are key data from the consolidated balance sheets (in NIS billion):
Total financial assets in respect of yield-dependent contracts and cash and cash equivalents in respect of yield-dependent contracts as of June 30, 2022, amounted to approximately NIS 95.2 billion, compared to approximately NIS 87.3 billion as of June 30, 2021, and NIS 97.1 billion as of December 31, 2021.
Other assets as of June 30, 2022 amounted to NIS 50.9 billion, compared with NIS 45.6 billion as of June 30, 2021 and NIS 46.5 billion as of December 31, 2021.
Liabilities in respect of insurance contracts and yield-dependent investment contracts amounted to approximately NIS 93.1 billion as of June 30, 2022, compared to approximately NIS 86.2 billion as of June 30, 2021, and NIS 95.6 billion as of December 31, 2021.
Other liabilities as of June 30, 2022, amounted to NIS 43.0 billion, compared with NIS 37.9 billion as of June 30, 2021, and NIS 38.1 billion as of December 31, 2021.
The increase in other assets a d ltner liabilities stems, among other things, from Excellence's (a Company subsidiary) performance of spread transactions involving financial instruments; the said transactions are presented at fair value through profit or loss. Those transactions are presented in the Company's books of account at their gross amount. Spread transactions include derivatives, underlying assets, credit and deposits, which are managed by the Company as a single financial transaction, whose purpose is to fix the spread with no exposure to market risk or third party credit risk. These transactions are normally conducted with banking corporations with a maximum ILAAA
rating, in dedicated accounts that the bank may offset against one another. As of the financial statements date, the income generated from the said spread transactions is immaterial. In view of the increase in this activity, the Company is currently assessing the option of entering into an agreement with the bank in connection therewith; such an agreement will be in line with the transaction's characteristics as a single transaction settled on a net cash flow basis.
As from the financial statements as of March 31, 2022, the Company takes into account a 3% real return for analysis purposes in the health insurance subsegment also on its LAT reserve for the individual long-term care subsegment; the Company reclassified its comparative figures.
As from the financial statements as of June 30, 2022, the Company separates - for analysis purposes - the UGL component (excess of illiquid assets) in the property and casualty insurance segment from its underwriting profits, and classifies it to interest effects. The Company reclassified the comparative figures.
5.4.1.4. In the life insurance and savings segment, the profitability analysis is based on a breakdown to underwriting profits - which assumes a real return of 3%, including income from variable management fees in the profit participating portfolio based on said rate, fixed management fees and a financial margin in guaranteed return policies, which assumes said return both for the free portion and non-free portion of the portfolio,

investment income after offsetting return credited to policyholders, and profit stemming from capital market effects, which include income from nostro investments and management fees calculated above or below a real return of 3%, the effect of the interest rate curve, including changes in the K factor, and other Special Items.
5.4.1.5. In order to separate the financial results between profits attributed to insurance and profits arising from other core activities, the Company splits the "other" segment. The split is made for convenience purposes and the Company views the capital and unattributed segment as a single operating segment.
The Company allocates the assets which are not measured at fair value in accordance with the provisions of the law and Company's procedures, and specifically the allocation in accordance with the consolidated circular on testing the appropriateness of the LAT reserve (see Note 3 to the financial statements). This allocation may have an effect on investment income allocated to the different segments.
Financial liabilities that serve the Company's equity requirements and finance expenses in respect thereof are not allocated to the operating segments. In the capital segment, the financial margin arises from investment income, with a 3% real return assumption, net of actual finance expenses.

(*) Pension and provident - the Company decided to launch a new operating segment - "asset management - pension and provident" as from December 2021.
For the effects on the results at the segment level, please see details in Sections 5.5-5.6 below.


(*) Please see Section 5.4.1.
(**) For information about the Special Items at segment level, see Section 5.4.5, and results at segment level in Sections 5.5-5.6 below.
(***) Reclassified.

Operating profit after deducting effects of the capital market, Special Items and interest increased by NIS 287 million in the reporting period, compared with the corresponding quarter last year. In the reporting period, the negative nominal return from nostro investments was (0.4%). After transferring annual real return of 3%, and an amount in respect of variable management fees, which is calculated based on the said real return, the negative effect of the capital market after the said deduction is NIS 1.553 million, see Section 5.4.1 regarding the review of sources of profit. Total decrease in investment income (in excess of real return of 3%) in the reporting period compared to the corresponding period last year amounted to NIS 2,358 million. The said decrease is in respect of the change in investment income, which decreased in the reporting period by NIS 1,978 million compared to the corresponding period last year (in excess of real return of 3%), in view of the slumps in financial markets in Israel and globally, and a NIS 380 million change in collection of variable management fees (in excess of real return of 3%) in the reporting period compared to the collection in the corresponding quarter last year, due to the slumps in financial markets in Israel and globally, which caused a decrease in the value of planholders' portfolio in the reporting period compared with the corresponding period last year.
As of June 30, 2022, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 507 million, before tax (as of the report publication date - NIS 421 million before tax).
The decrease in investment income was partially offset against an increase in the risk-free interest rate curve in the reporting period compared with the corresponding period last; this increase caused a NIS 1,182 million decrease in insurance reserves in the reporting period, compared with the corresponding period last year.
The total net effect of the interest and capital market effects (in excess of a real return of 3%) in the reporting period amounted to a pre-tax loss of NIS 451 million as reflected in the above chart. During the reporting period, the special items line item decreased by NIS 24 million compared with the corresponding period last year; most of the decrease stemmed from the recognition of a higher one-off earning in the corresponding period last year as a result of assuming control in Gama, and compared to the recognition of a one-off earning from the transfer of the Company's rights in Phoeniclass Ltd. to The Phoenix Insurance and assuming control in Capital (for more information, see Section 1.2.5.1 above) and in a subsidiary agency.
Furthermore, in the reporting period, the special items line item includes the effect of a study on retirement age and pension uptake rates (see Section 1.2.7 above), which was partially offset by revising the assumptions of the mortality schedules (see Section 1.2.6 above).
For further details regarding the effects on the results at the segment level, please see Sections 5.5-5.6 below.

(*) See Section 5.4.1.
(**) For information about the Special Items at segment level, see Section 5.4.5, and results at segment level in Sections 5.5-5.6 below.


As of June 30, 2022, the Company's LAT reserve amounts to NIS 477 million. For information on the sensitivity to interest rates, see Section 6 and Section 2.1.5.
| 1-6/2022 | 1-6/2021 | 4-6/2022 | 4-6/2021 | 1-12/2021 | |
|---|---|---|---|---|---|
| Return on shareholders' equity for the period (based on comprehensive income for the period) (*) |
11.4% | 29.6% | 7.9% | 44.2% | 26.3% |
(*) Return on equity is calculated based on the income for the period or comprehensive income for the period attributable to Company's shareholders, adjusted to reflect a one-year period and divided by the average equity for the period.

Following is a description of the developments in the group's financial performance, by operating segment:
5.5. Description of developments in core areas - insurance
Set forth below is a composition of the main effects and changes on the results of the property and casualty insurance subsegment for the reporting period compared to the corresponding period last year (in NIS million, before tax):

(*) Reclassified, see Section 5.4.1.3 above.
The NIS 95 million decrease in underwriting profits in the reporting period compared with the corresponding period last year stems mainly from the motor property subsegment as a result of an increase in costs of claims and in incidence in the reporting period; the Company is taking steps to improve underwriting results in the motor property subsegment. The increase in underwriting profits in the liability subsegments in the reporting period, compared with the corresponding period last year, stems mainly from a positive development in claims in respect of previous years in the employers liability insurance subsegment.
The NIS 609 million decrease in investment income in the reporting period compared to the corresponding period last year stemmed from slumps in financial markets in Israel and across the world during the reporting period compared with the corresponding period last year.
The NIS 60 million increase in the effect of interest stems mainly from the revision of illiquid assets in the motor property subsegment to their fair value, see Section 5.4.1.3 above, and Note 8A(6) to the financial statements.

Following is the composition of the main effects and changes on the results of the property and casualty insurance subsegment for the second quarter of 2022 compared to the corresponding quarter last year (in NIS million before tax):

(*) Reclassified, see Section 5.4.1.3 above.
The NIS 29 million decrease in underwriting profits in the second quarter of the reporting period compared with the corresponding quarter last year stems mainly from the motor property subsegment as a result of an increase in costs of claims and in incidence in the reporting period; the Company is taking steps to improve underwriting results in the motor property subsegment. On the other hand, underwriting profits in the other property subsegments improved in the second quarter of the reporting period, compared with the corresponding quarter last year, mainly in the business insurance and personal accidents insurance subsegments.
The NIS 359 million decrease in investment income in the second quarter of the reporting period compared to the corresponding period last year stemmed from slumps in financial markets in Israel and across the world in the second quarter of the reporting period compared with the rallies in the corresponding quarter last year. The NIS 64 million increase in the effect of interest stems mainly from the revision of illiquid assets in the motor property subsegment to their fair value, see Section 5.4.1.3 above, and Note 8A(6) to the financial statements.


Set forth below is the pre-tax underwriting profit in the various subsegments of property and casualty insurance (P&C) for the reporting period compared with the corresponding period last year (in NIS million):

(*) Reclassified, see Section 5.4.1.3 above.
The NIS 95 million decrease in underwriting profits in the reporting period compared with the corresponding period last year stems mainly from the motor property subsegment as a result of an increase in costs of claims and in incidence in the reporting period.
The increase in underwriting profits in the liability subsegments in the reporting period, compared with the corresponding period last year, stems mainly from a positive development in claims in respect of previous years in the employers liability insurance subsegment.
The increase in underwriting profits in other property subsegments compared with the corresponding period last year stems mainly from improvement in underwriting profits in the property loss insurance and home insurance subsegments.



The NIS 29 million decrease in underwriting profits in the second quarter of the reporting period compared with the corresponding quarter last year stems mainly from a NIS 22 million decrease in the motor property subsegment as a result of an increase in costs of claims and in incidence. The Company is taking steps to improve its underwriting profits in the motor property subsegment. The NIS 8 million decrease in underwriting profits in the compulsory motor insurance in the second quarter of the reporting period compared with the corresponding quarter last year stems mainly from an increase in losses in respect of the current year compared with the corresponding quarter last year.
On the other hand, underwriting profits in the other property subsegments improved in the second quarter of the reporting period by NIS 8 million, compared with the corresponding quarter last year, mainly in the business insurance and personal accidents insurance subsegments.
| Motor property (*) | |||||||
|---|---|---|---|---|---|---|---|
| In % | |||||||
| 1-6/2022 | 1-6/2021 | 4-6/2022 | 4-6/2021 | 1-12/2021 | |||
| Gross loss ratio | 86.0% | 71.0% | 69.8% | 76.9% | 80.3% | ||
| Retention loss ratio |
86.1% | 71.0% | 69.9% | 76.9% | 80.3% | ||
| Gross combined ratio |
110.7% | 98.7% | 96.0% | 107.7% | 108.9% | ||
| Retention combined ratio |
110.7% | 98.7% | 96.0% | 107.7% | 108.9% |
| Property and other subsegments | |||||||
|---|---|---|---|---|---|---|---|
| In % | |||||||
| 1-6/2022 | 1-6/2021 | 4-6/2022 | 4-6/2021 | 1-12/2021 | |||
| Gross loss ratio | 35.0% | 31.1% | 34.1% | 32.9% | 33.2% | ||
| Retention loss ratio |
21.9% | 21.2% | 20.8% | 22.5% | 23.5% | ||
| Gross combined ratio |
62.5% | 57.5% | 63.4% | 61.4% | 61.2% | ||
| Retention combined ratio |
51.9% | 56.6% | 59.6% | 67.7% | 60.4% |
(*) Includes UGL (value of illiquid assets); for more information, see Section 5.5.1 above.
Profits on investments affects the profitability of this segment, some of whose products (such as long-term care coverage) are characterized by accrual of significant reserves over long periods. Investment profits are affected by financial market fluctuations, as well as changes in interest rates and the rate of change in the Israeli consumer price index, which affect the yields on liquid financial asset portfolios held against insurance and contingent claims reserves. It should be noted that at this stage, the Company has ceased to market long-term care insurance policies in view of the guaranteed return in long-term care insurance plans, and the complexity of the related reinsurance in this area.


The NIS 39 million increase in underwriting profits in the reporting period compared with the corresponding period last year is mainly due to an increase in underwriting profits from long-term care insurance policies, and specifically underwriting profits from critical illness and personal accidents insurance policies compared with the corresponding period last year.
The NIS 45 million decline in investment income in the reporting period compared with the corresponding period last year stems from slumps in financial markets in Israel and globally during the reporting period, compared with the corresponding period last year.
The impact of increase in the risk-free interest rate curve in the reporting period compared with the decline in the risk-free interest rate curve in the corresponding period last year caused a NIS 709 million increase in profit, including the change in excess value of illiquid assets carried to LAT.
In addition, the results in the reporting period compared with the corresponding period last year were affected from a NIS 121 million increase in profit in the Special Items line item. Most of the increase is attributed to the recognition of a one-off earning of NIS 99 million as a result of the transfer of the Company's rights in Phoeniclass Ltd. to The Phoenix Insurance; this one-off earning was recognized in LAT as part of the excess value of illiquid assets; for more information, see Section 1.2.10 to the Report of the Board of Directors as of March 31, 2022.
For further details, please see Note 8 to the Financial Statements.


(*) Reclassified, see Section 5.4.1.3 above.
The NIS 15 million increase in underwriting profits in the second quarter of the reporting period compared with the corresponding quarter last year is mainly due to an increase in profit from individual long-term care insurance policies and critical illness insurance policies.
The NIS 7 million decline in investment income in the reporting period compared with the corresponding period last year stems from slumps in financial markets in Israel and globally during the reporting period, compared with the corresponding period last year.
The impact of increase in the risk-free interest rate curve in the reporting period compared with the decline in the risk-free interest rate curve in the corresponding period last year caused a NIS 160 million increase in profit, including the change in excess value of illiquid assets carried to LAT.
For further details, please see Note 8 to the Financial Statements.




(*) Reclassified, see Section 5.4.1.3 above.

The NIS 39 million increase in underwriting profits in the reporting period compared with the corresponding period last year is mainly due to individual long-term care insurance policies (NIS 19 million), stemming mainly from the increase in the CPI. The NIS 16 million increase in underwriting profits from long-term policies in the reporting period compared with the corresponding period last year is mainly due to an increase in underwriting profits from critical illness and personal accidents insurance policies.

(*) Reclassified, see Section 5.4.1.3 above.
The NIS 15 million increase in underwriting profits in the second quarter of the reporting period compared with the corresponding quarter last year is mainly due to a NIS 6 million increase in profit from individual long-term care insurance policies, mainly due to the increase in the CPI. The NIS 7 million increase in underwriting profits from long-term policies in the reporting period compared with the corresponding period last year is mainly due to an increase in underwriting profits from critical illness insurance policies.
5.5.3.1. Profits on investments have a material effect on the profitability of this segment, which is characterized by accrual of significant reserves over long periods. Investment profit are affected by financial market fluctuations, as well as changes in interest rates and the rate of change in the Israeli consumer price index, which affect the yields on liquid financial asset portfolios held against insurance and contingent claims reserves. It should be noted that a significant portion of the investment income was carried to participating policies and has no direct effect on the Company's results.


The results in the reporting period were affected by the NIS 112 million increase in underwriting profits, which stemmed mainly from an increase in the fixed management fees that was partially offset against the decrease in the profitability of the life insurance products, and from an improvement in the historical effects as a result of a decrease in annuities uptake rate compared with the expected uptake.
In addition, compared with the corresponding period last year, the results in the reporting period were mainly impacted by the decrease in investment income that were offset against the increase in risk-free interest that triggered a decrease in insurance reserves. The NIS 665 million decrease in investment income (in excess of real return of 3%) stemmed from a NIS 285 million decrease in income from the nostro portfolio, mainly due to the slumps in financial markets in Israel and globally, and from a NIS 380 million decrease in variable management fees (in excess of real return of 3%) as a result of non-collection of variable management fees in the first quarter of the reporting period compared to the collection in the corresponding period last year, due to the slumps in financial markets in Israel and globally, which caused a decrease in the value of planholders' portfolio in the reporting period compared with the corresponding period last year.
The impact of the change in interest in the reporting period compared with the corresponding period last year caused a NIS 413 million increase in profit mainly due to the increase in the interest rate curve in the reporting period compared with the decline in the interest rate curve in the corresponding period last year, which had a direct effect on the supplementary retirement pension reserve.As of June 30, 2022, the effect of the decline in planholders' portfolios will lead to non-

collection of future variable management fees in the amount of approx. NIS 507 million, before tax (as of the report publication date - NIS 421 million before tax).
The NIS 44 million decrease in the special items line item stems from a NIS 84 million increase in profit in the reporting period mainly as a result of the effects of a study on retirement age and pension uptake rates, which was partially offset by reimplementation regarding the revision of mortality assumptions (for more information, see Sections 1.2.6 and 1.2.7), compared with a NIS 128 million increase in profit in the corresponding period last year as a result of changes in assumptions and model revisions.

The results in the second quarter of the reporting period were affected by the NIS 94 million increase in underwriting profits, which stemmed mainly from an increase in the fixed management fees that was partially offset against the decrease in the profitability of the life insurance products, and from an improvement in the historical effects as a result of a decrease in annuities uptake rate compared with the expected uptake.
Compared with the corresponding quarter last year, the results in the second quarter of the reporting period were mainly impacted by the decrease in investment income that were offset against the increase in risk-free interest that triggered a decrease in insurance reserves. The NIS 258 million decrease in investment income (in excess of real return of 3%) stemmed from a NIS 82 million decrease in income from the nostro portfolio, mainly due to the slumps in financial markets in Israel and globally, and from a NIS 176 million decrease in variable management fees (in excess of real return of 3%) as a result of non-collection of variable management fees in the second quarter of the reporting period compared to the collection in the corresponding quarter last

year, due to the slumps in financial markets in Israel and globally, which caused a decrease in the value of planholders' portfolio in the second quarter of the reporting period compared with the corresponding quarter last year.
As of June 30, 2022, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 507 million, before tax (as of the report publication date - NIS 421 million before tax).
The impact of the change in interest in the second quarter of the reporting period compared with the corresponding quarter last year caused a NIS 130 million increase in profit mainly due to the increase in the interest rate curve in the second quarter of the reporting period compared with the decline in the interest rate curve in the corresponding quarter last year, which had a direct effect on the supplementary retirement pension reserve.
The NIS 38 million decrease in the special items line item stems from a NIS 103 million increase in profit in the second quarter in the reporting period mainly as a result of the effects of a study on retirement age and pension uptake rates, which was partially offset by reimplementation regarding the revision of mortality assumptions (for more information, see Sections 1.2.6 and 1.2.7), compared with a NIS 141 million increase in profit in the corresponding quarter last year as a result of changes in assumptions and model revisions.



| 1-6/2022 | 1-6/2021 | 4-6/2022 | 4-6/2021 | 1-12/2021 | |
|---|---|---|---|---|---|
| In NIS million | |||||
| Investment gains (losses) credited to policyholders net of management fees Management fees |
(5,442) 300 |
5,916 631 |
(4,272) 149 |
3,071 307 |
10,222 1,221 |
(*) Excluding investment gains credited (debited) to policyholders in the health insurance segment.
Set forth below are the nominal returns on participating policies in respect of policies issued through 2004 (from 1992 to 2003):
| Policies issued up to 2004 (Fund J) | |||||
|---|---|---|---|---|---|
| 1-6/2022 | 1-6/2021 | 4-6/2022 | 4-6/2021 | 1-12/2021 | |
| Nominal returns before payment of management fees Nominal returns after |
(5.54%) | 9.55% | (4.68%) | 5.00% | 17.40% |
| payment of management fees |
(5.84%) | 8.01% | (4.82%) | 4.31% | 14.44% |

| Policies issued up to 2004 (Fund J) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1-6/2022 | 1-6/2021 | 4-6/2022 | 4-6/2021 | 1-12/2021 | |||||
| Real returns before payment of management fees Real returns after |
(8.41%) | 8.03% | (6.48%) | 3.65% | 14.64% | ||||
| payment of management fees |
(8.70%) | 6.52% | (6.62%) | 2.97% | 11.76% |
Fluctuations in these returns are a function of capital market returns in Israel and abroad, changes in the consumer price index, and changes in the exchange rate of the shekel against major currencies.
| Policies issued from 2004 and thereafter | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1-6/2022 | 1-6/2021 | 4-6/2022 | 4-6/2021 | 1-12/2021 | |||||
| Nominal returns before payment of management fees Nominal returns after |
(6.61%) | 8.78% | (5.44%) | 4.40% | 15.33% | ||||
| payment of management fees Real returns before |
(7.05%) | 8.25% | (5.66%) | 4.15% | 14.25% | ||||
| payment of management fees Real returns after |
(9.44%) | 7.27% | (7.23%) | 3.06% | 12.63% | ||||
| payment of management fees |
(9.87%) | 6.75% | (7.45%) | 2.81% | 11.57% |

The NIS 875 million decrease in other capital gains in the reporting period compared with the corresponding period last year stems mainly from slumps in financial markets in Israel and globally.

The NIS 633 million decrease in other capital gains in the second quarter of the reporting period compared with the corresponding quarter last year, stems mainly from slumps in financial markets in Israel and globally.
The group manages various types of pension funds and provident funds through The Phoenix Pension and Provident Fund. In addition, the group manages - through Halman-Aldubi IEC Gemel Ltd. - the central provident fund for annuity of Israel Electric Corporation employees. As of the report date, the Company holds - directly and indirectly - 100% of the shares of The Phoenix Pension and Provident, and 100% of the shares of Halman-Aldubi IEC Gemel Ltd.
Set forth below is the composition of the main effects and changes on the results of the investment management - pension and provident subsegment for the reporting period compared to the corresponding period last year (in NIS million):

Set forth below is the composition of the main effects and changes on the results of the asset management - pension and provident segment for the second quarter of 2022 compared to the corresponding quarter last year (in NIS million):

The NIS 29 million and NIS 14 million increase in underwriting profits in the reporting period and in the second quarter, respectively, compared with the corresponding periods last year is mainly due to synergies arising from the acquisition of the Halman Aldubi investment house.
The NIS 18 million and NIS 10 million decline in investment income in the reporting period and in the second quarter, respectively, compared with the corresponding periods last year stems mainly from slumps in financial markets in Israel and globally during the reporting period, compared with rallies in the corresponding periods last year, which impacted the margins of a yield-guaranteed provident fund and the margins of the management company's nostro investments.
The increase in the special items line item in the reporting period and in the second quarter compared with the corresponding periods last year stems mainly from a one-off pre-tax profit of NIS 14 million as a result of the sale of the IRA portfolio, which was owned by Halman Aldubi.
The group manages provident and advanced education funds through The Phoenix Pension and Provident, a wholly owned subsidiary of the Company, which manages benefits and severance pay funds, advanced education funds, a central benefits and severance pay fund, a yield-guaranteed provident fund, an investment provident fund, a child long-term investment provident fund for savings, a self-directed benefits provident fund, and a personally managed advanced education fund. The pre-tax comprehensive income in the reporting period amounted to approximately NIS 54 million compared to approximately NIS 20 million during the corresponding period last year. The pre-tax comprehensive income in the second quarter in the reporting period amounted to approximately NIS 37 million compared to approximately NIS 8 million during the corresponding quarter last year.
Contributions towards benefits (NIS billion) Assets under management (NIS


billion)


Based on Ministry of Finance data,5 aggregate contributions towards benefits in the provident funds subsegment in the first half of 2022 totaled approximately NIS 27.0 billion, compared to a total of approximately NIS 26.9 billion in the corresponding half last year, reflecting an increase of approximately 0.1%. According to the Ministry of Finance data, as of June 30, 2022, total assets under management in the provident funds subsegment amounted to approximately NIS 644 billion, compared to approximately NIS 638 billion as of June 30, 2021, an increase of approximately 8.2%.
The group's pension subsegment is conducted through The Phoenix Pension and Provident, a wholly-owned subsidiary of the Company.
The pre-tax profit in the reporting period amounted to NIS 5 million compared with pre-tax profit of NIS 9 million in the corresponding period last year. the pre-tax comprehensive income in the second quarter in the reporting period amounted to approximately NIS 1 million compared to approximately NIS 7 million during the corresponding quarter last year.

Based on Ministry of Finance data,6 aggregate contributions towards benefits in the new comprehensive provident funds subsegment in the first half of 2022 totaled approximately NIS 27.7 billion, compared to a total of approximately NIS 23.7 billion in the corresponding half of last year, reflecting an increase of approximately 16.4%.
According to Ministry of Finance data, as of June 30, 2022, total assets under management in the new comprehensive pension funds subsegment amounted to a total of approximately NIS 574 billion, compared to approximately NIS 523 billion on June 30, 2021, an increase of approximately 9.6%.
5 Based on Gemel Net data.
6 Based on Pension Net data.
Most of the segment's activities are carried out through Excellence, and as from June 30, 2022, through The Phoenix Advanced Investments.

The NIS 5 million increase in operating profit in the reporting period compared with the corresponding period last year arises mainly from an increase in the interest spread from deposits and loans, which was offset against non-collection of variable management fees. The NIS 78 million increase in the special items line-item stems mainly from the recognition of a one-off capital gain as a result of assuming control in Capital (for more information, see Section 1.2.5.2), which was offset against an increase in acquisition expenses as a result of the growth strategy in the retail brokerage portfolio, and zero management fees in KSM.
Following is the composition of the main effects and changes on the results of the financial services segment for the second quarter of 2022 compared to the corresponding quarter last year (in NIS million):


The NIS 10 million increase in underwriting profits in the reporting period compared with the corresponding period last year arises mainly from an increase in the interest spread from deposits and loans, and from an increase in management fees.
The NIS 83 million increase in the special items line-item stems mainly from the recognition of a one-off capital gain as a result of assuming control in Capital (for more information, see Section 1.2.5.2), which was offset against an increase in acquisition expenses as a result of the growth strategy in the retail brokerage portfolio, and zero management fees in KSM.

Following is the composition of the main effects and changes on the results of the insurance agencies segment for the second quarter of 2022 compared to the corresponding quarter last year (in NIS million):


Most of the increase in the Insurance Agencies Segment's operating profit stems primarily from continued growth, increase in agencies' sales further to the continued implementation of the Company's strategy of acquiring new agencies and operations. Furthermore, the NIS 22 million increase in the special items line-item stems from assuming control in an agency held by a subsidiary agency of the Company.
In June 2021, Gama Management and Clearing Ltd. completed its IPO on the TASE following the Supplementary Prospectus for of the sale offer and initial public offering of shares, and listing of its shares on the TASE, dated May 31, 2021. Simultaneously with the execution of the Offering in accordance with the Prospectus, The Phoenix Investments purchased additional Gama shares, such that after the Offering and the acquisition of the Purchased Shares, The Phoenix Investments holds approximately 60% of Gama's issued and paid-up share capital and voting rights therein and became the controlling shareholder in Gama. During the reporting period, the Company consolidated Gama's financial statements for the first time.


Set forth below is the composition of the main effects and changes on the results of the credit segment for the second quarter of 2022 compared to the corresponding quarter last year (in NIS million):

It should be noted that Gama's operating profit in the reporting period is included based on full consolidation, subsequent to assuming control (60%), as described above, compared with the profit in the corresponding period last year, which was included in accordance with the Company's stake in Gama at the time (49%). The NIS 220 million decrease and the NIS 223 million decrease in the special items line item in the reporting period and in the second quarter of the reporting period, respectively, compared with the corresponding periods last year, arises from the recording of a one-off capital gain in the corresponding period last year as a result of assuming control in Gama.
Set forth below is the composition of the main effects and changes on the results of "other" segment and activity that is not attributed to activity segments in the reporting period compared to the corresponding period last year (in NIS million, before tax):

Following is the composition of the main effects and changes on the results of "other" segment and activity that is not attributed to activity segments in the second quarter of 2022 compared to the corresponding quarter last year (in NIS million before tax):


The consolidated cash flows from operating activities in the reporting period amounted to approximately NIS 839 million. The consolidated cash flows used in investing activities in the reporting period amounted to approximately NIS 241 million and included mainly a total of NIS 147 million used to purchase intangible assets and to capitalize costs of intangible assets, NIS 64 million used to purchase property, plant and equipment, and a total of NIS 58 million arising from investing activities in an associate. The consolidated cash flows provided by financing activities in the reporting period amounted to approximately NIS 711 million; the cash flows included, among other things, a total of NIS 1,306 million arising from the issuance of financial liabilities, a total of NIS 452 million used to repay financial liabilities, a total of NIS 369 million arising from short-term credit from banking corporations, and a total of NIS 56 million used to purchase Company's shares. The group's cash and cash-equivalent balances increased from a total of approximately NIS 15,940 million at the beginning of the reporting period to approximately NIS 17,249 million at the end of
the reporting period.
For liquidity purposes, the Company relies, among other things, on net financial assets and on distribution of dividends by some of its investees. Set forth below is a breakdown of the material investees for liquidity purposes.
It is hereby clarified that some of the investees are subject to regulatory provisions in addition to the distribution restrictions set in the Companies Law, 1999:
A. The Phoenix Insurance - the dividends from The Phoenix Insurance depend on the solvency ratio target set by the Board of Directors, which is higher than the minimum target set by the Banking Supervision Department; the dividends also depend on the policy set by the Board of Directors of The Phoenix Insurance, see Section 2.1 above.
For the purpose of making a conservative assessment of the Company's future cash flows, the Company assumes a payment of dividend by The Phoenix Insurance to the Company in accordance with the work plan.
The Company considers its holding in a Restricted Tier 1 capital instrument of The Phoenix Insurance, which is traded on the TACT-Institutionals trading platform as a source of liquidity, and classifies this holding as a financial investment.
B. The Phoenix Pension and Provident - the dividend paid by The Phoenix Pension and Provident depend on the capital requirements set by the Banking Supervision Department, and on The Phoenix Pension and Provident's dividend distribution policy. The Company does not expect payment of dividend by The Phoenix Pension and Provident in the next two years. However, for
purposes of the future cash flow, the Company takes into account the repayment of the loan it extended to The Phoenix Pension and Provident.
Furthermore, the Company controls the following entities which are not subject to special Regulatory Restrictions in addition to the Companies Law:
It should be noted that such work plans are reflected in the Company's targets as stated in Section 4 above.
Set forth below is a table providing a breakdown of the net financial debt (the table includes the following companies: the Company, The Phoenix Investments and The Phoenix Agencies as stated above, and does not include The Phoenix Insurance and The Phoenix Pension and Provident, which are subject to Regulatory Restrictions in addition to the distribution restrictions set out in the Companies Law, 1999):

| June 30, 2022 |
As of December 31, 2021 |
|
|---|---|---|
| Financial assets | ||
| Cash and cash equivalents | 184 | 154 |
| Other financial investments | 1,135 | 1,101 |
| Loans | ||
| Total assets | 1,318 | 1,255 |
| Less current maturities | ||
| current (*) Financial liabilities - |
35 | 316 |
| Current financial assets net of current | ||
| maturities | 1,284 | 940 |
| Non-current financial liabilities | ||
| Non-current financial liabilities | 1,418 | 1,130 |
| Other liabilities | 5 | 10 |
| Total liabilities | 1,423 | 1,140 |
| Net financial debt | (140) | (200) |
| LTV | 2% | 2% |
(*) The other financial investments include an investment in a Restricted Tier 1 capital instrument of The Phoenix Insurance, which is traded on the TACT-Institutionals trading platform, amounting to NIS 970 million (fair value as of June 30, 2022, in accordance with Fair Spread Ltd. data - NIS 992 million).
(**) The Company LTV is calculated as net financial debt as described above, in relation to the Company's market value as of March 31, 2022. For the calculation of LTV in accordance with financial covenants, please see Section 9.2 below.
Generally, during the reporting period there were no material changes in the exposure to market risks and the manner of management of those risks compared to what is described in the Q1 2022 report.
| NIS | Foreign currency | Other non monetary |
pension | company in | ETNs - linkage to |
Israeli insurance |
|||
|---|---|---|---|---|---|---|---|---|---|
| Non-linked | CPI-linked | items | companies in | Israel | various | company | Total | ||
| Intangible Assets | - | - - |
1,707,983 | 442,768 | 5,950 | - | 762,425 | 2,919,126 | |
| Deferred tax assets | - | - - |
60,747 | 63 | 6,233 | - | - | 67,043 | |
| Deferred acquisition costs | - | - - |
3,535 | 700,677 | - | - | 1,576,814 | 2,281,026 | |
| Property, plant & equipment | - | - - |
178,256 | 8,109 | 8,461 | - | 751,439 | 946,265 | |
| Investments in investees | 94,367 | 17,830 | - | 69,467 | - | 59 | - | 1,292,677 | 1,474,400 |
| Investment property in respect of yield-dependent | |||||||||
| contracts | - | - - |
- | - | - | - | 1,903,600 | 1,903,600 | |
| Investment property - other | - | - - |
- | - | - | - | 1,038,015 | 1,038,015 | |
| Reinsurance assets | - | - - |
- | - | - | - | 3,167,199 | 3,167,199 | |
| Credit for purchase of securities | 695,630 | - 58,370 |
- | - | - | - | - | 754,000 | |
| Current tax assets | - | 25,757 | - | - | - | 5,210 | - | 350 | 31,317 |
| Receivables and debit balances | 440,204 | - - |
- | 31,195 | 14,899 | - | 585,866 | 1,072,164 | |
| Premiums collectible | - | - - |
- | - | - | - | 933,629 | 933,629 | |
| Held-for-sale assets of disposal group | - | - - |
- | - | - | - | - | - | |
| Financial investments in respect of yield | |||||||||
| dependent contracts | - | - - |
- | - | - | - | 78,267,921 | 78,267,921 | |
| Financial investments for holders of bonds, ETNs, | |||||||||
| short ETNs, composite ETNs, deposit certificates | |||||||||
| and structured bonds | - | - - |
- | - | - | 217,000 | - | 217,000 | |
| Credit in respect of factoring, clearing and | |||||||||
| financing | - | - - |
- | - | 3,208,322 | - | - | 3,208,322 | |
| Liquid debt assets | 10,309 | 20,328 | 847 | - | 57,742 | - | - | 6,312,247 | 6,401,473 |
| Non-liquid debt assets | 1,588,980 | 422,019 | 87,000 | - | 977,404 | 11,508 | - | 14,106,324 | 17,193,235 |
| Shares | - | - - |
344,823 | 24,792 | - | - | 2,144,175 | 2,513,790 | |
| Other | 1,000 | - 22,309 |
63,881 | 25,961 | - | - | 4,358,036 | 4,471,187 | |
| Cash and cash equivalents in respect of yield | |||||||||
| dependent contracts | - | - - |
- | - | - | - | 14,789,357 | 14,789,357 | |
| Other cash and cash equivalents | 375,328 | - 22,000 |
- | 69,233 | 10,909 | - | 1,981,770 | 2,459,240 | |
| - | - | ||||||||
| Total assets | 3,205,818 | 485,934 | 190,526 | 2,428,692 | 2,337,944 | 3,271,551 | 217,000 | 133,971,844 | 146,109,309 |
| Liabilities in respect of insurance contracts and | |||||||||
| non-yield-dependent investment contracts | - | - - |
- | 989,995 | - | - | 24,325,518 | 25,315,513 | |
| Liabilities in respect of insurance contracts and | |||||||||
| yield-dependent investment contracts | - | - - |
- | - | - | - | 93,114,756 | 93,114,756 | |
| Liabilities in respect of deferred taxes | - | - - |
60,490 | 72,634 | - | - | 421,249 | 554,373 | |
| Liability for employee benefits, net | 20,648 | - - |
- | 881 | 6,158 | - | 55,833 | 83,520 | |
| Liability in respect of current taxes | - | 17,961 | - | - | 8,859 | 2,085 | - | 44,561 | 73,466 |
| Payables and credit balances | 536,572 | - - |
- | 252,697 | 26,567 | - | 2,442,802 | 3,258,638 | |
| Liabilities for bonds, ETNs, short ETNs, composite | |||||||||
| ETNs and structured bonds | - | - - |
- | - | - | 215,058 | - | 215,058 | |
| Payable dividend | - | - - |
- | - | - | - | - | - | |
| Financial liabilities | 3,060,659 | 1,172,337 | 177,000 | - | 3,624 | 2,926,171 | - | 6,092,210 | 13,432,001 |
| Total liabilities | 3,617,879 | 1,190,298 | 177,000 | 60,490 | 1,328,690 | 2,960,981 | 215,058 | 126,496,929 | 136,047,325 |
| Total exposure | (412,061) | (704,364) | 13,526 | 2,368,202 | 1,009,254 | 310,570 | 1,942 | 7,474,915 | 10,061,984 |
| NIS | Other non | Provident and | Credit | ETNs - | Israeli | ||||
|---|---|---|---|---|---|---|---|---|---|
| Non-linked | CPI-linked | Foreign currency | monetary items |
pension companies in |
companies in Israel |
linkage to various |
insurance company |
Total | |
| Intangible Assets | - | - | - | 1,514,265 | 441,313 | 3,577 | - | 696,110 | 2,655,265 |
| Deferred tax assets | - | - | - | 54,992 | 607 | 3,239 | - | - | 58,838 |
| Deferred acquisition costs | - | - | - | - | 432,498 | - | - | 1,437,910 | 1,870,408 |
| Property, plant & equipment | - | - | - | 149,732 | 21,954 | 9,242 | - | 663,770 | 844,698 |
| 32,118 | 16,810 | - | 43,643 | 762 | - | - | 482,215 | 575,548 | |
| Investments in investees Investment property in respect of yield-dependent |
|||||||||
| contracts | - | - | - | - | - | - | - | 1,938,918 | 1,938,918 |
| Investment property - other | - | - | - | - | - | - | - | 1,060,819 | 1,060,819 |
| Reinsurance assets | - | - | - | - | - | - | - | 2,605,989 | 2,605,989 |
| Credit for purchase of securities | 430,000 | - | 48,000 | - | - | - | - | - | 478,000 |
| Current tax assets | - | 17,678 | - | - | 1,702 | 8,750 | - | 152 | 28,282 |
| Receivables and debit balances | 207,001 | - | - | - | 50,099 | 6,691 | - | 430,527 | 694,318 |
| Credit in respect of factoring, clearing and | |||||||||
| financing | - | - | - | - | - | 2,283,531 | - | - | 2,283,531 |
| Premiums collectible | - | - | - | - | - | - | - | 699,620 | 699,620 |
| Held-for-sale assets of disposal group | - | - | - | 40,957 | 3,447 | - | - | 1,836,709 | 1,881,113 |
| Financial investments in respect of yield | |||||||||
| dependent contracts | - | - | - | - | - | - | - | 74,114,354 | 74,114,354 |
| Financial investments for holders of bonds, ETNs, | |||||||||
| short ETNs, composite ETNs, deposit certificates | |||||||||
| and structured bonds | - | - | - | - | - | - | 229,000 | - | 229,000 |
| Liquid debt assets | 13,090 | 13,816 | - | - | 68,500 | - | - | 7,167,362 | 7,262,768 |
| Non-liquid debt assets | 537,254 | 235,656 | 14,000 | - | 904,997 | 11,500 | - | 12,248,364 | 13,951,771 |
| Shares | - | - | - | 98,619 | 18,662 | 994 | - | 2,570,777 | 2,689,052 |
| Other | 1,000 | - | 7,400 | 19,931 | 37,963 | - | - | 3,684,537 | 3,750,831 |
| Cash and cash equivalents in respect of yield | |||||||||
| dependent contracts | - | - | - | - | - | - | - | 11,098,327 | 11,098,327 |
| Other cash and cash equivalents | 312,301 | - | 29,712 | - | 68,458 | 3,558 | - | 1,690,949 | 2,104,978 |
| Total assets | 1,532,764 | 283,960 | 99,112 | 1,922,139 | 2,050,962 | 2,331,082 | 229,000 | 124,427,409 | 132,876,428 |
| Liabilities in respect of insurance contracts and | |||||||||
| non-yield-dependent investment contracts | - | - | - | - | 936,175 | - | - | 23,360,868 | 24,297,043 |
| Liabilities in respect of insurance contracts and | |||||||||
| yield-dependent investment contracts | - | - | - | - | - | - | - | 86,163,297 | 86,163,297 |
| Liabilities in respect of deferred taxes | - | - | - | 23,670 | 63,824 | - | - | 741,093 | 828,587 |
| Liability for employee benefits, net | 17,495 | - | - | - | 4,736 | 5,428 | - | 54,392 | 82,051 |
| Liability in respect of current taxes | - | 18,533 | - | - | 8,577 | - | - | 52,996 | 80,106 |
| Payables and credit balances | 295,344 | - | - | - | 121,972 | 27,561 | - | 2,124,333 | 2,569,210 |
| Held-for-sale liabilities of disposal group | - | - | - | 9,113 | 1,348 | - | - | 869,904 | 880,365 |
| Liabilities for bonds, ETNs, short ETNs, composite | |||||||||
| ETNs and structured bonds | - | - | - | - | - | - | 228,000 | - | 228,000 |
| Financial liabilities | 1,484,427 | 1,100,411 | 59,500 - |
- | 18,635 | 2,021,233 | - | 4,129,544 | 8,813,750 |
| Total liabilities | 1,797,266 | 1,118,944 | 59,500 | 32,783 | 1,155,267 | 2,054,222 | 228,000 | 117,496,427 | 123,942,409 |
| Total exposure | (264,502) | (834,984) | 39,612 | 1,889,356 | 895,695 | 276,860 | 1,000 | 6,930,982 | 8,934,019 |
.
| NIS | Other non | ETNs - linkage | Israeli | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Non-linked | CPI-linked | Foreign currency | monetary items |
pension companies in |
company in Israel |
to various indices |
insurance company |
Total | |
| Intangible Assets | - | - - |
1,571,622 | 461,337 | 4,264 | - | 737,837 | 2,775,060 | |
| Deferred tax assets | |||||||||
| Deferred acquisition costs | - | - - |
63,049 | 93 | 4,508 | - | - | 67,650 | |
| Property, plant & equipment | - - |
- - - - |
- 166,154 |
541,050 23,844 |
- 9,489 |
- - |
1,469,598 702,752 |
2,010,648 902,239 |
|
| Investments in investees | 35,208 | 17,399 | - | 73,193 | 1,606 | 59 | - | 1,218,918 | 1,346,383 |
| Investment property in respect of yield-dependent | |||||||||
| contracts | - | - - |
- | - | - | - | 2,062,862 | 2,062,862 | |
| Investment property - other | - | - - |
- | - | - | - | 1,124,834 | 1,124,834 | |
| Reinsurance assets | - | - - |
- | - | - | - | 2,806,546 | 2,806,546 | |
| Credit for purchase of securities | 426,000 | - 71,000 |
- | - | - | - | - | 497,000 | |
| Current tax assets | - | 28,037 | - | - | 5,064 | 6,237 | - | 68,796 | 108,134 |
| Receivables and debit balances | 144,879 | - - |
- | 46,565 | 13,478 | - | 507,702 | 712,624 | |
| Premiums collectible | - | - - |
- | - | - | - | 672,556 | 672,556 | |
| Held-for-sale assets of disposal group | - | - - |
- | - | - | - | - | - | |
| Financial investments in respect of yield | |||||||||
| dependent contracts | - | - - |
- | - | - | - | 81,098,659 | 81,098,659 | |
| Financial investments for holders of bonds, ETNs, | |||||||||
| short ETNs, composite ETNs, deposit certificates | |||||||||
| and structured bonds | - | - - |
- | - | - | 206,000 | - | 206,000 | |
| Credit in respect of factoring, clearing and | |||||||||
| financing | - | - - |
- | - | 2,550,392 | - | - | 2,550,392 | |
| Liquid debt assets | 8,061 | 25,266 | 1,623 | - | 64,846 | - | - | 7,373,137 | 7,472,933 |
| Non-liquid debt assets | 390,000 | 224,669 | 66,000 | - | 926,127 | 11,502 | - | 12,346,143 | 13,964,441 |
| Shares | - | - - |
130,655 | 27,549 | 1,520 | - | 2,602,173 | 2,761,897 | |
| Other | 1,000 | - 32,210 |
27,709 | 36,689 | - | - | 4,401,363 | 4,498,971 | |
| Cash and cash equivalents in respect of yield | |||||||||
| dependent contracts | - | - - |
- | - | - | - | 13,785,593 | 13,785,593 | |
| Other cash and cash equivalents | 325,076 | - 20,921 |
- | 93,605 - |
13,006 - |
- | 1,701,545 | 2,154,153 | |
| Total assets | 1,330,224 | 295,371 | 191,754 | 2,032,382 | 2,228,375 | 2,614,455 | 206,000 | 134,681,014 | 143,579,575 |
| Liabilities in respect of insurance contracts and | |||||||||
| non-yield-dependent investment contracts | - | - - |
- | 949,349 | - | - | 24,163,637 | 25,112,986 | |
| Liabilities in respect of insurance contracts and | |||||||||
| yield-dependent investment contracts | - | - - |
- | - | - | - | 95,628,584 | 95,628,584 | |
| Liabilities in respect of deferred taxes | - | - - |
62,797 | 70,390 | - | - | 740,115 | 873,302 | |
| Liability for employee benefits, net | 17,406 | - - |
- | 1,918 | 6,064 | - | 47,013 | 72,401 | |
| Liability in respect of current taxes | - | 25,669 | - | - | 1,868 | 991 | - | - | 28,528 |
| Payables and credit balances | 282,447 | - - |
- | 220,394 | 21,483 | - | 2,398,679 | 2,923,003 | |
| Liabilities for bonds, ETNs, short ETNs, | |||||||||
| composite ETNs and structured bonds | - | - - |
- | - | - | 205,000 | - | 205,000 | |
| Financial liabilities | 1,277,957 | 1,184,966 | 74,000 | - | 24,760 | 2,287,842 | - | 3,963,157 | 8,812,682 |
| Total liabilities | 1,577,810 | 1,210,635 | 74,000 | 62,797 | 1,268,679 | 2,316,380 | 205,000 | 126,941,185 | 133,656,486 |
| Total exposure | (247,586) | (915,264) | 117,754 | 1,969,585 | 959,696 | 298,075 | 1,000 | 7,739,829 | 9,923,089 |
.

Amendment No. 3 to the Securities Regulations (Periodic and Immediate Reports), 2009 (hereinafter - "ISOX"), which deals with internal controls over financial reporting and the disclosure thereof (hereinafter - the "Regulations"), was published in December 2009. The amendment enacts a number of changes aimed at improving the quality of financial reporting and disclosure by reporting corporations.
As from the publication date of the ISOX amendment, and as set out in the Company's previous Reports of the Board of Directors, the Company has acted and is acting on an ongoing basis to implement the required procedure in The Phoenix group in accordance with the provisions of the ISOX amendment. In accordance with the provisions of the ISOX amendment, the Company opted to implement to the internal controls of all of its consolidated institutional entities the provisions of the Commissioner's circulars applicable thereto - the Institutional Entities Circular 2009-9-10, "Management's Responsibility for Internal Control over Financial Reporting"; Institutional Entities Circular 2010-9-6, "Management's Responsibility for Internal Control over Financial Reporting - Amendment"; Circular 2010-9-7 "Internal Control over Financial Reporting - Statements, Reports and Disclosures" (hereinafter - "Management's Responsibility Circulars").
The reports and statements required in accordance with the ISOX amendment are attached below to the periodic financial statements, please see Part 5 - Report on the Effectiveness of Internal Control over Financial Reporting and Disclosure.
The processes relating to the activities of institutional entities are also addressed in the Insurance Commissioner's Circulars, please see Section 8.1.2. below.
Alongside the process described in Section 8.1.1 above, The Phoenix group's institutional entities apply the provisions of Management's Responsibility Circulars pertaining to controls and procedures regarding disclosure and internal controls over financial reporting of an institutional entity, and implement the procedures required in connection therewith, as described below; this is done in accordance with the stages and dates set out in the abovementioned circulars and in collaboration with external consultants engaged for that purpose. As part of this process, the group's institutional entities adopted the internal control model of COSO - the Committee of Sponsoring Organization of the Treadway Commission - which is a generally accepted framework for assessment of internal controls.

Managements of the institutional entities, together with their CEOs and CFOs, assessed the effectiveness of the controls and procedures concerning the said institutional entities' disclosure in their Financial Statements as of the end of the period covered in this report. Based on this assessment, the CEOs and CFOs of the institutional entities in The Phoenix group concluded that, as of the end of this period, the controls and procedures as to the institutional entities' disclosure are sufficiently effective for recording, processing, summarizing, and reporting the information that the institutional entities are required to disclose in their quarterly report in accordance with the provisions of the law and the reporting provisions set by the Commissioner of the Capital Market, Insurance, and Savings and on the date set out in these provisions.
During the quarter ending June 30, 2022, no changes took place in the internal control over financial reporting of the group's institutional entities that had a material effect, or is expected to have a material effect, on the institutional entities' internal control over financial reporting. Furthermore, the group's institutional entities are improving and streamlining processes and/or internal controls and/or customer service.
The reports and statements relating to the relevant processes are attached to the financial statements of The Phoenix group's institutional entities, in accordance with the provisions of Management's Responsibility Circulars.
For further details regarding events subsequent to the balance sheet date, please see Note 9 to the Financial Statements.
| Series/issuance date | Bonds Series 4 | Bonds Series 5 | Bonds Series 6 |
|---|---|---|---|
| Rating agency | Midroog / Ma'alot | Midroog / Ma'alot | Midroog / Ma'alot |
| Rating as of the report date | Aa3.il ilAA /- | Aa3.il ilAA /- | Aa3.il ilAA /- |
| Par value on issuance date | NIS 391,384,000 | NIS 822,616,000 | NIS 300,000,000 |
| Interest type | Non-linked | CPI-linked | CPI-linked |
| Nominal interest | The Bank of Israel's variable quarterly interest rate plus a 1.28% spread |
0.44% | 1.94% |
| Effective interest rate on issuance date |
1.7% | 0.55% | 2.01% |
| Listed on the TASE | Yes | Yes | Yes |
| Principal payment dates | 2 equal annual installments of 12% on July 31 of each of the years 2020 and 2021 and 4 equal annual installments of 19% on July 31 of each of the years 2025 through 2028. |
3 equal annual installments of 4% on July 1 of each of the years 2022 through 2024, one installment of 28% on May 1, 2028, and 2 equal annual installments of 30% on May 1 of each of the years 2029 through 2030. |
9 annual installments: 1 installment of 4% on December 31, 2024, 3 equal installments of 12% on December 31 of each of the years 2025 through 2027, 3 equal installments of 10% on December 31 of each of the years 2028 through 2030, and 2 installments of 15% ??? on December 31 of each of the years 2031 through 2032. |
| Interest payment dates | Quarterly interest on January 31, April 30, July 31, and October 31 |
Semi-annual interest on May 1 and November 1 |
Semi-annual interest on June 30 and December 31 |
| Nominal p.v. as of June 30, 2022 | NIS 338 million | NIS 789 million | NIS 300 million |
| CPI-linked nominal p.v. as of June 30, 2022 |
NIS 338 million | NIS 832 million | NIS 300 million |
| Carrying amount of bonds' outstanding balances as of June 30, 2022 |
NIS 336 million | NIS 819 million | NIS 297 million |
| Carrying amount of interest payable as of June 30, 2022 |
NIS 0.8 million | NIS 0.8 million | - |
| Market value as of June 30, 2022 (*) |
NIS 335 million | NIS 788 million | NIS 268 million |
| Series' materiality | The series is material as this term is defined in Regulation 10(b)13(a) of the Securities Regulations (Periodic and Immediate Reports), 1970 |
The series is material as this term is defined in Regulation 10(b)13(a) of the Securities Regulations (Periodic and Immediate Reports), 1970 |
The series is material as this term is defined in Regulation 10(b)13(a) of the Securities Regulations (Periodic and Immediate Reports), 1970 |
(*) The market value includes interest accrued as of June 30, 2022.

As part of the deed of trust of the Company's Series 6 Bonds, the Company undertook not to place a general floating charge on its assets as long as Series 6 bonds are not repaid in full, unless it has obtained the bondholders' consent in advance and placed on that date a lien of the same rank in favor of Series 6 bondholders. Furthermore, with respect to Series 6 bonds, the Company assumed restrictions on distribution of dividends and expansion of the Bonds (Series 6); the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 3.6 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 48% for two consecutive quarters. For further details, please see the Shelf Offering Report dated January 5, 2022.
As part of the deed of trust of the Company's Series 4 bonds, the Company undertook not to place a general floating charge on its assets as long as Series 4 bonds are not repaid in full, unless it has obtained the bondholders' consent in advance and placed on that date a lien of the same rank in favor of Series 4 bondholders. Furthermore, with respect to Series 4 bonds, the Company assumed restrictions on distribution of dividends and expansion of the Bonds (Series 4); the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 2.9 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 50% for two consecutive quarters. For further details, please see the Shelf Offering Report Dated May 7, 2019.
As part of the deed of trust of the Company's Series 5 Bonds, the Company undertook not to place a general floating charge on its assets as long as Series 5 bonds are not repaid in full, unless it has obtained the bondholders' consent in advance and placed on that date a lien of the same rank in favor of Series 5 bondholders.
Furthermore, with respect to Series 5 bonds, the Company assumed restrictions on dividend distribution; the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 3.2 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 50% for two consecutive quarters. In addition, a mechanism for adjusting the rate of change in interest rate due to noncompliance with financial covenants was set: In the event that the Company's shareholders' equity falls below NIS 3.5 billion, the annual interest rate will increase by the rate set in Section 5.9 of the Deed of Trust. For further details, please see the shelf offering report dated February 20, 2020.

As of balance sheet date, the Company complies with the financial covenants described above. The net financial debt ratio as of June 30, 2022, was approximately 3% (including Series N bonds issued by The Phoenix Insurance through Phoenix Capital Raising), and the Company's shareholders' equity as per its separate financial statements as of June 30, 2022, was approximately NIS 9,708 million, which is higher than the above required shareholders' equity.
For further details – please see Note 27 to the Company's Financial Statements as of December 31, 2021.
The members of the Board of Directors thank the Company's management, employees and agents for their contribution to the Company.
Benjamin Gabbay Chairman of the Board Eyal Ben Simon CEO
August 24, 2022

Consolidated Interim Financial Statements

| Page | |
|---|---|
| Review Report of the Independent Auditors……………………………………………3-4 | |
| Condensed Consolidated Interim Statements of Financial Position…………….5-6 | |
| Condensed Consolidated Interim Income Statements………………………………7 | |
| Condensed Consolidated interim Statements of Comprehensive Income……8 | |
| Condensed Consolidated Interim Statements of Changes in Equity…………9-13 | |
| Condensed Consolidated Interim Statements of Cash Flow ………14-16 |
|
| Notes to the Condensed Consolidated Interim Financial Statements………17-107 | |
| Appendix to the Condensed Consolidated Interim Financial Statements…108-111 |

Kost Forer Gabbay & Kasierer Menachem Begin Road 144A, Tel Aviv 6492102 www.ey.com Tel. +972-3-6232525 Fax +972-3-5622555
We have reviewed the accompanying financial information of The Phoenix Holdings Ltd. and subsidiaries ("the Company"), the condensed consolidated financial statement of financial position as of June 30, 2022, the related condensed consolidated statements of profit or loss, comprehensive income, changes in equity and cash flows for the six and three-month period then ended. The Company's Board of Directors and management are responsible for the preparation and presentation of interim financial information for this interim periods in accordance with IAS 34, "Interim Financial Reporting", and are responsible for the disclosure requirements set by the Commissioner of the Capital Market, Insurance and Savings and in accordance with the Financial Services (Insurance) Supervision Law, 1981 and they are also responsible for preparing financial information for this interim periods under Chapter D of the Securities Regulations (Periodic and Immediate Reports), 1970, insofar as these regulations apply to a corporation that consolidates an insurance company. Our responsibility is to express a conclusion regarding the financial information for these interim periods based on our review.
We did not review the condensed interim financial information of certain subsidiary, whose assets included in consolidation constitute approximately 2.2% of total consolidated assets as of June 30, 2022, and whose revenues included in consolidation constitute approximately 7.2% and 4% of total consolidated revenues for the six and threemonth periods then ended, respectively. Furthermore, we did not review the condensed interim financial information of certain companies accounted for at equity. The investment in which, at equity, amounted to approximately NIS 724,938 thousand as of June 30, 2022, and the Company's share in the earning amounted to approximately NIS 2,070 thousand and 7,988 thousand for the six and three-month periods then ended. The condensed interim financial information of those companies was reviewed by other auditors, whose review reports have been furnished to us, and our conclusion, insofar as it relates to financial information in respect of those companies, is based on the review reports of the other auditors.
We conducted our review in accordance with Review Standard (Israel) 2410 of the Institute of Certified Public Accountants in Israel, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and of applying analytical and other review procedures. A review is substantially less in scope than an audit performed pursuant to Israeli GAAP and, as a result, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the accompanying interim financial information is not prepared, in all material respects, in accordance with IAS 34 and in accordance with the disclosure requirements prescribed by the Commissioner of the Capital Market, Insurance and Savings, pursuant to the Financial Services Supervision Law (Insurance), 1981.
In addition to that which is stated in the previous paragraph, based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the abovementioned financial information does not comply, in all material respects, with the disclosure provisions of Chapter D of the Israel Securities Regulations (Periodic and Immediate Reports), 1970, insofar as these regulations apply to a corporation consolidating an insurance company.
Without qualifying the above conclusion, we draw attention to Note 7 to the financial statements regarding exposure to contingent liabilities.
Tel Aviv, Kost Forer Gabbay & Kasierer August 24, 2022 Certified Public Accountants
Condensed Cons olidat ed Int erim Statem ents of Financial Position

| As of | ||||
|---|---|---|---|---|
| June 30, | December | |||
| 2022 | June 30, 2021 | 31, 2021 | ||
| Unaudited | Audited | |||
| Note | NIS thousand | |||
| Assets | ||||
| Intangible assets | 2,919,126 | 2,655,265 | 2,775,060 | |
| Deferred tax assets | 67,043 | 58,838 | 67,650 | |
| Deferred acquisition costs | 2,281,026 | 1,870,408 | 2,010,648 | |
| Property, plant & equipment | 946,265 | 844,698 | 902,239 | |
| Investments in associates | 1,474,400 | 575,548 | 1,346,383 | |
| Investment property in respect of yield-dependent | ||||
| contracts | 1,903,600 | 1,938,918 | 2,062,862 | |
| Investment property - other | 1,038,015 | 1,060,819 | 1,124,834 | |
| Reinsurance assets | 3,167,199 | 2,605,989 | 2,806,546 | |
| Credit for purchase of securities | 754,000 | 478,000 | 497,000 | |
| Current tax assets | 31,317 | 28,282 | 108,134 | |
| Receivables and debit balances | 1,072,164 | 694,318 | 712,624 | |
| Premiums collectible | 933,629 | 699,620 | 672,556 | |
| Held-for-sale assets of disposal group | - | 1,881,113 | - | |
| Financial investments in respect of yield-dependent | ||||
| contracts | 4A | 78,267,921 | 74,114,354 | 81,098,659 |
| Financial investments for holders of deposit | ||||
| certificates and structured bonds | 217,000 | 229,000 | 206,000 | |
| Credit assets in respect of factoring, clearing and | ||||
| financing | 4C | 3,208,322 | 2,283,531 | 2,550,392 |
| Other financial investments: | ||||
| Liquid debt assets | 6,401,473 | 7,262,768 | 7,472,933 | |
| Illiquid debt assets | 17,193,235 | 13,951,771 | 13,964,441 | |
| Shares | 2,513,790 | 2,689,052 | 2,761,897 | |
| Other | 4,471,187 | 3,750,831 | 4,498,971 | |
| Total other financial investments | 4B | 30,579,685 | 27,654,422 | 28,698,242 |
| Cash and cash equivalents in respect of yield | ||||
| dependent contracts | 14,789,357 | 11,098,327 | 13,785,593 | |
| Other cash and cash equivalents | 2,459,240 | 2,104,978 | 2,154,153 | |
| Total assets | 146,109,309 | 132,876,428 | 143,579,575 | |
| Total assets for yield-dependent contracts | 95,216,686 | 87,342,815 | 97,116,663 | |

| As of | ||||
|---|---|---|---|---|
| June 30, 2022 |
June 30, 2021 |
December 31, 2021 |
||
| Unaudited | Audited | |||
| Note | NIS thousand | |||
| Equity | ||||
| Share capital | 310,514 | 310,059 | 310,323 | |
| Premium and capital reserves in respect of shares | 845,296 | 839,186 | 849,309 | |
| Treasury shares | 7I | (155,628) | (93,271) | (99,769) |
| Capital reserves | 934,615 | 1,139,769 | 1,261,509 | |
| Retained earnings | 7,773,062 | 6,489,114 | 7,331,992 | |
| Total equity attributable to the Company's | ||||
| shareholders | 9,707,859 | 8,684,857 | 9,653,364 | |
| Non-controlling interests | 354,125 | 249,162 | 269,725 | |
| Total equity | 10,061,984 | 8,934,019 | 9,923,089 | |
| Liabilities | ||||
| Liabilities in respect of insurance contracts and non | ||||
| yield-dependent investment contracts | 25,315,513 | 24,297,043 | 25,112,986 | |
| Liabilities in respect of insurance contracts and yield | ||||
| dependent investment contracts | 93,114,756 | 86,163,297 | 95,628,584 | |
| Liabilities in respect of deferred taxes | 554,373 | 828,587 | 873,302 | |
| Liability for employee benefits, net | 83,520 | 82,051 | 72,401 | |
| Liability in respect of current taxes | 73,466 | 80,106 | 28,528 | |
| Payables and credit balances | 3,258,638 | 2,569,210 | 2,923,003 | |
| Held-for-sale liabilities of disposal group | - | 880,365 | - | |
| Liabilities in respect of structured products | 215,058 | 228,000 | 205,000 | |
| Financial liabilities | 4D | 13,432,001 | 8,813,750 | 8,812,682 |
| Total liabilities | 136,047,325 | 123,942,409 | 133,656,486 | |
| Total capital and liabilities | 146,109,309 | 132,876,428 | 143,579,575 | |
| Benjamin Gabbay | Eyal Ben Simon | Eli Schwartz |
|---|---|---|
| Chairman of the Board | CEO | EVP, CFO |
Date of approval of the financial statements - August 24, 2022
Condensed Consolidated Interim Statements of Income
| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
|||
|---|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | 2021 | |
| Unaudited | Audited | ||||
| NIS thousand | |||||
| Premiums earned, gross | 6,032,809 | 5,361,420 | 3,018,421 | 2,743,098 | 11,161,431 |
| Premiums earned by reinsurers | 791,985 | 647,233 | 400,792 | 336,289 | 1,345,459 |
| Premiums earned - retention | 5,240,824 | 4,714,187 | 2,617,629 | 2,406,809 | 9,815,972 |
| Investment income (losses), net | |||||
| and finance income | (5,435,372) | 8,144,333 | (4,753,868) | 4,289,738 | 14,626,925 |
| Income from management fees | 762,044 | 1,015,551 | 389,199 | 528,678 | 2,049,366 |
| Income from fees and | |||||
| commissions | 430,265 | 338,671 | 197,051 | 171,044 | 691,414 |
| Income from other financial | |||||
| services | 101,000 | 76,000 | 57,000 | 35,000 | 154,000 |
| Income from factoring and | |||||
| clearing | 63,827 | - | 35,215 | - | 52,871 |
| Other income | 136,787 | 263,351 | 132,104 | 250,445 | 708,186 |
| Total income | 1,299,375 | 14,552,093 | (1,325,670) | 7,681,714 | 28,098,734 |
| Payments and change in liabilities | |||||
| in respect of insurance contracts | |||||
| and investment contracts, gross | (1,282,558) | 11,835,806 | (2,217,378) | 6,029,877 | 22,658,016 |
| Reinsurers' share in payments | |||||
| and in changes in liabilities in | |||||
| respect of insurance contracts | 607,294 | 307,691 | 308,137 | 103,828 | 802,092 |
| Payments and change in liabilities | |||||
| in respect of insurance contracts | |||||
| and investment contracts - | |||||
| retention | (1,889,852) | 11,528,115 | (2,525,515) | 5,926,049 | 21,855,924 |
| Fees and commissions, marketing | |||||
| expenses and other purchase | |||||
| expenses | 922,167 | 816,329 | 458,682 | 435,906 | 1,696,075 |
| General and administrative | |||||
| expenses | 877,458 | 788,743 | 444,592 | 425,012 | 1,675,317 |
| Other expenses | 31,509 | 27,923 | 14,926 | 17,178 | 67,454 |
| Finance expenses | 150,105 | 103,433 | 90,464 | 61,888 | 218,002 |
| Total expenses | 91,387 | 13,264,543 | (1,516,851) | 6,866,033 | 25,512,772 |
| Share in profits of equity | |||||
| accounted investees | 30,274 | 23,226 | 26,355 | 7,199 | 111,504 |
| Net income before taxes on | |||||
| income | 1,238,262 | 1,310,776 | 217,536 | 822,880 | 2,697,466 |
| Taxes on income | 336,902 | 359,422 | 6,367 | 197,653 | 673,554 |
| Net income for the period | 901,360 | 951,354 | 211,169 | 625,227 | 2,023,912 |
| Attributed to: | |||||
| Company's shareholders | 859,963 | 928,252 | 184,866 | 612,848 | 1,964,696 |
| Non-controlling interests | 41,397 | 23,102 | 26,303 | 12,379 | 59,216 |
| Net income for the period | 901,360 | 951,354 | 211,169 | 625,227 | 2,023,912 |
| Earnings per share | |||||
| attributable to the Company's | |||||
| shareholders (in NIS): | |||||
| Basic earnings per share | |||||
| Earnings per ordinary share of | |||||
| NIS 1 par value (in NIS) | 3.42 | 3.70 | 0.74 | 2.46 | 7.76 |
| Diluted earnings per share | |||||
| Earnings per ordinary share of | |||||
| NIS 1 par value (in NIS) | 3.34 | 3.51 | 0.71 | 2.43 | 7.64 |

| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
||||
|---|---|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |||
| Unaudited | Unaudited NIS thousand |
Audited | ||||
| Net income for the period | 901,360 | 951,354 | 211,169 | 625,227 | 2,023,912 | |
| Other comprehensive | ||||||
| income (loss): | ||||||
| Amounts that will be or | ||||||
| that have been | ||||||
| reclassified to profit or | ||||||
| loss when specific | ||||||
| conditions are met Net change in fair value of |
||||||
| financial assets classified as | ||||||
| available for sale, carried to | ||||||
| capital reserves | (634,247) | 696,124 | (233,659) | 442,948 | 1,176,873 | |
| Net change in fair value of | ||||||
| financial assets classified as | ||||||
| available for sale, carried to | ||||||
| the income statement Gain on impairment of |
(300,044) | (393,418) | (102,476) | (163,308) | (811,111) | |
| financial assets classified as | ||||||
| available for sale, carried to | ||||||
| the income statement | 414,604 | 41,036 | 311,690 | 5,128 | 159,522 | |
| Adjustments arising from | ||||||
| translation of financial | ||||||
| statements of foreign | ||||||
| operations | 18,823 | (2,495) | 16,416 | (3,552) | (18,608) | |
| Tax effect | 177,241 | (116,657) | 8,073 | (97,128) | (179,619) | |
| Total components of net other comprehensive income |
||||||
| (loss) subsequently | ||||||
| reclassified to profit or loss | (323,623) | 224,590 | 44 | 184,088 | 327,057 | |
| Amounts that shall not be | ||||||
| subsequently reclassified | ||||||
| to profit or loss | ||||||
| Revaluation of property, | ||||||
| plant and equipment Actuarial gain (loss) in |
- | - | - | - | 29,342 | |
| respect of defined benefit | ||||||
| plans | 1,110 | - | - | - | (2,882) | |
| Company's share in other | ||||||
| comprehensive income | ||||||
| (loss), net of equity | ||||||
| accounted companies | - | - | - | - | 3,479 | |
| Tax effect Total components of other |
(255) | - | - | - | (5,886) | |
| comprehensive income that | ||||||
| shall not be subsequently | ||||||
| reclassified to profit or loss | 855 | - | - | - | 24,053 | |
| Total other | ||||||
| comprehensive income | ||||||
| (loss), net | (322,768) | 224,590 | 44 | 184,088 | 351,110 | |
| Total comprehensive | 578,592 | 1,175,944 | 211,213 | 809,315 | 2,375,022 | |
| income for the period Attributed to: |
||||||
| Company's shareholders | 536,933 | 1,152,842 | 184,910 | 796,936 | 2,316,035 | |
| Non-controlling interests | 41,659 | 23,102 | 26,303 | 12,379 | 58,987 | |
| Comprehensive income | ||||||
| for the period | 578,592 | 1,175,944 | 211,213 | 809,315 | 2,375,022 |

| Conde nsed Consolida ted Inte rim Sta tements of Change s in Equity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attributed to Company's shareholders | |||||||||||||
| Capital | |||||||||||||
| Capital | reserve | ||||||||||||
| Premium | reserve | from | Capital | Capital | |||||||||
| and | from | transaction | reserve | reserve in | |||||||||
| capital | transactions | with | from | Reserve | respect of | ||||||||
| reserves | with non | controlling | share | from | available | Non | |||||||
| Share | in respect | Treasury | Retained | controlling | shareholder | based | Revaluation | translation | for-sale | controlling | |||
| capital | of shares | shares | earnings | interests | - bonus |
payment | reserve | differences | assets | Total | interests | Total equity | |
| NIS thousand | |||||||||||||
| Balance on January 1, | |||||||||||||
| 2022 (audited) | 310,323 | 849,309 | (99,769) | 7,331,992 | (45,655) | 11,000 | 51,652 | 131,354 | (41,946) | 1,155,104 | 9,653,364 | 269,725 | 9,923,089 |
| Net income | - | - | - | 859,963 | - | - | - | - | - | - | 859,963 | 41,397 | 901,360 |
| Other comprehensive | |||||||||||||
| income (loss) | - | - | - | 593 | - | - | - | - | 18,823 | (342,446) | (323,030) | 262 | (322,768) |
| Total comprehensive | |||||||||||||
| income (loss) | - | - | - | 860,556 | - | - | - | - | 18,823 | (342,446) | 536,933 | 41,659 | 578,592 |
| Share-based payment | - | (4,993) | - | - | - | 10,035 | - | - | - | 5,042 | - | 5,042 | |
| Dividend paid to non | |||||||||||||
| controlling interests | - | - | - | - | - | - | - | - | - | - | - | (8,716) | (8,716) |
| Acquisition of treasury | |||||||||||||
| shares (Note 8I) | - | - | (55,859) | - | - | - | - | - | - | - | (55,859) | - | (55,859) |
| Exercise of employee | |||||||||||||
| options | 191 | 980 | - | - | - | - | (1,171) | - | - | - | - | - | - |
| Commencement of | |||||||||||||
| consolidation (Note 4) | - | - | - | - | - | - | - | - | - | - | - | 50,624 | 50,624 |
| Transfer from | |||||||||||||
| revaluation reserve in | |||||||||||||
| respect of revaluation | |||||||||||||
| of property, plant and | |||||||||||||
| equipment, at the | |||||||||||||
| depreciation amount | - | - | - | 1,514 | - | - | - | (1,514) | - | - | - | - | - |
| Dividend (Note 8G) | - | - | - | (421,000) | - | - | - | - | - | - | (421,000) | - | (421,000) |
| Allocation of shares of | |||||||||||||
| a consolidated | |||||||||||||
| subsidiary to minority | |||||||||||||
| interests | - | - | - | - | 1,379 | - | - | - | - | - | 1,379 | 833 | 2,212 |
| Acquisition of non | |||||||||||||
| controlling interests | - | - | - | - | (12,000) | - | - | - | - | - | (12,000) | - | (12,000) |
| Balance as of June | |||||||||||||
| 30, 2022 (unaudited) | 310,514 | 845,296 | (155,628) | 7,773,062 | (56,276) | 11,000 | 60,516 | 129,840 | (23,123) | 812,658 | 9,707,859 | 354,125 | 10,061,984 |

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder - bonus |
Capital reserve from share based payment NIS thousand |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale assets |
Total | Non controlling interests |
Total equity |
|
| Balance on January 1, 2021 (audited) Net income Other comprehensive |
309,951 - |
833,592 - |
(26,411) - |
5,939,754 928,252 |
(43,622) - |
11,000 - |
44,943 - |
114,614 - |
(23,338) - |
809,439 - |
7,969,922 928,252 |
111,908 23,102 |
8,081,830 951,354 |
| income (loss) | - | - | - | - | - | - | - | - | (2,495) | 227,085 | 224,590 | - | 224,590 |
| Total comprehensive | |||||||||||||
| income (loss) Share-based |
- | - | - | 928,252 | - | - | - | - | (2,495) | 227,085 | 1,152,842 | 23,102 | 1,175,944 |
| payment Dividend paid to non-controlling |
- | 4,638 | - | - | - | - | 4,315 | - | - | - | 8,953 | - | 8,953 |
| interests Acquisition of |
- | - | - | - | - | - | - | - | - | - | - | (7,549) | (7,549) |
| treasury shares | - | - | (66,860) | - | - | - | - | - | - | - | (66,860) | - | (66,860) |
| Dividend Commencement of |
- | - | - | (380,000) | - | - | - | - | - | - | (380,000) | - | (380,000) |
| consolidation Exercise of employee |
- | - | - | - | - | - | - | - | - | - | - | 121,701 | 121,701 |
| options Transfer from revaluation reserve in respect of revaluation of property, plant and |
108 | 956 | - | - | - | - | (1,064) | - | - | - | - | - | - |
| equipment, at the depreciation amount Balance as of June |
- | - | - | 1,108 | - | - | - | (1,108) | - | - | - | - | - |
| 30, 2021 (unaudited) |
310,059 | 839,186 | (93,271) | 6,489,114 | (43,622) | 11,000 | 48,194 | 113,506 | (25,833) | 1,036,524 | 8,684,857 | 249,162 | 8,934,019 |

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premium and capital reserves in respect |
Capital reserve from transactions with non |
Capital reserve from transaction with controlling |
Capital reserve from share |
Reserve from |
Capital reserve in respect of available |
Non | |||||||
| Share | of | Treasury | Retained | controlling | shareholder | based | Revaluation | translation | for-sale | controlling | |||
| capital | shares | shares | earnings | interests | - bonus |
payment | reserve | differences | assets | Total | interests | Total equity | |
| Balance as of April | NIS thousand | ||||||||||||
| 1, 2022 (unaudited) Net income Other |
310,366 - |
851,131 - |
(155,628) - |
7,587,379 184,866 |
(45,408) - |
11,000 - |
56,835 - |
130,657 - |
(39,539) - |
829,030 - |
9,535,823 184,866 |
278,224 26,303 |
9,814,047 211,169 |
| comprehensive income (loss) |
- | - | - | - | - | - | - | - | 16,416 | (16,372) | 44 | - | 44 |
| Total comprehensive income (loss) Share-based |
- | - | - | 184,866 | - | - | - | - | 16,416 | (16,372) | 184,910 | 26,303 | 211,213 |
| payment Dividend to non |
- | (6,568) | - | - | - | - | 4,562 | - | - | - | (2,006) | - | (2,006) |
| controlling interests Exercise of |
- | - | - | - | - | - | - | - | - | - | - | (1,780) | (1,780) |
| employee options Commencement of |
148 | 733 | - | - | - | - | (881) | - | - | - | - | - | - |
| consolidation (Note 4) Transfer from revaluation reserve in respect of revaluation of property, plant, and |
- | - | - | - | - | - | - | - | - | - | - | 50,624 | 50,624 |
| equipment, at the depreciation amount |
- | - | - | 817 | - | - | - | (817) | - | - | - | - | - |
| Transaction with minority interest Allocation of shares of a consolidated |
- | - | - | - | - | - | - | - | - | - | - | 85 | 85 |
| subsidiary to minority interests Acquisition of non |
- | - | - | - | 1,132 | - | - | - | - | - | 1,132 | 669 | 1,801 |
| controlling interests Balance as of June |
- | - | - | - | (12,000) | - | - | - | - | - | (12,000) | - | (12,000) |
| 30, 2022 (unaudited) |
310,514 | 845,296 | (155,628) | 7,773,062 | (56,276) | 11,000 | 60,516 | 129,840 | (23,123) | 812,658 | 9,707,859 | 354,125 | 10,061,984 |

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder - bonus |
Capital reserve from share based payment NIS thousand |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale assets |
Total | Non controlling interests |
Total equity |
|
| Balance as of April 1, 2021 (unaudited) Net income Other |
309,961 - |
837,324 - |
(26,411) - |
5,875,712 612,848 |
(43,622) - |
11,000 - |
47,150 - |
114,060 - |
(22,281) - |
848,884 - |
7,951,777 612,848 |
117,861 12,379 |
8,069,638 625,227 |
| comprehensive income (loss) |
- | - | - | - | - | - | - | - | (3,552) | 187,640 | 184,088 | - | 184,088 |
| Total | |||||||||||||
| comprehensive income (loss) |
- | - | - | 612,848 | - | - | - | - | (3,552) | 187,640 | 796,936 | 12,379 | 809,315 |
| Share-based payment Dividend to |
- | 1,003 | - | - | - | - | 2,001 | - | - | - | 3,004 | - | 3,004 |
| non-controlling interests |
- | - | - | - | - | - | - | - | - | - | - | (2,371) | (2,371) |
| Acquisition of treasury shares Commencement |
- | - | (66,860) | - | - | - | - | - | - | - | (66,860) | - | (66,860) |
| of consolidation Exercise of |
- | - | - | - | - | - | - | - | - | - | - | 121,293 | 121,293 |
| employee options Transfer from revaluation reserve in respect of revaluation of |
98 | 859 | - | - | - | - | (957) | - | - | - | - | - | - |
| property, plant and equipment, at the depreciation amount Balance as of |
- | - | - | 554 | - | - | - | (554) | - | - | - | - | - |
| June 30, 2021 (unaudited) |
310,059 | 839,186 | (93,271) | 6,489,114 | (43,622) | 11,000 | 48,194 | 113,506 | (25,833) | 1,036,524 | 8,684,857 | 249,162 | 8,934,019 |

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transactions with controlling shareholders |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale assets |
Total | Non controlling interests |
Total equity |
|
| NIS thousand | |||||||||||||
| Balance on January 1, 2021 (audited) Net income Other comprehensive |
309,951 - |
833,592 - |
(26,411) - |
5,939,754 1,964,696 |
(43,622) - |
11,000 - |
44,943 - |
114,614 - |
(23,338) - |
809,439 - |
7,969,922 1,964,696 |
111,908 59,216 |
8,081,830 2,023,912 |
| income (loss) | - | - | - | (1,787) | - | - | - | 26,069 | (18,608) | 345,665 | 351,339 | (229) | 351,110 |
| Total comprehensive income (loss) |
- | - | - | 1,962,909 | - | - | - | 26,069 | (18,608) | 345,665 | 2,316,035 | 58,987 | 2,375,022 |
| Share-based payment | - | 13,083 | - | - | - | - | 9,715 | - | - | - | 22,798 | - | 22,798 |
| Exercise of employee options Acquisition of treasury |
372 | 2,634 | - | - | - | - | (3,006) | - | - | - | - | - | - |
| shares Dividend paid to non |
- | - | (73,358) | - | - | - | - | - | - | - | (73,358) | - | (73,358) |
| controlling interests Commencement of |
- | - | - | - | - | - | - | - | - | - | - | (34,481) | (34,481) |
| consolidation | - | - | - | - | - | - | - | - | - | - | - | 123,564 | 123,564 |
| Dividend Transfer from revaluation reserve in respect of revaluation of property, plant, |
- | - | - | (580,000) | - | - | - | - | - | - | (580,000) | - | (580,000) |
| and equipment, at the depreciation amount Allocation of shares of a consolidated |
- | - | - | 9,329 | - | - | - | (9,329) | - | - | - | - | - |
| subsidiary to minority interests |
- | - | - | - | (3,256) | - | - | - | - | - | (3,256) | 4,115 | 859 |
| Transaction with minority interest |
- | - | - | - | 1,223 | - | - | - | - | - | 1,223 | 5,632 | 6,855 |
| Balance on December 31, 2021 (audited) |
310,323 | 849,309 | (99,769) | 7,331,992 | (45,655) | 11,000 | 51,652 | 131,354 | (41,946) | 1,155,104 | 9,653,364 | 269,725 | 9,923,089 |
Condensed Consolidated Interim Stat ements of Cash Flow Consolidated Int erim Statements of Cash Flow

| For the six months ended | For the year ended December 31 |
||||||
|---|---|---|---|---|---|---|---|
| June 30 2022 2021 |
ended June 30 2022 |
2021 | 2021 | ||||
| Unaudited | Audited | ||||||
| Appendix | NIS thousand | ||||||
| Cash flows from operating activities | |||||||
| Net income for the period Adjustments required to present cash flows |
901,360 | 951,354 | 211,169 | 625,227 | 2,023,912 | ||
| from operating activities | (a) | (62,472) | 952,109 | 47,255 | (103,977) | 2,523,387 | |
| Net cash from operating activities | 838,888 | 1,903,463 | 258,424 | 521,250 | 4,547,299 | ||
| Cash flows from investing activities | |||||||
| Purchase of property, plant and equipment | (64,222) | (29,455) | (34,538) | (17,066) | (78,390) | ||
| Proceeds from disposal of property, plant | |||||||
| and equipment | 171 | - | 10 | - | 201 | ||
| Investment in associates | (57,525) | (18,498) | (56,295) | (7,866) | (61,767) | ||
| Dividend from associates | 19,657 | 18,124 | 7,802 | 6,206 | 19,405 | ||
| Receipt of a loan from an associate | 705 | 90 | 355 | - | 90 | ||
| Acquisition of consolidated companies | |||||||
| consolidated for the first time Proceeds from the sale of pension funds, |
(b) | (6,407) | (457,876) | (6,949) | (120,805) | (475,521) | |
| provident funds, and fees and commissions | |||||||
| portfolios | 25,049 | - | 25,014 | - | 43,934 | ||
| Sale of previously-consolidated subsidiary | - | - | - | - | 596,166 | ||
| Proceeds from disposal of investment in | |||||||
| associate | - | - | - | - | 24,288 | ||
| Acquisition and capitalization of intangible | |||||||
| assets costs | (146,623) | (105,575) | (76,936) | (54,193) | (283,387) | ||
| Acquisition of minority interest in a | |||||||
| consolidated company | (12,000) | - | (12,000) | - | - | ||
| Net cash used in investing activities | (241,195) | (593,190) | (153,537) | (193,724) | (214,981) | ||
| Cash flows from financing activities | |||||||
| Acquisition of Company shares | (55,859) | (66,860) | - | (66,860) | (73,358) | ||
| Short term credit from banks, net | 369,000 | 348,457 | 302,000 | - | 90,000 | ||
| Repayment of financial liabilities | (452,150) | (187,699) | (37,782) | (117,000) | (207,270) | ||
| Dividend to shareholders | (421,000) | (380,000) | (421,000) | (380,000) | (580,000) | ||
| Repayment of lease liability principal | (26,028) | (14,836) | (17,652) | (2,331) | (37,347) | ||
| Issuance of financial liabilities | 1,305,911 | 193,000 | 697,568 | 76,000 | 829,080 | ||
| Change in liability for REPO, net | - | 3,755 | - | (43,665) | (389,315) | ||
| Dividend paid to non-controlling interests | (8,716) | (7,549) | (1,780) | (2,372) | (34,481) | ||
| Repayment of contingent liability in respect | |||||||
| of a put option to non-controlling interests | - | (5,355) | - | - | - | ||
| Net cash provided by (used in) financing | |||||||
| activities | 711,158 | (117,087) | 521,354 | (536,228) | (402,691) | ||
| Increase (decrease) in cash and cash | |||||||
| equivalents | 1,308,851 | 1,193,186 | 626,241 | (208,702) | 3,929,627 | ||
| Balance of cash and cash equivalents at | |||||||
| beginning of period Balance of cash and cash equivalents at end |
(c) | 15,939,746 | 12,010,119 | 16,622,356 | 13,412,007 | 12,010,119 | |
| of period | (c) | 17,248,597 | 13,203,305 | 17,248,597 | 13,203,305 | 15,939,746 |

| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
|||
|---|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | 2021 | |
| Unaudited | Audited | ||||
| NIS thousand | |||||
| Adjustments required to present cash flows | |||||
| from operating activities: | |||||
| Items not involving cash flows | |||||
| Investment losses (income), net on financial | |||||
| investments in respect of insurance contracts | |||||
| and yield-dependent investment contract | 6,135,612 | (7,071,901) | 4,957,622 | (3,638,531) | (12,117,791) |
| Change in fair value of investment property in | |||||
| respect of yield-dependent contracts | - | - | - | - | (228,229) |
| Losses (income), net on other financial | |||||
| investments | |||||
| Liquid debt assets | 11,775 | (215,324) | (3,435) | (101,735) | (284,661) |
| Illiquid debt assets | (747,487) | (453,367) | (441,559) | (256,830) | (852,872) |
| Shares | (199,548) | (206,378) | 48,444 | (82,970) | (376,472) |
| Other | 622,718 | (42,171) | 544,721 | (120,374) | (444,387) |
| Depreciation and amortization | 194,191 | 163,133 | 104,098 | 86,298 | 354,191 |
| Profit (loss) from disposal of property, plant | |||||
| and equipment | (2) | 13 | - | 8 | - |
| Gain from sale of provident funds | (14,185) | - | (14,185) | - | - |
| Change in fair value of investment property | 6,286 | (36,378) | - | (36,378) | (160,567) |
| Change in provision for impairment of | |||||
| property, plant and equipment | - | (842) | - | 1,387 | 1,982 |
| Disposal of an associate / assuming control | (108,942) | (240,775) | (108,942) | (240,292) | (645,930) |
| Change in financial liabilities (*) | 3,374,687 | (11,386) | 3,017,433 | (251,813) | 30,749 |
| Income tax expenses | 336,902 | 359,422 | 6,367 | 197,653 | 673,554 |
| Company's share in the profits of associates, | |||||
| net | (30,274) | (23,226) | (26,355) | (7,199) | (111,504) |
| Payroll expenses in respect of share-based | |||||
| payment | 10,035 | 4,315 | 4,562 | 2,001 | 9,715 |
| Changes in other balance sheet line items, net: | |||||
| Change in liabilities in respect of non-yield | |||||
| dependent insurance contracts | 202,527 | 827,156 | 342,705 | 392,067 | 1,643,099 |
| Change in liabilities in respect of yield | |||||
| dependent contracts | (2,513,828) | 9,306,384 | (3,489,199) | 4,866,894 | 18,771,671 |
| Change in liabilities for bonds, ETFs | 10,058 | (10,000) | 23,058 | - | (33,000) |
| Change in financial investments for holders of | |||||
| ETFs, certificates of deposit | (11,000) | 10,000 | (24,000) | 2,000 | 33,000 |
| Change in credit assets in respect of factoring, | |||||
| clearing and financing | (657,930) | - | (497,151) | - | (266,861) |
| Change in deferred acquisition costs | (270,378) | (138,731) | (124,758) | (50,945) | (278,971) |
| Change in reinsurance assets | (360,653) | (74,330) | (204,172) | 44,220 | (274,887) |
| Change in liabilities for employee benefits, net | 11,850 | 15,973 | 698 | 3,710 | 2,635 |
| Change in accounts receivable and collectible | |||||
| premiums | (623,726) | (219,451) | (401,776) | (108,308) | (219,222) |
| Change in payables and credit balances | 307,484 | 79,472 | 234,851 | 124,441 | 393,714 |
| Change in credit for purchase of securities | (257,000) | (75,000) | (201,000) | (26,000) | (94,000) |
| Change in loans granted to associates | 2,403 | (2,762) | 3,479 | (1,664) | (3,816) |
| Financial investments and investment property | |||||
| in respect of insurance contracts and yield | |||||
| dependent investment contracts: | |||||
| Acquisition of real estate properties | (60,582) | (99,342) | (34,422) | (85,854) | (138,251) |
| Proceeds on sale of real estate properties | 219,844 | - | 123,045 | - | 143,194 |
| Sales (acquisitions), net of financial | |||||
| investments | (3,304,874) | (1,472,006) | (1,239,699) | (1,345,761) | (3,410,421) |
| Financial investments and other investment | |||||
| property: | |||||
| Sales (acquisitions), net of financial | |||||
| investments | (2,064,056) | 956,935 | (2,337,427) | 737,356 | 1,232,033 |
| Acquisition of real estate properties | (38,522) | (56,145) | (18,005) | (42,843) | (99,526) |
| Proceeds on sale of real estate properties | 119,055 | - | 66,255 | - | 71,810 |
| Cash paid and received during the period for: | |||||
| Taxes paid | (401,238) | (508,936) | (265,070) | (173,818) | (985,771) |
| Taxes received | 36,326 | 187,757 | 1,072 | 9,303 | 189,179 |
| Total cash flows provided by (used for) | |||||
| operating activities | (62,472) | 952,109 | 47,255 | (103,977) | 2,523,387 |
(*) Mainly change in derivatives, see also Note 8O.

| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
||||
|---|---|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | 2021 | ||
| Unaudited | Audited | |||||
| NIS thousand | ||||||
| (b) | Acquisition of consolidated companies consolidated for the first time Assets and liabilities of the consolidated companies as of acquisition date: |
|||||
| Working capital (excluding cash and cash equivalents) |
22,346 | 32,079 | 21,879 | 12,120 | 44,955 | |
| Deferred acquisition costs Financial assets |
- - |
(19,047) (44,915) |
- - |
- (12,494) |
(19,047) (44,915) |
|
| Credit in respect of factoring, clearing and financing |
- | (2,283,531) | - | (2,283,531) | (2,283,531) | |
| Property, plant and equipment, net Goodwill arising from acquisition Intangible assets recognized as part of |
(783) (82,272) |
(45,105) (405,347) |
(145) (35,741) |
(9,242) (266,694) |
(46,291) (430,593) |
|
| acquisition Deferred taxes |
(64,925) 6,190 |
(310,552) 34,968 |
(64,925) 4,173 |
(122,235) 25,832 |
(336,031) 43,559 |
|
| Minority interests Investments in investees |
50,624 (74,732) |
121,701 271 |
50,624 (74,732) |
121,293 - |
123,564 271 |
|
| Disposal of investment in an associate Financial liabilities Loan from parent company |
114,983 733 - |
340,262 2,055,394 50,000 |
114,983 733 - |
337,485 2,021,233 50,000 |
342,728 2,055,394 50,000 |
|
| Liability for payment in respect of acquisition of an investee Liabilities for employee benefits |
21,050 379 |
5,487 10,459 |
(23,950) 152 |
- 5,428 |
13,788 10,628 |
|
| (c) | Sale of previously-consolidated company | (6,407) | (457,876) | (6,949) | (120,805) | (475,521) |
| Working capital (excluding cash and cash equivalents) |
- | - | - | - | (14,656) | |
| Property, plant & equipment Investment property |
- - |
- - |
- - |
- - |
81,553 1,753,667 |
|
| Intangible assets Financial liabilities |
- - |
- - |
- - |
- - |
23,848 (629,015) |
|
| Liabilities for employee benefits Deferred taxes |
- - |
- - |
- - |
- - |
(3,106) (246,153) |
|
| Investment in an associate Capital gain from the disposal of a |
- | - | - | - | (710,767) | |
| consolidated company | - - |
- - |
- - |
- - |
340,795 596,166 |
|
| (c) | Cash and cash equivalents Balance of cash and cash equivalents at beginning of period: |
|||||
| Cash and cash equivalents Cash and cash equivalents in respect of |
2,154,153 | 1,545,903 | 3,380,462 | 2,249,354 | 1,545,903 | |
| yield-dependent contracts | 13,785,593 15,939,746 |
10,464,216 12,010,119 |
13,241,894 16,622,356 |
11,162,653 13,412,007 |
10,464,216 12,010,119 |
|
| Balance of cash and cash equivalents at end of period: |
||||||
| Cash and cash equivalents Cash and cash equivalents in respect of |
2,459,240 | 2,104,978 | 2,459,240 | 2,104,978 | 2,154,153 | |
| yield-dependent contracts | 14,789,357 17,248,597 |
11,098,327 13,203,305 |
14,789,357 17,248,597 |
11,098,327 13,203,305 |
13,785,593 15,939,746 |
|
| (d) | Significant non-cash activities Recognition of right-of-use asset against a lease liability Breakdown of amounts included in operating |
(40,334) | (13,320) | (35,654) | (7,644) | (31,241) |
| (e) | activities Interest paid |
75,514 | 59,714 | 27,690 | 19,341 | 125,850 |
| Interest received Dividend received |
438,572 29,591 |
388,737 24,127 |
318,828 21,961 |
330,155 6,440 |
758,536 57,702 |

Notes to the Condensed Consolidated Int erim Financial Stat ements
A. The Phoenix Holdings Ltd. (hereinafter - the "Company") is an Israeli resident company incorporated in Israel, whose official address is 53 Derech Hashalom St., Givatayim, Israel. These financial statements were prepared in condensed format as of June 30, 2022, and for the sixmonth and three-month periods then ended (hereinafter - the "Condensed Consolidated Interim Financial Statements"). These financial statements should be read in conjunction with the Company's annual financial statements as of December 31, 2021, and for the year then ended and the accompanying notes (hereinafter - the "Consolidated Annual Financial Statements").
| B. | Definitions | |
|---|---|---|
| The Company | The Phoenix Holdings Ltd. - |
|
| The Phoenix | The Phoenix Insurance Company Ltd., a wholly -owned subsidiary of the Company. - |
|
| Insurance | ||
| The Phoenix | The Phoenix Investments and Finances Ltd., a wholly-owned subsidiary of the | |
| Investments | Company. | |
| Excellence | Excellence Investments Ltd., a wholly -owned subsidiary of The Phoenix - Investments Ltd. |
|
| Gama | Gama Management and Clearing Ltd., a subsidiary in which The Phoenix Investments is a controlling shareholder. |
|
| The Phoenix | The Phoenix Insurance Agencies 1989 Ltd. - a company wholly-owned by the | |
| Agencies | Company. | |
| The Phoenix | The Phoenix Pension and Provident Fund Ltd. (formerly The Phoenix Excellence - |
|
| Pension and Provident Fund |
Pension and Provident Funds Ltd.), a wholly-owned subsidiary of the Company. | |
| The Phoenix | The Phoenix Advanced Investments Ltd. (formerly Halman Aldubi Investment | |
| Advanced | House Ltd.) is a wholly-owned subsidiary of The Phoenix Investments (see Section | |
| Investments | D below). | |
| The Phoenix | The Phoenix Capital Raising (2009) Ltd., a wholly-owned subsidiary of The Phoenix | |
| Capital Raising | Insurance. | |
| Belenus Lux S.a.r.l | The controlling shareholder of the Company is Belenus Lux S.à.r.l. (hereinafter - | |
| "Belenus"), which is held indirectly by Centerbridge Partners LP and Gallatin Point Capital LLC. Gallatin Point Capital LLC is held by Matthew Botein and Lewis (Lee) |
||
| Sachs. | ||
| Ad 120 | Ad 120 Residence Centers for Senior Citizens Ltd. is an investee of The Phoenix Insurance. |
|
| Phoeniclass | Phoeniclass Ltd., a subsidiary of The Phoenix Investments, holds approximately 67% of Phoeniclass's share capital. |
Following global macro-economic developments that took place in the first half of 2022 and in particular in the second quarter of 2022, inflation rates in Israel and across the world have increased. As part of the steps taken to keep inflation under control, central banks across the world, including the Bank of Israel, started announcing interest rates hikes.
Changes in inflation and interest rates affect the financial results of the Company and in particular those of The Phoenix Insurance. For more information regarding the effect on the Company's financial results of the change in interest rate in the reporting periods, see Note 7A below.
The Company calculates and publishes analyses on the financial results' sensitivity to changes in interest and inflation rates in the risk management note to its annual financial statements. The Company estimated the sensitivity of its results to changes in interest rates as of June 30, 2022, and according to this estimation, there is no material change in the sensitivity to changes in interest rates compared with the sensitivity calculated as of December 31, 2021. For further information as to the Company's sensitivity to changes in interest and inflation rates, see Note 41 to the Company's Annual Financial Report as of December 31, 2021.
The Company also tested for impairment assets measured in accordance with IAS 36 and IAS 28 and concluded that their recoverable amount exceeds their fair value.

In January 2022, the board of directors of The Phoenix Advanced Investments authorized a restructuring of the companies it controls and the distribution of the following companies that it holds to the Company, as a dividend in kind: Halman-Aldubi Pension Insurance Agency (2005) Ltd. and Quality Pension Insurance Agency (2017) Ltd., and 16% of the shares it holds in The Phoenix Pension and Provident. It should be noted that the decision by The Phoenix Advanced Investments' Board of Directors is subject to the Court's approval since it does not meet the profit criteria. In May 2022, the Court's approval for the distribution was received. As of the report publication date, the Israel Tax Authority's approval for the restructuring has not been received.
Furthermore, The Phoenix Advanced Investments' Board of Directors approved the sale of Halman-Aldubi IEC Gemel Ltd. to the Company; this sale was completed in March 2022.
At the same time, the Company authorized the transfer of its holding in The Phoenix Advanced Investments to The Phoenix Investments, and The Phoenix Investments authorized the transfer of its holdings in the alternative funds it holds to The Phoenix Advanced Investments. When this process is complete, the alternative investments activities will be managed in its entirety under The Phoenix Advanced Investments.
Further to what is stated in Note 1K to the Consolidated Annual Financial Statements regarding the transfer of 49% of the issued and paid up share capital of Phoeniclass from The Phoenix Insurance to The Phoenix Insurance, on March 31, 2022, the said transfer of shares was completed upon receipt of the approval of the Israel Tax Authority, which was a condition precedent for the completion of the transaction.
As part of the completion of the transfer of Phoeniclass' shares to The Phoenix Insurance, and in accordance with the illiquid assets allocation circular applicable to The Phoenix Insurance, the latter carried out a valuation of Phoeniclass' shares through an external independent appraiser. In accordance with the valuation, during the first quarter of 2022 The Phoenix Insurance recognized a one-off pre-tax earning of NIS 99 million from revaluation of excess fair value of the investment against LAT in the health insurance subsegment.
As of the report date, Excellence holds approximately 84% of the shares of KSM ETN Holdings Ltd. (hereinafter - "KSM Holdings"), and 16% of the shares of KSM are held by three partners (hereinafter - the "Minority Shareholders in KSM Holdings"), of which approximately 9.55% of the shares are held by Avner Hadad and Boaz Nagar, pari passu (hereinafter - the "Managers"). In May 2022, the parties signed binding agreements, and an application for a statutory merger of KSM ETN Holdings Ltd. (hereinafter - "KSM Holdings") with Excellence. Following the merger and further actions, the Company holds through The Phoenix Investments 88.44% of the shares of Excellence and the minority shareholders in KSM Holdings hold approximately 11.56% of the shares of Excellence, of which the share of Avner Hadad and Boaz Nagar will be 7.5%. Furthermore, options arrangements were established to execute transactions, from 2016 to 2029, between The Phoenix Investments and the Managers in connection with their holdings in Excellence at the market price to be determined, in accordance with an agreed-upon mechanism, based on valuations. The said arrangements enable the Company to pay the Managers the consideration by allotting them shares of the Company by way of a private placement, provided the options are exercised and at the Company's discretion. In accordance with the agreements that were signed, Excellence intends to focus on managing the core business of Excellence, which includes the activity of KSM Mutual Funds, the TASE member, portfolio management and ESOP. Other activities were transferred from Excellence to other group companies as stated in Section D above. For further details, please see immediate report dated March 15, 2022 (Ref. No.: 2022-01-025548).

The Consolidated Interim Financial Statements have been prepared in accordance with generally accepted accounting principles for the preparation of interim financial statements as prescribed by IAS 34, "Interim Financial Reporting", as well as in accordance with the disclosure requirements set by the Commissioner of the Capital Market, Insurance and Savings in accordance with the Financial Services Supervision Law (Insurance), 1981. In addition, the financial statements were prepared in accordance with the disclosure provisions in Chapter D of the Securities Regulations (Periodic and Immediate Reports), 1970, insofar as these regulations apply to a corporation consolidating an insurance company.
In preparing the condensed financial statements in accordance with International Financial Reporting Standards (IFRS), the Company is required to exercise discretion in assessments, estimates and assumptions that affect the implementation of the policy and the amounts of assets and liabilities, income and expenses. It is clarified that the actual results may differ from those estimates. Management's discretion in applying the group's accounting policies and the key assumptions used in assessments involving uncertainty is consistent with that which is applied in the preparation of the annual financial statements. For further information regarding changes in critical estimates and assumptions used to calculate the insurance reserves, please see Note 8.A.
The accounting policies applied in the preparation of the Consolidated Interim Financial Statements are consistent with those implemented in the preparation of the Consolidated Annual Financial Statements, with the exception of what is stated below:
In May 2020, the IASB published an amendment to IAS 16 (hereinafter - the "Amendment"). The amendment prohibits the deduction of proceeds received from the sale of items manufactured while a company is preparing its property, plant and equipment for its designated use from its cost. Rather, the Company should recognize the proceeds from the sale and the related costs in profit or loss.
The Amendment shall be applied as from annual periods beginning on January 1, 2022. The Amendment was applied retrospectively, but only to property, plant, and equipment items that are brought to the location and condition necessary for them to operate in the manner intended by management at the beginning of the earliest annual reporting period presented in the financial statements in which the Company first applies the Amendment.
The cumulative effect of the first-time application of the Amendment is recognized as an adjustment to the opening balance of the retained earnings (or other equity component, where relevant) at the beginning of the earliest period presented.
The above Amendment did not have a material effect on the consolidated interim financial statements of the Company.
In May 2020, the IASB issued an amendment to IAS 37 regarding costs that a company must include in assessing whether a contract is an onerous contract (hereinafter - the "Amendment"). According to the amendment, the testing should include both incremental costs (such as raw materials and direct working hours) and the allocation of other costs directly related to the fulfillment of the contract (such as amortization of property, plant, and equipment used to fulfill the contract).

The Amendment shall be applied to annual reporting periods starting on January 1, 2022; the Amendment will apply to contracts for which the obligations have not yet been fulfilled as of January 1, 2022.
The Company believes that the above amendments are not expected to have a material effect on the financial statements.
In May 2020, the IASB published an amendment to IFRS 3 - Business Combinations - which updated the reference to the Conceptual Framework. The amendment was designed to replace a reference to the Conceptual Framework for Preparation and Presentation of Financial Statements with a reference to the Conceptual Framework for Financial Reporting published in March 2018 without significantly changing its requirements.
The amendment adds an exception to the principle of recognizing a liability in accordance with IFRS 3, in order to avoid recognizing a day 2 profit or loss stemming from liabilities and contingent liabilities, that would have been within the scope of IAS 37 or IFRIC 21, had they been recognized separately.
In accordance with the exception, liabilities or contingent liabilities which are within the scope of IAS 37 or IFRIC 21 shall be recognized on acquisition date in accordance with the provisions of IAS 37 or IFRIC 21, rather than in accordance with the Conceptual Framework.
The amendment also clarifies that contingent assets will not be recognized on the business combination date.
The amendment will be applied prospectively for annual reporting periods beginning on January 1, 2022.
The above Amendment did not have a material effect on the interim financial statements of the Company.
Further to what is stated in Note 2FF(1) to the Annual Financial Statements regarding the draft "Revised Roadmap for the Adoption of International Financial Reporting Standard (IFRS) 17 - Insurance Contracts", published by the Capital Market, Insurance and Savings Authority on January 5, 2022. (hereinafter - the "Roadmap"). On May 23, 2022, the Capital Market, Insurance and Savings Authority published the final text of the said Roadmap (hereinafter - the "Revised Roadmap"). The Revised Roadmap did not change the first-time application date of IFRS 17 in Israel, that will take place starting with the quarterly and annual periods beginning on January 1, 2024; (accordingly, the transition date shall apply on January 1, 2023). However, the Revised Roadmap includes a small number of updates in relation to the draft Roadmap. In accordance with the Revised Roadmap, as part of the financial statements for the second quarter of 2023 and the 2023 annual financial statements companies will be required to include - in a dedicated note to the financial statements - key proforma statements (statement of financial position and statement of comprehensive income at the very least, and without comparative figures), that will be prepared in accordance with the provisions of IFRS 17 and IFRS 9 according to the disclosure format attached to the Revised Roadmap.

Furthermore, the Revised Roadmap lists the key preparations and time tables that the Capital Market, Insurance and Savings Authority believes should be taken and met in order to ensure Israeli insurance companies' preparedness for a successful application of the standard, including, among other things, in connection with the adaptation of the IT system, completion of the formulation of accounting policies and preparations for the various required disclosures, conducting a quantitative assessment as to fair value in the lead up to the transition date, preparations for the calculation of the risk adjustment for non-financial risk, and preparations for the independent auditors' audit.
The Company continues assessing the effects of the adoption of the said standards on its financial statements, and is preparing for the adoption of the standard.
| CPI | Representative exchange rate of |
||||
|---|---|---|---|---|---|
| Known CPI % |
In lieu CPI % |
US dollar % |
|||
| For the six months ended on: | |||||
| June 30, 2022 | 3.1 | 3.2 | 12.5 | ||
| June 30, 2021 | 1.4 | 1.6 | 1.4 | ||
| For the three months ended on: | |||||
| June 30, 2022 | 1.9 | 1.7 | 10.2 | ||
| June 30, 2021 | 1.3 | 0.8 | (2.2) | ||
| For the year ended December 31, 2021 | 2.4 | 2.8 | (3.3) |

The Company operates in the following operating segments:
The life insurance and savings segment includes the life insurance subsegments and related coverages. The segment includes various categories of insurance policies as well insurance coverages in respect of various risks such as: death, disability, permanent health insurance, and more.
The health insurance segment includes the group's health insurance activity. The segment includes long-term care, medical expenses, surgery and transplants, dental, travel and foreign workers insurance and more.
The property and casualty insurance segment includes the liability and property subsegments. In accordance with the Commissioner's directives, the property and casualty insurance segment in Israel is broken down into compulsory motor insurance, motor property, other property and other liability subsegments:
▪ Compulsory motor insurance subsegment
The compulsory motor subsegment focuses on coverage, the purchase of which by the vehicle owner or driver is mandatory, in respect of bodily injury caused as a result of the use of a motor vehicle (to the driver, passengers, or pedestrians).
The motor property subsegment focuses on coverage against property damage to the policyholder's vehicle and third-party property damage caused by the insured vehicle.
▪ Other liability subsegments
The liability subsegments provide coverage in respect of the policyholder's liability for any thirdparty damage he/she may cause. These subsegments include: third-party liability, employers' liability, professional liability and product liability.
▪ Property and other subsegments Property subsegments other than motor and liability as well as other insurance subsegments.
As from December 31, 2021, the Company presents the pension and provident activity as a reportable segment for the first time; through the said date, the activity was presented as part of the long-term savings segment. The comparative figures in the operating segments note were revised retrospectively as required under accounting standards.
As part of the implementation of the Company's strategy in the field of asset management in general and in the pension and provident activities in particular, on December 7, 2020 the Company entered into a merger agreement with Halman-Aldubi, such that as from March 31, 2021, upon the completion of the transaction, the Company consolidates Halman-Aldubi's results in its financial statements.
The pension and provident segment includes the management of pension funds and provident funds through The Phoenix Pension and Provident, which is a wholly-owned subsidiary of the Company.

In accordance with the Commissioner's directives, segment activity is described separately for the pension activity and the provident activity.
For more information, see Note 4A to the consolidated financial statements as of December 31, 2021.
The financial services segment includes Excellence's results. The segment includes investment management activity, including mutual funds, ETFs, brokerage services, underwriting services, market making in various securities and other services.
In addition, the results of this segment include those of The Phoenix Investments and The Phoenix Advanced Investments.
The insurance agencies segment includes the activity of the pension arrangement agencies and other insurance agencies in the group.
The credit segment includes Gama. Gama is a credit aggregator providing financing against postdated checks (factoring), clearing, and management of credit vouchers services, financing against real estate properties, loans and credit, equipment financing and supplier financing. As of June 2021, as a result of assuming control over Gama, the Company presents the company's results as a reportable segment. Until this date, Gama's results were presented under the "Other segment". For more information, please see Note 4B to the 2021 consolidated financial statements.
This activity includes part of the group's HQ function that is not attributed to the operating segments, activities which are ancillary/overlapping with the group's activity and holding assets and liabilities against the Company's share capital in accordance with the Capital Regulations. Financial liabilities that serve the Company's equity requirements and finance expenses in respect thereof are not allocated to the operating segments.
As of the fourth quarter of 2021, the Company has classified the operations included under the "Other segment" to the "Financial services segment". The comparative figures have been reclassified. The said reclassification has no material effect on the financial services segment.
It should be noted that the Company allocates the assets which are not measured at fair value in accordance with the provisions of the law and Company's procedures, and specifically the allocation in accordance with the consolidated circular on testing the appropriateness of the LAT reserve (for more information, see Note 41, Section 5.1 to the consolidated financial statements as of December 31, 2021). This allocation may have an effect on investment income allocated to the different segments.

| For the 6-month period ended June 30, 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance and savings (a) |
Health (b) | Property and casualty insurance (c) |
Pension and provident funds (d) |
Financial services |
Insurance agencies |
Credit | Not attributed to operating segments |
Adjustments and offsets |
Total | |
| Unaudited | ||||||||||
| Premiums earned, gross | 2,916,520 | 1,479,230 | 1,637,059 | - | NIS thousand - |
- | - | - | - | 6,032,809 |
| Premiums earned by reinsurers | 164,347 | 106,451 | 521,187 | - | - | - | - | - | - | 791,985 |
| Premiums earned - retention | 2,752,173 | 1,372,779 | 1,115,872 | - | - | - | - | - | - | 5,240,824 |
| Investment income (losses), net and finance income | (4,652,642) | (665,610) | 79,815 | 50,829 | 4,417 | 4,498 | 29,851 | (270,761) | (15,769) | (5,435,372) |
| Income from management fees | 298,435 | - | - | 328,313 | 155,826 | 1,589 | - | 2,055 | (24,174) | 762,044 |
| Income from fees and commissions (e) | 38,545 | 26,960 | 121,265 | - | - | 353,652 | - | - | (110,157) | 430,265 |
| Income from financial services | - | - | - | - | 101,000 | - | - | - | - | 101,000 |
| Income from factoring and clearing | - | - | - | - | - | - | 63,827 | - | - | 63,827 |
| Other income | - | - | - | 14,853 | 91,367 | 31,302 | - | 2 | (737) | 136,787 |
| Total income | (1,563,489) | 734,129 | 1,316,952 | 393,995 | 352,610 | 391,041 | 93,678 | (268,704) | (150,837) | 1,299,375 |
| Payments and change in liabilities in respect of insurance contracts | ||||||||||
| and investment contracts, gross | (2,346,987) | (258,730) | 1,269,744 | 53,415 | - | - | - | - | - | (1,282,558) |
| Reinsurers' share in payments and in changes in liabilities in respect of | ||||||||||
| insurance contracts | 121,965 | 139,514 | 345,815 | - | - | - | - | - | - | 607,294 |
| Payments and change in liabilities in respect of insurance contracts | ||||||||||
| and investment contracts - retention | (2,468,952) | (398,244) | 923,929 | 53,415 | - | - | - | - | - | (1,889,852) |
| Fees and commissions and other purchase expenses | 277,629 | 227,294 | 319,029 | 150,384 | 36,500 | 8,854 | 2,410 | - | (99,933) | 922,167 |
| General and administrative expenses | 187,477 | 75,733 | 60,836 | 113,535 | 165,388 | 204,951 | 44,538 | 52,617 | (27,617) | 877,458 |
| Other expenses (income) | (353) | - | - | 10,286 | 6,453 | 11,290 | 4,059 | - | (226) | 31,509 |
| Finance expenses (income) | 1,044 | - | 19,777 | 7,627 | (2,758) | 1,344 | 19,205 | 118,306 | (14,440) | 150,105 |
| Total expenses | (2,003,155) | (95,217) | 1,323,571 | 335,247 | 205,583 | 226,439 | 70,212 | 170,923 | (142,216) | 91,387 |
| Company's share in the net results of investees | 16,899 | 12,456 | (2,969) | - | 1,397 | 2,491 | - | - | - | 30,274 |
| Profit (loss) before taxes on income | 456,565 | 841,802 | (9,588) | 58,748 | 148,424 | 167,093 | 23,466 | (439,627) | (8,621) | 1,238,262 |
| Other comprehensive income (loss) before taxes on income | 20,934 | 1,249 | (224,814) | - | (1,035) | - | 850 | (296,938) | - | (499,754) |
| 477,499 | 843,051 | (234,402) | 58,748 | 147,389 | 167,093 | 24,316 | (736,565) | (8,621) | 738,508 | |
| Total comprehensive income (loss) before taxes on income | ||||||||||
| June 30, 2022 | ||||||||||
| Unaudited | ||||||||||
| NIS thousand | ||||||||||
| Liabilities, gross in respect of insurance contracts and yield-dependent | 87,356,951 | 5,757,805 | - | - | - | - | - | - | - | 93,114,756 |
| investment contracts Liabilities, gross in respect of insurance contracts and non-yield |
||||||||||
| dependent investment contracts | 12,340,232 | 4,661,998 | 7,323,289 | 989,994 | - | - | - | - | - | 25,315,513 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.

| For the 6-month period ended June 30, 2021 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance |
Property and casualty |
Pension and |
Not attributed to |
|||||||
| and savings | Health | insurance | provident | Financial | Insurance | operating | Adjustments | |||
| (a) | (b) | (c) | funds (d) | services | agencies | Credit | segments | and offsets | Total | |
| Unaudited NIS thousand |
||||||||||
| Premiums earned, gross | 2,595,541 | 1,332,330 | 1,433,549 | - | - | - | - | - | - | 5,361,420 |
| Premiums earned by reinsurers | 57,817 | 104,968 | 484,448 | - | - | - | - | - | - | 647,233 |
| Premiums earned - retention | 2,537,724 | 1,227,362 | 949,101 | - | - | - | - | - | - | 4,714,187 |
| Investment income, net and finance income | 7,051,573 | 659,698 | 195,043 | 46,011 | 2,190 | 12,294 | - | 190,156 | (12,632) | 8,144,333 |
| Income from management fees | 630,190 | - | - | 240,216 | 166,339 | 380 | - | 1,598 | (23,172) | 1,015,551 |
| Income from fees and commissions (e) | 16,522 | 25,209 | 107,169 | - | - | 260,458 | - | - | (70,687)(1) | 338,671 |
| Income from financial services | - | - | - | - | 76,000 | - | - | - | - | 76,000 |
| Other income | 10,944 | 699 | - | 408 | 2,446 | 8,901 | 240,292 | 352 | (691) | 263,351 |
| Total income | 10,246,953 | 1,912,968 | 1,251,313 | 286,635 | 246,975 | 282,033 | 240,292 | 192,106 | (107,182) | 14,552,093 |
| Payments and change in liabilities in respect of insurance contracts and investment | ||||||||||
| contracts, gross | 9,237,222 | 1,599,697 | 963,341 | 35,546 | - | - | - | - | - | 11,835,806 |
| Reinsurers' share in payments and in changes in liabilities in respect of insurance | ||||||||||
| contracts | 21,982 | (25,430) | 311,139 | - | - | - | - | - | - | 307,691 |
| Payments and change in liabilities in respect of insurance contracts and investment | ||||||||||
| contracts - retention | 9,215,240 | 1,625,127 | 652,202 | 35,546 | - | - | - | - | - | 11,528,115 |
| Fees and commissions and other purchase expenses | 257,693 | 202,837 | 283,272 | 98,624 | 29,886 | 2,720 | - | - | (58,703) | 816,329 |
| General and administrative expenses | 199,705 | 73,347 | 65,558 | 116,166 | 145,586 | 162,208 | 3,966 | 51,634 | (29,427) | 788,743 |
| Other expenses | 7,967 | - | - | 5,612 | 6,000 | 8,267 | - | 305 | (228) | 27,923 |
| Finance expenses | 17,243 | 553 | 3,008 | 2,072 | 2,269 | 558 | - | 89,003 | (11,273) | 103,433 |
| Total expenses | 9,697,848 | 1,901,864 | 1,004,040 | 258,020 | 183,741 | 173,753 | 3,966 | 140,942 | (99,631) | 13,264,543 |
| Company's share in the net results of investees | 19,976 | 1,033 | (628) | - | 847 | 2,615 | (618) | 1 | - | 23,226 |
| Profit before income tax | 569,081 | 12,137 | 246,645 | 28,615 | 64,081 | 110,895 | 235,708 | 51,165 | (7,551) | 1,310,776 |
| Other comprehensive income before taxes on income | 93,323 | 6,723 | 163,052 | - | 465 | - | - | 77,684 | - | 341,247 |
| 662,404 | 18,860 | 409,697 | 28,615 | 64,546 | 110,895 | 235,708 | 128,849 | (7,551) | 1,652,023 | |
| Total comprehensive income before taxes on income | ||||||||||
| June 30, 2021 Unaudited |
||||||||||
| NIS thousand | ||||||||||
| Liabilities, gross in respect of insurance contracts and yield-dependent investment | ||||||||||
| contracts | 80,335,256 | 5,828,041 | - | - | - | - | - | - | - | 86,163,297 |
| Liabilities, gross in respect of insurance contracts and non-yield-dependent | ||||||||||
| investment contracts | 12,267,371 | 4,578,695 | 6,514,802 | 936,175 | - | - | - | - | - | 24,297,043 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.

| For the 3-month period ended June 30, 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance and savings (a) |
Health (b) | Property and casualty insurance (c) |
Pension and provident funds (d) |
Financial services |
Insurance agencies |
Credit | Not attributed to operating segments |
Adjustments and offsets |
Total | |
| Unaudited | ||||||||||
| NIS thousand | ||||||||||
| Premiums earned, gross | 1,418,185 | 755,168 | 845,068 | - | - | - | - | - | - | 3,018,421 |
| Premiums earned by reinsurers | 83,068 | 54,799 | 262,925 | - | - | - | - | - | - | 400,792 |
| Premiums earned - retention | 1,335,117 | 700,369 | 582,143 | - | - | - | - | - | - | 2,617,629 |
| Investment income (losses), net and finance income | (3,884,676) | (572,269) | (21,967) | 27,419 | 3,431 | 2,010 | 16,317 | (314,114) | (10,019) | (4,753,868) |
| Income from management fees | 148,360 | - | - | 168,199 | 81,024 | 1,589 | - | 1,215 | (11,188) | 389,199 |
| Income from fees and commissions (e) | 20,646 | 12,041 | 59,286 | - | - | 180,115 | - | - | (75,037) | 197,051 |
| Income from financial services | - | - | - | - | 57,000 | - | - | - | - | 57,000 |
| Income from factoring and clearing | - | - | - | - | - | - | 35,215 | - | - | 35,215 |
| Other income | - | - | - | 14,538 | 90,012 | 27,916 | - | - | (362) | 132,104 |
| Total income | (2,380,553) | 140,141 | 619,462 | 210,156 | 231,467 | 211,630 | 51,532 | (312,899) | (96,606) | (1,325,670) |
| Payments and change in liabilities in respect of insurance contracts and | ||||||||||
| investment contracts, gross | (2,737,755) | (87,124) | 576,971 | 30,530 | - | - | - | - | - | (2,217,378) |
| Reinsurers' share in payments and in changes in liabilities in respect of | ||||||||||
| insurance contracts | 66,076 | 85,437 | 156,624 | - | - | - | - | - | - | 308,137 |
| Payments and change in liabilities in respect of insurance contracts and | ||||||||||
| investment contracts - retention | (2,803,831) | (172,561) | 420,347 | 30,530 | - | - | - | - | - | (2,525,515) |
| Fees and commissions and other purchase expenses | 134,920 | 117,697 | 172,874 | 80,489 | 17,571 | 4,168 | 1,123 | - | (70,160) | 458,682 |
| General and administrative expenses | 94,287 | 36,688 | 30,321 | 51,599 | 85,497 | 106,270 | 22,884 | 29,978 | (12,932) | 444,592 |
| Other expenses (income) | (1,503) | - | - | 4,944 | 3,453 | 6,116 | 2,029 | - | (113) | 14,926 |
| Finance expenses (income) | 425 | - | 16,175 | 4,532 | (557) | 752 | 13,392 | 65,099 | (9,354) | 90,464 |
| Total expenses | (2,575,702) | (18,176) | 639,717 | 172,094 | 105,964 | 117,306 | 39,428 | 95,077 | (92,559) | (1,516,851) |
| Company's share in the net results of investees | 9,766 | 17,262 | (2,221) | - | 641 | 907 | - | - | - | 26,355 |
| Profit (loss) before taxes on income | 204,915 | 175,579 | (22,476) | 38,062 | 126,144 | 95,231 | 12,104 | (407,976) | (4,047) | 217,536 |
| Other comprehensive income (loss) before taxes on income | 108,755 | 12,141 | (69,459) | - | (1,269) | (260) | - | (57,937) | - | (8,029) |
| Total comprehensive income (loss) before taxes on income | 313,670 | 187,720 | (91,935) | 38,062 | 124,875 | 94,971 | 12,104 | (465,913) | (4,047) | 209,507 |
| June 30, 2022 | ||||||||||
| Unaudited | ||||||||||
| NIS thousand | ||||||||||
| Liabilities, gross in respect of insurance contracts and yield-dependent | ||||||||||
| investment contracts | 87,356,951 | 5,757,805 | - | - | - | - | - | - | - | 93,114,756 |
| Liabilities, gross in respect of insurance contracts and non-yield | ||||||||||
| dependent investment contracts | 12,340,232 | 4,661,998 | 7,323,289 | 989,994 | - | - | - | - | - | 25,315,513 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.

| For the 3-month period ended June 30, 2021 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance |
Property and casualty |
Pension and |
Not attributed to |
|||||||
| and savings | Health | insurance | provident | Financial | Insurance | operating | Adjustments | |||
| (a) | (b) | (c) | funds (d) | services | agencies | Credit | segments | and offsets | Total | |
| Unaudited NIS thousand |
||||||||||
| Premiums earned, gross | 1,333,728 | 671,700 | 737,670 | - | - | - | - | - | - | 2,743,098 |
| Premiums earned by reinsurers | 29,799 | 53,257 | 253,233 | - | - | - | - | - | - | 336,289 |
| Premiums earned - retention | 1,303,929 | 618,443 | 484,437 | - | - | - | - | 2,406,809 | ||
| Investment income, net and finance income | 3,678,634 | 333,533 | 100,856 | 29,506 | 1,333 | 7,899 | - | 146,228 | (8,251) | 4,289,738 |
| Income from management fees | 306,766 | - | - | 141,057 | 89,925 | 152 | - | 836 | (10,058) | 528,678 |
| Income from fees and commissions (e) | 7,953 | 12,854 | 52,990 | - | - | 135,144 | - | - | (37,897)(1) | 171,044 |
| Income from financial services | - | - | - | - | 35,000 | - | - | - | - | 35,000 |
| Other income (expenses) | 5,643 | 360 | - | 218 | 1,119 | 4,599 | 240,292 | (1,300) | (486) | 250,445 |
| Total income | 5,302,925 | 965,190 | 638,283 | 170,781 | 127,377 | 147,794 | 240,292 | 145,764 | (56,692) | 7,681,714 |
| Payments and change in liabilities in respect of insurance contracts and | ||||||||||
| investment contracts, gross | 4,751,884 | 755,209 | 499,310 | 23,474 | - | - | - | - | - | 6,029,877 |
| Reinsurers' share in payments and in changes in liabilities in respect of | ||||||||||
| insurance contracts | 11,231 | (80,123) | 172,720 | - | - | - | - | - | - | 103,828 |
| Payments and change in liabilities in respect of insurance contracts and | ||||||||||
| investment contracts - retention | 4,740,653 | 835,332 | 326,590 | 23,474 | - | - | - | - | - | 5,926,049 |
| Fees and commissions and other purchase expenses | 130,474 | 101,907 | 156,066 | 54,788 | 18,886 | 2,720 | - | - | (28,935) | 435,906 |
| General and administrative expenses | 101,242 | 35,609 | 34,303 | 70,402 | 73,098 | 82,019 | 1,275 | 41,765 | (14,701) | 425,012 |
| Other expenses | 3,918 | - | - | 5,336 | 3,000 | 5,036 | - | 1 | (113) | 17,178 |
| Finance expenses (income) | 13,319 | 501 | (2,496) | 2,069 | 1,189 | 422 | - | 54,456 | (7,572) | 61,888 |
| Total expenses | 4,989,606 | 973,349 | 514,463 | 156,069 | 96,173 | 90,197 | 1,275 | 96,222 | (51,321) | 6,866,033 |
| Company's share in the net results of investees | 9,455 | 418 | 539 | - | 786 | 1,028 | (5,028) | 1 | - | 7,199 |
| Profit (loss) before taxes on income | 322,774 | (7,741) | 124,359 | 14,712 | 31,990 | 58,625 | 233,989 | 49,543 | (5,371) | 822,880 |
| Other comprehensive income (loss) before taxes on income | 63,280 | 3,615 | 107,816 | - | (122) | - | - | 106,627 | - | 281,216 |
| 386,054 | (4,126) | 232,175 | 14,712 | 31,868 | 58,625 | 233,989 | 156,170 | (5,371) | 1,104,096 | |
| Total comprehensive income (loss) before taxes on income | ||||||||||
| June 30, 2021 | ||||||||||
| Unaudited NIS thousand |
||||||||||
| Liabilities, gross in respect of insurance contracts and yield-dependent | ||||||||||
| investment contracts | 80,335,256 | 5,828,041 | - | - | - | - | - | - | - | 86,163,297 |
| Liabilities, gross in respect of insurance contracts and non-yield | ||||||||||
| dependent investment contracts | 12,267,371 | 4,578,695 | 6,514,802 | 936,175 | - | - | - | - | - | 24,297,043 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.

| For the year ended December 31, 2021 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance and savings (a) |
Health (b) |
Property and casualty insurance (c) |
Pension and provident funds (d) |
Financial services |
Insurance agencies |
Credit | Not attributed to operating segments |
Adjustments and offsets |
Total | |
| Audited | ||||||||||
| NIS thousand | ||||||||||
| Premiums earned, gross | 5,422,835 | 2,735,295 | 3,003,301 | - | - | - | - | - | - | 11,161,431 |
| Premiums earned by reinsurers | 117,372 | 212,807 | 1,015,280 | - | - | - | - | - | - | 1,345,459 |
| Premiums earned - retention | 5,305,463 | 2,522,488 | 1,988,021 | - | - | - | - | - | - | 9,815,972 |
| Investment income, net and finance income | 12,538,375 | 1,134,567 | 357,247 | 87,687 | 3,342 | 21,453 | 25,033 | 482,791 | (23,570) | 14,626,925 |
| Income from management fees | 1,217,741 | - | - | 542,942 | 335,707 | 380 | - | 4,112 | (51,516) | 2,049,366 |
| Income from fees and commissions (e) | 37,401 | 51,859 | 233,640 | - | - | 569,036 | - | - | (200,522) | 691,414 |
| Income from financial services | - | - | - | - | 154,000 | - | - | - | - | 154,000 |
| Income from factoring and clearing | - | - | - | - | - | - | 52,871 | - | - | 52,871 |
| Other income | 224,543 | 188,680 | - | 2,712 | 8,526 | 44,485 | 240,292 | 123 | (1,175) | 708,186 |
| Total income | 19,323,523 | 3,897,594 | 2,578,908 | 633,341 | 501,575 | 635,354 | 318,196 | 487,026 | (276,783) | 28,098,734 |
| Increase in insurance liabilities and payments in respect of insurance | ||||||||||
| contracts | 17,087,723 | 3,442,141 | 2,060,741 | 67,411 | - | - | - | - | - | 22,658,016 |
| Reinsurers' share in payments and in changes in liabilities in respect of | ||||||||||
| insurance contracts | 50,414 | 115,238 | 636,440 | - | - | - | - | - | - | 802,092 |
| Payments and change in liabilities in respect of insurance contracts and | ||||||||||
| investment contracts - retention | 17,037,309 | 3,326,903 | 1,424,301 | 67,411 | - | - | - | - | - | 21,855,924 |
| Fees and commissions and other purchase expenses | 531,826 | 424,718 | 629,755 | 219,693 | 62,862 | 8,905 | 1,754 | 196 | (183,634) | 1,696,075 |
| General and administrative expenses | 399,875 | 150,508 | 132,198 | 274,197 | 313,769 | 337,422 | 43,347 | 81,170 | (57,169) | 1,675,317 |
| Other expenses | 15,127 | - | - | 16,185 | 12,000 | 18,691 | 4,059 | 1,845 | (453) | 67,454 |
| Finance expenses (income) | 28,877 | 2,607 | (1,507) | 7,406 | 6,706 | 2,049 | 10,610 | 182,784 | (21,530) | 218,002 |
| Total expenses | 18,013,014 | 3,904,736 | 2,184,747 | 584,892 | 395,337 | 367,067 | 59,770 | 265,995 | (262,786) | 25,512,772 |
| Company's share in the net results of investees | 93,614 | 8,624 | 497 | - | 4,860 | 4,539 | (630) | - | - | 111,504 |
| Profit before income tax | 1,404,123 | 1,482 | 394,658 | 48,449 | 111,098 | 272,826 | 257,796 | 221,031 | (13,997) | 2,697,466 |
| Other comprehensive income (loss) before taxes on income | 130,548 | 6,756 | 90,708 | - | 2,060 | (645) | (425) | 307,613 | - | 536,615 |
| Total comprehensive income before taxes on income | 1,534,671 | 8,238 | 485,366 | 48,449 | 113,158 | 272,181 | 257,371 | 528,644 | (13,997) | 3,234,081 |
| As of December 31, 2021 | ||||||||||
| Audited | ||||||||||
| NIS thousand | ||||||||||
| Liabilities, gross in respect of insurance contracts and yield-dependent | ||||||||||
| investment contracts | 89,264,766 | 6,363,818 | - | - | - | - | - | - | - | 95,628,584 |
| Liabilities, gross in respect of insurance contracts and non-yield-dependent | ||||||||||
| investment contracts | 12,350,253 | 5,104,796 | 6,708,588 | 949,349 | - | - | - | - | - | 25,112,986 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.

| Policies including a savings component (including appendices) by policy issuance date |
Policies without a savings component |
|||||
|---|---|---|---|---|---|---|
| Until Until |
Since 2004 | Risk insurance sold as a single policy |
||||
| 1990 (1) | 2003 | Yield dependent |
Individual | Group | Total | |
| Unaudited | ||||||
| NIS thousand | ||||||
| Gross premiums Proceeds in respect of investment contracts credited |
29,109 | 584,954 | 1,938,463 | 302,978 | 61,016 | 2,916,520 |
| directly to insurance reserves (4) Financial margin |
- | - | 4,522,230 | - | - | 4,522,230 |
| including management fees (2) Payments and change in liabilities in |
(44,355) | 100,044 (3) | 197,942 | - | - | 253,631 |
| respect of insurance contracts, gross Payments and change in liabilities |
127,077 | (1,540,181) (5) | 19,648 (5) | 170,031 | 54,638 | (1,168,787) |
| for investment contracts Total payments and change in liabilities from life insurance |
- | - | (1,178,200) (5) | - | - | (1,178,200) |
| and long-term savings Total comprehensive income (loss) from life insurance and |
(2,346,987) | |||||
| savings business | 386,404 (6) | 81,776 (6) | (9,550) | 13,365 | 5,504 | 477,499 |

| Policies including a savings component (including appendices) by policy issuance date |
Policies without a savings component |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Until | Until | Since 2004 Yield |
single policy | Risk insurance sold as a | ||||||||
| 1990 (1) | dependent | Individual | Group | Total | ||||||||
| 2003 | Unaudited | |||||||||||
| NIS thousand | ||||||||||||
| Gross premiums | 31,824 | 558,951 | 1,656,579 | 285,272 | 62,915 | 2,595,541 | ||||||
| Proceeds in respect of investment contracts |
||||||||||||
| credited directly to insurance reserves (4) |
- | - | 2,774,034 | - | - | 2,774,034 | ||||||
| Financial margin including management fees (2) |
233,490 | 464,175 (3) | 165,572 | - | - | 863,237 | ||||||
| Payments and change in liabilities in respect of insurance contracts, gross |
400,489 | 3,601,945 (5) | 4,240,515 (5) | 54,021 | 57,028 | 8,353,998 | ||||||
| Payments and change in liabilities for investment contracts |
- | - | 883,224 (5) | - | - | 883,224 | ||||||
| Total payments and change in liabilities from life insurance and long term savings Total comprehensive |
9,237,222 | |||||||||||
| income from life insurance business |
183,754 (6) | 326,160 (6) | 8,135 | 132,232 | 12,123 | 662,404 |

| Policies including a savings component (including appendices) by policy issuance date |
Policies without a savings component Risk insurance sold as a |
|||||
|---|---|---|---|---|---|---|
| Until 1990 (1) |
Until 2003 |
Since 2004 Yield dependent |
single policy Individual |
Group | Total | |
| Unaudited | ||||||
| NIS thousand | ||||||
| Gross premiums | 14,772 | 295,277 | 924,974 | 151,921 | 31,241 | 1,418,185 |
| Proceeds in respect of investment contracts |
||||||
| credited directly to insurance reserves (4) |
- | - | 1,829,247 | - | - | 1,829,247 |
| Financial margin including management fees (2) |
31,183 | 49,005 (3) | 99,134 | - | - | 179,322 |
| Payments and change in liabilities in respect of insurance contracts, gross |
88,918 | (1,420,614) (5) | (569,786) (5) | 82,192 | 27,983 | (1,791,307) |
| Payments and change in liabilities for investment contracts Total payments and change |
- | - | (946,448) (5) | - | - | (946,448) |
| in liabilities from life insurance and long-term savings Total comprehensive income |
(2,737,755) | |||||
| from the life insurance and savings businesses |
248,349 (6) | 44,286 (6) | 317 | 15,492 | 5,226 | 313,670 |

| Policies including a savings component (including appendices) by policy issuance date |
Policies without a savings component |
|||||||
|---|---|---|---|---|---|---|---|---|
| Since 2004 | Risk insurance sold as a single policy |
|||||||
| Until 1990 (1) |
Until 2003 |
Yield dependent |
Individual | Group | Total | |||
| Unaudited | ||||||||
| NIS thousand | ||||||||
| Gross premiums Proceeds in respect of investment contracts |
15,470 | 282,469 | 863,504 | 142,946 | 29,339 | 1,333,728 | ||
| credited directly to insurance reserves (4) |
- | - | 1,653,225 | - | - | 1,653,225 | ||
| Financial margin including management fees (2) |
109,201 | 219,652 (3) | 86,884 | - | - | 415,737 | ||
| Payments and change in liabilities in respect of insurance contracts, gross Payments and change in |
263,129 | 1,914,382 (5) |
2,123,312 (5) | (17,412) | 26,709 | 4,310,120 | ||
| liabilities for investment contracts Total payments and change in liabilities from life |
- | - | 441,764 (5) | - | - | 441,764 | ||
| insurance and long-term savings Total comprehensive income |
4,751,884 | |||||||
| (loss) from life insurance and savings business |
88,775 (6) | 182,925(6) | (430) | 108,473 | 6,311 | 386,054 |

| Policies including a savings component (including appendices) by policy issuance date |
Policies without a savings component Risk insurance sold as a single policy |
|||||
|---|---|---|---|---|---|---|
| Since 2004 | ||||||
| Until | Until | Yield | ||||
| 1990 (1) | 2003 | dependent Audited |
Individual | Group | Total | |
| NIS thousand | ||||||
| Gross premiums | 64,365 | 1,137,563 | 3,514,704 | 579,192 | 127,011 | 5,422,835 |
| Proceeds in respect of investment contracts credited |
||||||
| directly to insurance reserves (4) |
- | - | 7,757,707 | - | - | 7,757,707 |
| Financial margin including management fees (2) |
824,875 | 869,244 (3) | 347,578 | - | - | 2,041,697 |
| Payments and change in liabilities in respect of insurance contracts, gross |
767,923 | 6,617,590 (5) | 7,778,546 (5) | 209,818 | 118,551 | 15,492,428 |
| Payments and change in liabilities for investment contracts |
- | - | 1,595,295 (5) | - | - | 1,595,295 |
| Total payments and change in liabilities from life insurance and long-term savings Total comprehensive income |
17,087,723 | |||||
| from life insurance business (4) |
652,883 (6) | 664,113 (6) | 9,322 | 183,359 | 24,994 | 1,534,671 |

| For the 6-month period ended June 30, 2022 | |||||||
|---|---|---|---|---|---|---|---|
| Long-term care | Other (2) | ||||||
| Individual | Group | Long-term | Short term |
Total | |||
| Unaudited | |||||||
| Gross premiums Payments and change in |
132,214 | 541,539 | NIS thousand 777,055 (1) |
54,804 (1) | 1,505,612 | ||
| liabilities in respect of insurance contracts, gross |
(614,889) | (187,072) | 511,768 | 31,463 | (258,730) | ||
| Total comprehensive income from health insurance business |
762,668 (3) | 39,064 (3) | 41,952 | (633) | 843,051 |
(1) Of this, individual premiums in the amount of NIS 515,483 thousand and collective premiums in the amount of NIS 316,376 thousand.
| For the 6-month period ended June 30, 2021 | ||||||
|---|---|---|---|---|---|---|
| Long-term care | Other (2) | |||||
| Collective | ||||||
| Individual | (3) | Long-term | term | Total | ||
| Unaudited | ||||||
| NIS thousand | ||||||
| Gross premiums Payments and change in |
129,682 | 483,298 | 729,028(1) | 14,555(1) | 1,356,563 | |
| liabilities in respect of insurance contracts, gross Total comprehensive |
331,218 | 1,090,320 | 168,333 | 9,826 | 1,599,697 | |
| income (loss) from health insurance business |
(128,000) (3) | (42,860) (3) | 191,386 | (1,666) | 18,860 |
(1)Of this, individual premiums in the amount of NIS 436,808 thousand and collective premiums in the amount of NIS 306,775 thousand.
| For the 3-month period ended June 30, 2022 | |||||
|---|---|---|---|---|---|
| Long-term care | Other (2) | ||||
| Individual | Group | Long-term | Short-term | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Gross premiums | 66,587 | 273,418 | 382,285 (1) | 35,932 (1) | 758,222 |
| Payments and change in | |||||
| liabilities in respect of | (67,282) | (316,064) | 276,438 | 19,784 | (87,124) |
| insurance contracts, gross Total comprehensive |
|||||
| income (loss) from health | |||||
| insurance business | 139,572 (4) | 28,888 (4) | 17,737 | 1,523 | 187,720 |
(1) Of this, individual premiums in the amount of NIS 269,033 thousand and collective premiums in the amount of NIS 149,184 thousand.

| For the 3-month period ended June 30, 2021 | |||||||
|---|---|---|---|---|---|---|---|
| Long-term care Collective |
Other (2) Short |
||||||
| Individual | (3) | Long-term | term (7) | Total | |||
| Unaudited | |||||||
| NIS thousand | |||||||
| Gross premiums | 64,785 | 243,665 | 356,214 (1) | 10,560 (1) | 675,224 | ||
| Payments and change in | |||||||
| liabilities in respect of | |||||||
| insurance contracts, gross | 227,221 | 585,205 | (60,459) | 3,242 | 755,209 | ||
| Total comprehensive income | |||||||
| (loss) from health insurance business |
(137,582) (4) | (43,253) (4) | 176,969 | (260) | (4,126) |
(1) Of this, individual premiums in the amount of NIS 222,635 thousand and collective premiums in the amount of NIS 144,139 thousand.
| For the year ended December 31, 2021 | ||||||
|---|---|---|---|---|---|---|
| Long-term care | Other (2) | |||||
| Short | ||||||
| Individual | Group | Long-term | term | Total | ||
| Audited | ||||||
| NIS thousand | ||||||
| Gross premiums | 260,543 | 982,052 | 1,433,829 (1) | 61,440 (1) | 2,737,864 | |
| Payments and change in liabilities in respect of insurance contracts, gross |
760,897 | 1,967,249 | 677,734 | 36,261 | 3,442,141 | |
| Total comprehensive income (loss) from health insurance business |
(226,341) | (13,965) | 249,234 | (690) | 8,238 |
(1) Of this, individual premiums in the amount of NIS 924.266 thousand and collective premiums in the amount of NIS 571,003 thousand.
(2) The most material coverage included in other long-term health insurance is medical expenses; in short-term health insurance - travel insurance
(3) The profit in the six-month period ended June 30, 2022, includes a decrease in the insurance reserves (LAT) in the amount of approximately NIS 761 million, and the loss in the six-month period ended June 30, 2021 an increase in LAT of NIS 208 million.
(4) The profit in the three-month period ended June 30, 2022, includes a decrease in the insurance reserves (LAT) in the amount of approximately NIS 134 million, and the loss in the three-month period ended June 30, 2021 - an increase in LAT of NIS 168 million.

| For the 6-month period ended June 30, 2022 | |||||
|---|---|---|---|---|---|
| Compulsory motor insurance |
Motor property |
Property and other subsegments (*) |
Other liability subsegments (**) |
Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Gross premiums | 373,367 | 747,043 | 483,558 | 352,802 | 1,956,770 |
| Reinsurance premiums | 71,665 | 6 | 338,697 | 167,719 | 578,087 |
| Premiums - retention | 301,702 | 747,037 | 144,861 | 185,083 | 1,378,683 |
| Change in unearned premium | |||||
| balance, retention | 79,415 | 133,658 | 21,374 | 28,364 | 262,811 |
| Premiums earned - retention | 222,287 | 613,379 | 123,487 | 156,719 | 1,115,872 |
| Investment income, net and | |||||
| finance income | 34,101 | 10,281 | 3,511 | 31,922 | 79,815 |
| Income from fees and | |||||
| commissions | 32,325 | 153 | 69,628 | 19,159 | 121,265 |
| Total income | 288,713 | 623,813 | 196,626 | 207,800 | 1,316,952 |
| Payments and change in | |||||
| liabilities in respect of | |||||
| insurance contracts, gross | 329,391 | 528,245 | 140,223 | 271,885 | 1,269,744 |
| Reinsurers' share in | |||||
| payments and in changes in | |||||
| liabilities in respect of | |||||
| insurance contracts | 84,975 | 305 | 113,205 | 147,330 | 345,815 |
| Payments and change in | |||||
| liabilities for insurance | |||||
| contracts - retention | 244,416 | 527,940 | 27,018 | 124,555 | 923,929 |
| Fees and commissions, | |||||
| marketing expenses and other purchase expenses |
37,693 | 128,637 | 93,562 | 59,137 | 319,029 |
| General and administrative | |||||
| expenses | 13,573 | 22,828 | 13,130 | 11,305 | 60,836 |
| Finance expenses | 9,699 | - | 999 | 9,079 | 19,777 |
| Total expenses | 305,381 | 679,405 | 134,709 | 204,076 | 1,323,571 |
| Company's share in the net | |||||
| results of investees | (1,207) | (508) | (124) | (1,130) | (2,969) |
| Profit (loss) before taxes on | |||||
| income | (17,875) | (56,100) | 61,793 | 2,594 | (9,588) |
| Other comprehensive loss | |||||
| before taxes on income | (91,373) | (38,500) | (9,407) | (85,534) | (224,814) |
| Total comprehensive | |||||
| income (loss) for the | |||||
| period before taxes on | |||||
| income | (109,248) | (94,600) | 52,386 | (82,940) | (234,402) |
| Liabilities in respect of | |||||
| insurance contracts, | |||||
| gross, as of June 30, 2022 | |||||
| (unaudited) | 3,134,450 | 1,008,282 | 739,820 | 2,440,737 | 7,323,289 |
| Liabilities in respect of | |||||
| insurance contracts - | |||||
| retention - as of June 30, | |||||
| 2022 (unaudited) | 1,951,790 | 1,007,889 | 201,962 | 1,797,629 | 4,959,270 |
(*) Property and other insurance subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 83% of total premiums in these subsegments.
(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 80% of total premiums in these subsegments.

| For the 6-month period ended June 30, 2021 | |||||
|---|---|---|---|---|---|
| Property and | Other | ||||
| Compulsory | other | liability | |||
| motor | Motor | subsegments | subsegments | ||
| insurance | property | (*) | (**) | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Gross premiums | 328,682 | 590,981 | 388,696 | 304,398 | 1,612,757 |
| Reinsurance premiums | 138,432 | 1,020 | 258,589 | 132,284 | 530,325 |
| Premiums - retention Change in unearned premium |
190,250 | 589,961 | 130,107 | 172,114 | 1,082,432 |
| balance, retention | 34,158 | 69,555 | 12,139 | 17,479 | 133,331 |
| Premiums earned - retention | 156,092 | 520,406 | 117,968 | 154,635 | 949,101 |
| Investment income, net and | |||||
| finance income | 79,823 | 29,247 | 8,546 | 77,427 | 195,043 |
| Income from fees and | |||||
| commissions | 38,468 | 69 | 56,327 | 12,305 | 107,169 |
| Total income | 274,383 | 549,722 | 182,841 | 244,367 | 1,251,313 |
| Payments and change in | |||||
| liabilities in respect of | |||||
| insurance contracts, gross | 324,824 | 369,677 | 115,416 | 153,424 | 963,341 |
| Reinsurers' share in payments | |||||
| and in changes in liabilities in | |||||
| respect of insurance contracts | 168,574 | 335 | 90,396 | 51,834 | 311,139 |
| Payments and change in | |||||
| liabilities for insurance | |||||
| contracts - retention | 156,250 | 369,342 | 25,020 | 101,590 | 652,202 |
| Fees and commissions, | |||||
| marketing expenses and other | |||||
| purchase expenses General and administrative |
29,373 | 120,124 | 84,851 | 48,924 | 283,272 |
| expenses | 14,094 | 24,357 | 13,176 | 13,931 | 65,558 |
| Finance expenses | 1,448 | - | 155 | 1,405 | 3,008 |
| Total expenses | 201,165 | 513,823 | 123,202 | 165,850 | 1,004,040 |
| Company's share in the net | |||||
| results of investees | (256) | (96) | (27) | (249) | (628) |
| Net income before taxes on | |||||
| income | 72,962 | 35,803 | 59,612 | 78,268 | 246,645 |
| Other comprehensive income | |||||
| before taxes on income | 66,546 | 24,833 | 7,125 | 64,548 | 163,052 |
| Total comprehensive | |||||
| income for the period | |||||
| before taxes on income | 139,508 | 60,636 | 66,737 | 142,816 | 409,697 |
| Liabilities in respect of | |||||
| insurance contracts, gross, | |||||
| as of June 30, 2021 | |||||
| (unaudited) | 2,871,543 | 806,961 | 673,605 | 2,162,693 | 6,514,802 |
| Liabilities in respect of | |||||
| insurance contracts - retention - as of June 30, |
|||||
| 2021 (unaudited) | 1,756,615 | 805,986 | 193,210 | 1,734,889 | 4,490,700 |
(*) Property and other insurance subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 82% of total premiums in these subsegments.
(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 83% of total premiums in these subsegments.

| For the 3-month period ended June 30, 2022 | ||||||
|---|---|---|---|---|---|---|
| Compulsory motor insurance |
Motor property |
Property and other subsegments (*) |
Other liability subsegments (**) |
Total | ||
| Unaudited | ||||||
| NIS thousand | ||||||
| Gross premiums | 167,419 | 340,430 | 252,594 | 180,043 | 940,486 | |
| Reinsurance premiums | 32,775 | (12) | 188,348 | 92,609 | 313,720 | |
| Premiums - retention | 134,644 | 340,442 | 64,246 | 87,434 | 626,766 | |
| Change in unearned | ||||||
| premium balance, retention | 14,413 | 21,513 | 1,191 | 7,506 | 44,623 | |
| Premiums earned - retention | 120,231 | 318,929 | 63,055 | 79,928 | 582,143 | |
| Losses on investments, net | ||||||
| and finance income | (7,373) | (6,793) | (529) | (7,272) | (21,967) | |
| Income from fees and | ||||||
| commissions | 15,541 | 69 | 34,880 | 8,796 | 59,286 | |
| Total income | 128,399 | 312,205 | 97,406 | 81,452 | 619,462 | |
| Payments and change in | ||||||
| liabilities in respect of | ||||||
| insurance contracts, gross | 157,808 | 222,854 | 69,137 | 127,172 | 576,971 | |
| Reinsurers' share in | ||||||
| payments and in changes in | ||||||
| liabilities in respect of | ||||||
| insurance contracts | 31,643 | 74 | 56,039 | 68,868 | 156,624 | |
| Payments and change in | ||||||
| liabilities for insurance | ||||||
| contracts - retention | 126,165 | 222,780 | 13,098 | 58,304 | 420,347 | |
| Fees and commissions, | ||||||
| marketing expenses and | ||||||
| other purchase expenses | 19,039 | 72,027 | 52,738 | 29,070 | 172,874 | |
| General and administrative | ||||||
| expenses | 6,328 | 11,447 | 6,604 | 5,942 | 30,321 | |
| Finance expenses | 7,936 | - | 827 | 7,412 | 16,175 | |
| Total expenses | 159,468 | 306,254 | 73,267 | 100,728 | 639,717 | |
| Company's share in the net | ||||||
| results of investees | (904) | (378) | (95) | (844) | (2,221) | |
| Profit (loss) before taxes on | ||||||
| income | (31,973) | 5,573 | 24,044 | (20,120) | (22,476) | |
| Other comprehensive loss | ||||||
| before taxes on income | (28,536) | (11,484) | (3,286) | (26,153) | (69,459) | |
| Total comprehensive | ||||||
| income (loss) for the | ||||||
| period before taxes on | ||||||
| income | (60,509) | (5,911) | 20,758 | (46,273) | (91,935) | |
| Liabilities in respect of | ||||||
| insurance contracts, | ||||||
| gross, as of June 30, | ||||||
| 2022 (unaudited) | 3,134,450 | 1,008,282 | 739,820 | 2,440,737 | 7,323,289 | |
| Liabilities in respect of | ||||||
| insurance contracts - | ||||||
| retention - as of June 30, | 1,951,790 | 1,007,889 | 201,962 | 1,797,629 | 4,959,270 | |
| 2022 (unaudited) |
(*) Property and other insurance subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 85% of total premiums in these subsegments.
(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 80% of total premiums in these subsegments.

| For the 3-month period ended June 30, 2021 | |||||||
|---|---|---|---|---|---|---|---|
| Compulsory motor insurance |
Motor property |
Property and other subsegments (*) |
Other liability subsegments (**) |
Total | |||
| Unaudited | |||||||
| NIS thousand | |||||||
| Gross premiums | 142,754 | 261,540 | 160,150 | 140,720 | 705,164 | ||
| Reinsurance premiums | 59,365 | 439 | 107,759 | 69,957 | 237,520 | ||
| Premiums - retention | 83,389 | 261,101 | 52,391 | 70,763 | 467,644 | ||
| Change in unearned | |||||||
| premium balance, | |||||||
| retention | 2,121 | (3,885) | (6,929) | (8,100) | (16,793) | ||
| Premiums earned - retention |
81,268 | 264,986 | 59,320 | 78,863 | 484,437 | ||
| Investment income, net | |||||||
| and finance income | 40,986 | 15,643 | 4,502 | 39,725 | 100,856 | ||
| Income from fees and | |||||||
| commissions | 19,546 | 53 | 27,641 | 5,750 | 52,990 | ||
| Total income | 141,800 | 280,682 | 91,463 | 124,338 | 638,283 | ||
| Payments and change in | |||||||
| liabilities in respect of | |||||||
| insurance contracts, gross | 171,814 | 203,860 | 62,700 | 60,936 | 499,310 | ||
| Reinsurers' share in | |||||||
| payments and in changes | |||||||
| in liabilities in respect of | |||||||
| insurance contracts | 99,782 | 21 | 49,356 | 23,561 | 172,720 | ||
| Payments and change in | |||||||
| liabilities for insurance | |||||||
| contracts - retention | 72,032 | 203,839 | 13,344 | 37,375 | 326,590 | ||
| Fees and commissions, | |||||||
| marketing expenses and | |||||||
| other purchase expenses | 13,963 | 68,269 | 48,127 | 25,707 | 156,066 | ||
| General and administrative | |||||||
| expenses | 6,886 | 13,389 | 6,328 | 7,700 | 34,303 | ||
| Finance income | (1,205) | - | (121) | (1,170) | (2,496) | ||
| Total expenses | 91,676 | 285,497 | 67,678 | 69,612 | 514,463 | ||
| Company's share in the | |||||||
| net results of investees | 220 | 83 | 23 | 213 | 539 | ||
| Profit (loss) before taxes | |||||||
| on income | 50,344 | (4,732) | 23,808 | 54,939 | 124,359 | ||
| Other comprehensive | |||||||
| income before taxes on | |||||||
| income | 44,009 | 16,360 | 4,778 | 42,669 | 107,816 | ||
| Total comprehensive | |||||||
| income for the period | |||||||
| before taxes on income | 94,353 | 11,628 | 28,586 | 97,608 | 232,175 | ||
| Liabilities in respect of | |||||||
| insurance contracts, | |||||||
| gross, as of June 30, | |||||||
| 2021 (unaudited) | 2,871,543 | 806,961 | 673,605 | 2,162,693 | 6,514,802 | ||
| Liabilities in respect of | |||||||
| insurance contracts - | |||||||
| retention - as of June | 1,756,615 | 805,986 | 193,210 | 1,734,889 | 4,490,700 | ||
| 30, 2021 (unaudited) |
(*) Property and other insurance subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 81% of total premiums in these subsegments.
(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 83% of total premiums in these subsegments.

| For the year ended December 31, 2021 | |||||
|---|---|---|---|---|---|
| Compulsory motor insurance |
Motor property |
Property and other subsegments (*) |
Other liability subsegments (**) |
Total | |
| Audited | |||||
| NIS thousand | |||||
| Gross premiums | 653,843 | 1,155,436 | 759,375 | 586,698 | 3,155,352 |
| Reinsurance premiums | 270,705 | 1,759 | 512,033 | 263,550 | 1,048,047 |
| Premiums - retention | 383,138 | 1,153,677 | 247,342 | 323,148 | 2,107,305 |
| Change in unearned | 44,160 | 66,392 | 3,322 | 5,410 | 119,284 |
| premium balance, retention Premiums earned - retention |
338,978 | 1,087,285 | 244,020 | 317,738 | 1,988,021 |
| Investment income, net and finance income |
146,709 | 52,820 | 17,077 | 140,641 | 357,247 |
| Income from fees and | |||||
| commissions | 80,703 | 101 | 124,803 | 28,033 | 233,640 |
| 566,390 | 1,140,206 | 385,900 | 486,412 | 2,578,908 | |
| Total income | |||||
| Payments and change in | |||||
| liabilities in respect of | |||||
| insurance contracts, gross Reinsurers' share in |
611,086 | 874,384 | 254,462 | 320,809 | 2,060,741 |
| payments and in changes in | |||||
| liabilities in respect of | 314,908 | 1,035 | 197,238 | 123,259 | 636,440 |
| insurance contracts | |||||
| Payments and change in | |||||
| liabilities for insurance | 296,178 | 873,349 | 57,224 | 197,550 | 1,424,301 |
| contracts - retention | |||||
| Fees and commissions, | |||||
| marketing expenses and | |||||
| other purchase expenses | 69,940 | 262,071 | 188,009 | 109,735 | 629,755 |
| General and administrative | |||||
| expenses | 29,325 | 48,447 | 27,020 | 27,406 | 132,198 |
| Finance income | (726) | - | (85) | (696) | (1,507) |
| Total expenses | 394,717 | 1,183,867 | 272,168 | 333,995 | 2,184,747 |
| Company's share in the net | |||||
| results of investees | 204 | 73 | 24 | 196 | 497 |
| Profit (loss) before taxes on | |||||
| income | 171,877 | (43,588) | 113,756 | 152,613 | 394,658 |
| Other comprehensive income | |||||
| before taxes on income | 37,278 | 13,354 | 4,339 | 35,737 | 90,708 |
| Total comprehensive | |||||
| income (loss) for the | |||||
| period before taxes on | |||||
| income | 209,155 | (30,234) | 118,095 | 188,350 | 485,366 |
| Liabilities in respect of | |||||
| insurance contracts, | |||||
| gross, as of December 31, | |||||
| 2021 (audited) | 2,974,669 | 875,937 | 654,312 | 2,203,670 | 6,708,588 |
| Liabilities in respect of | |||||
| insurance contracts - | |||||
| retention - as of | |||||
| December 31, 2021 | |||||
| (audited) | 1,772,342 | 874,770 | 184,621 | 1,724,198 | 4,555,931 |
(*) Property and other insurance subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 82% of total premiums in these subsegments.
(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 82% of total premiums in these subsegments.

| For the 6-month period ended June 30, 2022 |
|||
|---|---|---|---|
| Provident funds |
Pension Unaudited |
Total | |
| NIS thousand | |||
| Investment income, net and finance income | 54,848 | (4,019) | 50,829 |
| Income from management fees | 208,152 | 120,161 | 328,313 |
| Other income (see Note 8L) | 14,192 | 661 | 14,853 |
| Total income | 277,192 | 116,803 | 393,995 |
| Change in liabilities for investment contracts | 53,415 | - | 53,415 |
| Fees and commissions, marketing expenses and | |||
| other purchase expenses | 81,795 | 68,589 | 150,384 |
| General and administrative expenses | 72,608 | 40,927 | 113,535 |
| Other expenses | 9,370 | 916 | 10,286 |
| Finance expenses | 5,728 | 1,899 | 7,627 |
| Total expenses | 222,916 | 112,331 | 335,247 |
| Total comprehensive income for the period before taxes on income |
54,276 | 4,472 | 58,748 |
| For the 6-month period ended June 30, 2021 (*) |
|||
|---|---|---|---|
| Provident funds |
Pension | Total | |
| Unaudited NIS thousand |
|||
| Investment income, net and finance income | 42,603 | 3,408 | 46,011 |
| Income from management fees | 142,177 | 98,039 | 240,216 |
| Other income | - | 408 | 408 |
| Total income | 184,780 | 101,855 | 286,635 |
| Change in liabilities for investment contracts | 35,546 | - | 35,546 |
| Fees and commissions, marketing expenses and | |||
| other purchase expenses | 53,651 | 44,973 | 98,624 |
| General and administrative expenses | 68,936 | 47,230 | 116,166 |
| Other expenses | 5,083 | 529 | 5,612 |
| Finance expenses | 1,604 | 468 | 2,072 |
| Total expenses | 164,820 | 93,200 | 258,020 |
| Total comprehensive income for the period before taxes on income |
19,960 | 8,655 | 28,615 |
(*) As of April 1, 2021, the operating results of provident funds and pension funds management include the results of Halman Aldubi Provident. For further details, please see Note 4A to the annual financial statements for 2021.

| For the 3-month period ended June 30, 2022 |
|||
|---|---|---|---|
| Provident funds |
Pension | Total | |
| Unaudited NIS thousand |
|||
| Investment income, net and finance income | 31,885 | (4,466) | 27,419 |
| Income from management fees | 103,955 | 64,244 | 168,199 |
| Other income (see Note 8L) | 14,186 | 352 | 14,538 |
| Total income | 150,026 | 60,130 | 210,156 |
| Change in liabilities for investment contracts | 30,530 | - | 30,530 |
| Fees and commissions, marketing expenses and | |||
| other purchase expenses | 42,936 | 37,553 | 80,489 |
| General and administrative expenses | 31,310 | 20,289 | 51,599 |
| Other expenses | 4,486 | 458 | 4,944 |
| Finance expenses | 3,408 | 1,124 | 4,532 |
| Total expenses | 112,670 | 59,424 | 172,094 |
| Total comprehensive income for the period before taxes on income |
37,356 | 706 | 38,062 |
| For the 3-month period ended June 30, 2021 (*) |
|||
|---|---|---|---|
| Provident | |||
| funds | Pension | Total | |
| Unaudited | |||
| NIS thousand | |||
| Investment income, net and finance income | 27,570 | 1,936 | 29,506 |
| Income from management fees | 87,486 | 53,571 | 141,057 |
| Other income | - | 218 | 218 |
| Total income | 115,056 | 55,725 | 170,781 |
| Change in liabilities for investment contracts | 23,474 | - | 23,474 |
| Fees and commissions, marketing expenses and | |||
| other purchase expenses | 31,477 | 23,311 | 54,788 |
| General and administrative expenses | 45,454 | 24,948 | 70,402 |
| Other expenses | 4,900 | 436 | 5,336 |
| Finance expenses | 1,601 | 468 | 2,069 |
| Total expenses | 106,906 | 49,163 | 156,069 |
| Total comprehensive income for the period before taxes on income |
8,150 | 6,562 | 14,712 |
(*) As of April 1, 2021, the operating results of provident funds and pension funds management include the results of Halman Aldubi Provident. For further details, please see Note 4A to the annual financial statements for 2021.

| For the year ended December 31, 2021 (*) |
|||
|---|---|---|---|
| Provident | |||
| funds | Pension Audited |
Total | |
| NIS thousand | |||
| Investment income, net and finance income | 77,103 | 10,584 | 87,687 |
| Income from management fees | 338,699 | 204,243 | 542,942 |
| Other income | - | 2,712 | 2,712 |
| Total income | 415,802 | 217,539 | 633,341 |
| Change in liabilities for investment contracts | 67,411 | - | 67,411 |
| Fees and commissions, marketing expenses and other | |||
| purchase expenses | 123,118 | 96,575 | 219,693 |
| General and administrative expenses | 177,343 | 96,854 | 274,197 |
| Other expenses | 15,383 | 802 | 16,185 |
| Finance expenses | 2,848 | 4,558 | 7,406 |
| Total expenses | 386,103 | 198,789 | 584,892 |
| Total comprehensive income for the period before taxes on income |
29,699 | 18,750 | 48,449 |
(*) As of April 1, 2021, the operating results of provident funds and pension funds management include the results of Halman Aldubi Provident. For further details, please see Note 4A to the annual financial statements for 2021.

In March 2022, the Company updated the targets of the multi-year strategic plan. As part of the implementation of the strategic plan, the Company took the following steps during the reporting period:
A. Completing the restructuring of The Phoenix Advanced Investments.
The Company took steps to holds all alternative investments of The Phoenix group under The Phoenix Advanced Investments Ltd. Accordingly, in the reporting period, various steps were taken in order to achieve the above, including: The distribution, as a dividend in kind from The Phoenix Advanced Investments Ltd. of Quality Pension Insurance Agency (2017) Ltd., and 16% of The Phoenix Pension and Provident's shares it held, and the sale of The Phoenix IEC Central Fund Ltd. (formerly - Halman-Aldubi IEC Gemel Ltd.) to the Company. Concurrently, the Company's holdings in The Phoenix Advanced Investments were transferred to The Phoenix Investments, and the holdings of The Phoenix Investments in The Phoenix Capital Ltd. (hereinafter - the "Phoenix Capital") and the Phoenix Investment Funds Ltd. (which manage the activity of alternative investment funds) were transferred to The Phoenix Advanced Investments.
B. Amendment to a Shareholders Agreement in The Phoenix Capital Ltd.
The Company has an indirect 65% stake in The Phoenix Capital, which is engaged in the establishment, management and distribution of alternative investment funds. The Phoenix Capital's activity constitutes a part of the Company's strategic plan to achieve growth in the area of investment management in general, and in the area of establishing, management and distribution of alternative investment funds in particular. The remaining holdings in The Phoenix Capital are held by Safra Consultation and Investments Ltd. (hereinafter - "Safra"). The parties have in place a shareholders agreement that regulates the management of The Phoenix Capital; the said agreement stipulates, among other things, that decisions in The Phoenix Capital will be made jointly, despite the fact that the parties' stakes in the company are not equal.
On June 29, 2022, the parties signed an addendum to the agreement, which regulated issues which are not material to the Company; the addendum also regulates the manner by which The Phoenix Capital is managed; among other things, and as part of the implementation of the Company's strategic plan, the addendum made changes to the decision-making processes in The Phoenix Capital, such that decisions are made based on the parties' stake in the company. As a result of the said amendment, the latter changed the recording of its holding in The Phoenix Capital from joint control to control.
A valuation of The Phoenix Capital was carried out by an independent external appraiser on July 27, 2022. The valuation was based on the fair value calculated in accordance with the discounted cash flow method (DCF). The value was calculated for each of the segments comprising The Phoenix Capital's activity. The future cash flows that the activity is expected to generate were foretasted based on a reasonable scenario, with a growth assumption of 2%- 3%, and were discounted using a 16% discount rate.
The Company recognized in its financial statements as of June 30, 2022, a one-off post-tax capital gain of NIS 86 million as a result of assuming control.

The Company recognized the fair value of the assets acquired and the liabilities assumed as part of the business combination according to a provisional measurement. As of the date of approval of the financial statements, a final valuation has not yet been received by an external appraiser in relation to the fair value of the identified assets acquired and the liabilities assumed. A final adjustment of the consideration for the purchase as well as the fair value of the assets and liabilities purchased can be carried out up to 12 months from the date of purchase. At the final measurement date, the adjustments were made by way of a restating the comparative results previously reported according to the provisional measurement. The Company has opted to measure the non-controlling interests in the acquired company according to the proportionate share of the non-controlling interests in the fair value of the net identified assets of the acquiree.
The fair value of The Phoenix Capital's identifiable assets and identifiable liabilities on consolidation commencement date (June 30, 2022):
| Unaudited | |
|---|---|
| NIS thousand | |
| Intangible assets | 34,640 |
| Receivables and debit balances | 5,226 |
| Investment in an associate | 74,732 |
| Cash and cash equivalents | 3,800 |
| Total assets | 118,398 |
| Payables and credit balances | (1,797) |
| Total liabilities | (1,797) |
| Identifiable assets net of identifiable liabilities | 116,601 |
| Non-controlling interests | (45,474) |
| Balance of investment in investee prior to the acquisition | (5,407) |
| Gain from assuming control | (86,850) |
| Goodwill arising from the acquisition | 21,130 |
| Total acquisition cost | - |
| Unaudited NIS thousand |
|
|---|---|
| Cash arising from the acquisition (used as acquisition proceeds): | |
| Cash and cash equivalents in the acquiree as of the acquisition date | 3,800 |
| Cash paid as acquisition proceeds | - |
| Cash, net | 3,800 |
As stated above, the date on which control was assumed is June 30, 2022, and therefore the results of The Phoenix Capital in the financial services segment for the 6 months period ended June 30, 2022, include the results of The Phoenix Capital in the Company's share in the net results of investees line item. In addition, the one-off gain from assuming control in the amount of NIS 86 million was imputed to other income.

During the second quarter of 2022, the Company completed a transaction for the acquisition of a further 20% stake in Dorbit Insurance Agency (1999) Ltd. (hereinafter - "Dorbit"), such that subsequent to the acquisition, the Company holds indirectly 70% of Dorbit's shares. Subsequent to the completion of the transaction, and as a result of assuming control in Dorbit, a consolidated company of The Phoenix Agencies (hereinafter - the "Company") recognized a pre- and post-tax profit of NIS 22 million.
As of the report date, the Company recognized the fair value of the assets acquired and the liabilities assumed as part of the business combination according to a provisional measurement. As of the date of approval of the financial statements, a final valuation has not yet been received by an external appraiser in relation to the fair value of the identified assets acquired and the liabilities assumed. A final adjustment of the consideration for the purchase as well as the fair value of the assets and liabilities purchased can be carried out up to 12 months from the date of purchase. At the time of the final measurement, the adjustments are made by way of a restating the comparison figures previously reported according to the provisional measurement. Accordingly, as part of the business combination, the Company included intangible assets comprising insurance portfolios totaling NIS 18 million, goodwill totaling NIS 23 million and other net assets whose amount is immaterial.
Further to what is stated in Section B above, during the reporting period, consolidated companies of The Phoenix Agencies acquired insurance agencies/ assumed control for the first time in insurance agencies. As a result of those acquisitions, the Company recognized intangible assets at the total amount of NIS 50 million.

1. Following is a breakdown of assets held against insurance contracts and investment contracts presented at fair value through profit and loss:
| As of December |
|||
|---|---|---|---|
| As of June 30 | 31 | ||
| 2022 | 2021 | 2021 | |
| Unaudited | Audited | ||
| NIS thousand | |||
| Investment property | 1,903,600 | 1,938,918 | 2,062,862 |
| Financial investments: | |||
| Liquid debt assets | 20,988,024 | 21,930,947 | 22,194,850 |
| Illiquid debt assets | 8,685,245 | 7,472,594 | 8,100,882 |
| Shares | 21,510,775 | 21,557,784 | 24,884,732 |
| Other financial investments | 27,083,877 | 23,153,029 | 25,918,195 |
| Total financial investments | 78,267,921 | 74,114,354 | 81,098,659 |
| Cash and cash equivalents | 14,789,357 | 11,098,327 | 13,785,593 |
| Other | 255,808 | 191,216 | 169,549 |
| Total assets for yield-dependent contracts | 95,216,686 | 87,342,815 | 97,116,663 |
The following table presents an analysis of assets held against insurance contracts and investment contracts presented at fair value through profit and loss. The different levels were defined as follows:
Level 1 - fair value measured using quoted prices (unadjusted) in an active market for identical instruments.
Level 2 - fair value measured using observable inputs, either directly or indirectly, that are not included in Level 1 above.
Level 3 - fair value measured using inputs that are not based on observable market inputs.
For financial instruments periodically recognized at fair value, the Company estimates, at the end of each reporting period, whether transfers have been made between the various levels of the fair value hierarchy.
During the reporting periods there were no material transfers between Level 1 and Level 2.

The Company holds the financial instruments measured at fair value according to the following classifications:
| June 30, 2022 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Financial investments: | ||||
| Liquid debt assets | 15,640,223 | 5,347,801 | - | 20,988,024 |
| Illiquid debt assets | - | 6,573,194 | 2,112,051 | 8,685,245 |
| Shares | 18,702,517 | 1,108,956 | 1,699,302 | 21,510,775 |
| Other financial investments | 9,241,380 | 1,695,516 | 16,146,981 | 27,083,877 |
| Total | 43,584,120 | 14,725,467 | 19,958,334 | 78,267,921 |
| June 30, 2021 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Financial investments: | ||||
| Liquid debt assets | 16,320,657 | 5,610,290 | - | 21,930,947 |
| Illiquid debt assets | - | 5,970,125 | 1,502,469 | 7,472,594 |
| Shares | 19,400,687 | 932,836 | 1,224,261 | 21,557,784 |
| Other financial investments | 9,373,504 | 1,422,778 | 12,356,747 | 23,153,029 |
| Total | 45,094,848 | 13,936,029 | 15,083,477 | 74,114,354 |
| As of December 31, 2021 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Audited | ||||
| NIS thousand | ||||
| Financial investments: | ||||
| Liquid debt assets | 16,866,619 | 5,328,231 | - | 22,194,850 |
| Illiquid debt assets | - | 6,378,393 | 1,722,489 | 8,100,882 |
| Shares | 22,087,156 | 1,174,596 | 1,622,980 | 24,884,732 |
| Other financial investments | 10,190,662 | 1,795,948 | 13,931,585 | 25,918,195 |
| Total | 49,144,437 | 14,677,168 | 17,277,054 | 81,098,659 |

Assets measured at fair value - Level 3
| Fair value measurement at the reporting date | ||||||
|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | ||||||
| Liquid | Illiquid | Other | ||||
| debt | debt | financial | ||||
| assets | assets | Shares | investments | Total | ||
| Unaudited | ||||||
| NIS thousand | ||||||
| Balance as of January 1, 2022 | - | 1,722,489 | 1,622,980 | 13,931,585 | 17,277,054 | |
| Total gains recognized in profit or | ||||||
| loss (*) | - | 15,268 | 144,922 | 1,766,457 | 1,926,647 | |
| Purchases | - | 945,560 | 256,614 | 1,730,951 | 2,933,125 | |
| Proceeds from interest and | ||||||
| dividend | - | (15,949) | (11,330) | (362,043) | (389,322) | |
| Redemptions / sales | - | (381,970) | - | (838,449) | (1,220,419) | |
| Transfers into Level 3 (**) | - | 85,126 | - | - | 85,126 | |
| Transfers from Level 3 (**) | - | (258,473) | (313,884) | (81,520) | (653,877) | |
| Balance on June 30, 2022 | - | 2,112,051 | 1,699,302 | 16,146,981 | 19,958,334 | |
| (*) Of which: Total unrealized | ||||||
| gains for the period recognized in | ||||||
| profit and loss in respect of | ||||||
| assets held as of June 30, 2022 | - | 4,523 | 61,625 | 1,426,085 | 1,492,233 | |
| Transfers into (from) Level 3: |
Transfers into Level 3 stem mainly from securities whose rating changed and from securities that were issued for the first time.
Transfers from Level 3 stem mainly from securities whose rating changed and from securities issued for the first time
| Fair value measurement at the reporting date | |||||||
|---|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | |||||||
| Liquid | Illiquid | Other | |||||
| debt | debt | financial | |||||
| assets | assets | Shares | investments | Total | |||
| Unaudited | |||||||
| NIS thousand | |||||||
| Balance as of January 1, 2021 | - | 1,692,181 | 1,249,004 | 10,148,125 | 13,089,310 | ||
| Total gains recognized in profit | |||||||
| or loss (*) | - | 50,743 | 62,501 | 1,432,634 | 1,545,878 | ||
| Purchases | - | 421,502 | 146,521 | 2,199,139 | 2,767,162 | ||
| Proceeds from interest and | |||||||
| dividend | - | (23,521) | (7,306) | (393,256) | (424,083) | ||
| Redemptions / sales | - | (351,186) | (41,597) | (855,374) | (1,248,157) | ||
| Transfers from Level 3 (**) | - | (287,250) | (184,862) | (174,521) | (646,633) | ||
| Balance on June 30, 2022 | - | 1,502,469 | 1,224,261 | 12,356,747 | 15,083,477 | ||
| (*) Of which: Total unrealized | |||||||
| gains for the period recognized | |||||||
| in profit and loss in respect of | |||||||
| assets held as of June 30, 2021 | - | 26,025 | 55,951 | 1,090,158 | 1,172,134 | ||
| Transfers into (from) Level 3: |
Transfers from Level 3 stem mainly from securities whose rating changed and from securities issued for the first time

| Assets measured at fair value - Level 3 (cont.) |
|---|
| ------------------------------------------------- |
| Fair value measurement at the reporting date | |||||||
|---|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | |||||||
| Illiquid | Other | ||||||
| Liquid debt | debt | financial | |||||
| assets | assets | Shares Unaudited |
investments | Total | |||
| NIS thousand | |||||||
| Balance as of April 1, 2022 Total gains recognized in |
- | 1,909,722 | 1,474,869 | 14,455,133 | 17,839,724 | ||
| profit or loss (*) | - | 32,168 | 61,786 | 1,397,196 | 1,491,150 | ||
| Purchases | - | 594,942 | 172,984 | 789,410 | 1,557,336 | ||
| Proceeds from interest and | |||||||
| dividend | - | (11,337) | (10,337) | (151,389) | (173,063) | ||
| Redemptions / sales | - | (240,097) | - | (343,369) | (583,466) | ||
| Transfers into Level 3 (**) | - | 85,126 | - | - | 85,126 | ||
| Transfers from Level 3 (**) | - | (258,473) | - | - | (258,473) | ||
| Balance on June 30, 2022 | - | 2,112,051 | 1,699,302 | 16,146,981 | 19,958,334 | ||
| (*) Of which: Total | |||||||
| unrealized gains for the | |||||||
| period recognized in profit | |||||||
| and loss in respect of assets | |||||||
| held as of June 30, 2022 | - | 6,052 | 51,949 | 1,258,529 | 1,316,530 | ||
| Transfers into (from) Level 3: |
Transfers from Level 3 stem mainly from securities whose rating changed Transfers from Level 3 stem mainly from securities whose rating changed
| Fair value measurement at the reporting date Financial assets at fair value through profit and loss |
|||||
|---|---|---|---|---|---|
| Liquid debt |
Illiquid debt |
Other financial |
|||
| assets | assets | Shares | investments | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Balance as of April 1, 2021 Total gains recognized in profit |
- | 1,732,240 | 1,230,847 | 11,081,610 | 14,044,697 |
| or loss (*) | - | 20,180 | 12,593 | 769,042 | 801,815 |
| Purchases | - | 64,334 | 76,863 | 1,206,658 | 1,347,855 |
| Proceeds from interest and | |||||
| dividend | - | (9,453) | - | (238,567) | (248,020) |
| Redemptions / sales | - | (142,310) | - | (461,996) | (604,306) |
| Transfers from Level 3 (**) | - | (162,522) | (96,042) | - | (258,564) |
| Balance as of June 30, 2021 | - | 1,502,469 | 1,224,261 | 12,356,747 | 15,083,477 |
| (*) Of which: Total unrealized gains for the period recognized in profit and loss in respect of |
|||||
| assets held as of June 30, 2021 Transfers into (from) Level 3: |
- | 4,335 | 12,593 | 579,891 | 596,819 |
Transfers from Level 3 stem mainly from securities whose rating changed and from securities issued for the first time

| Fair value measurement at the reporting date | ||||||||
|---|---|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | ||||||||
| Liquid debt Illiquid debt |
Other financial |
|||||||
| assets | assets | Shares | investments | Total | ||||
| Audited | ||||||||
| NIS thousand | ||||||||
| Balance as of January 1, | ||||||||
| 2021 | - | 1,692,181 | 1,249,004 | 10,148,125 | 13,089,310 | |||
| Total gains recognized in | ||||||||
| profit or loss (*) | - | 40,119 | 521,932 | 2,225,084 | 2,787,135 | |||
| Purchases | - | 1,173,964 | 359,500 | 4,280,637 | 5,814,101 | |||
| Proceeds from interest and | ||||||||
| dividend | - | (44,814) | (9,948) | (890,187) | (944,949) | |||
| Redemptions / sales | - | (851,711) | (125,369) | (1,657,553) | (2,634,633) | |||
| Transfers from Level 3 (**) | - | (287,250) | (372,139) | (174,521) | (833,910) | |||
| Balance as of December 31, | ||||||||
| 2021 | - | 1,722,489 | 1,622,980 | 13,931,585 | 17,277,054 | |||
| (*) Of which: Total | ||||||||
| unrealized gains (losses) for | ||||||||
| the period included in profit | ||||||||
| and loss in respect of assets | ||||||||
| - balance held as of | ||||||||
| December 31, 2021 | - | (3,628) | 374,098 | 1,381,647 | 1,752,117 | |||
Assets measured at fair value - Level 3 (cont.)
Transfers into (from) Level 3: Transfers from Level 3 stem mainly from securities whose rating changed and from securities issued for the first time
Composition:
| June 30, 2022 | |||
|---|---|---|---|
| Carrying | |||
| amount | Fair value | ||
| Unaudited | |||
| NIS thousand | |||
| Loans and receivables | |||
| Designated bonds and treasury deposits (*) | 8,477,307 | 11,917,819 | |
| Other non-convertible debt assets, excluding deposits with banks | 6,323,737 | 6,346,775 | |
| Deposits with banks (**) | 2,392,191 | 2,419,840 | |
| Total illiquid debt assets | 17,193,235 | 20,684,434 | |
| Impairments carried to profit and loss (cumulative) | 53,108 | ||
| (*) The fair value was calculated according to the contractual repayment date. |
(**) For information regarding spread transactions involving financial instruments, see Note 8O.

1. Illiquid debt assets (cont.)
| June 30, 2021 | |||
|---|---|---|---|
| Carrying amount |
Fair value | ||
| Unaudited | |||
| NIS thousand | |||
| Loans and receivables | |||
| Designated bonds (*) | 8,172,977 | 12,126,233 | |
| Other non-convertible debt assets, excluding deposits with banks | 4,658,409 | 4,939,680 | |
| Deposits with banks | 1,120,385 | 1,165,755 | |
| Total illiquid debt assets | 13,951,771 | 18,231,668 | |
| Impairments carried to profit and loss (cumulative) | 60,901 | ||
| (*) The fair value was calculated according to the contractual repayment date. |
| As of December 31, 2021 |
|||
|---|---|---|---|
| Carrying amount |
Fair value | ||
| Audited | |||
| NIS thousand | |||
| Loans and receivables | |||
| Designated bonds (*) | 8,166,309 | 12,915,459 | |
| Other non-convertible debt assets, excluding deposits with banks | 4,806,398 | 5,084,555 | |
| Deposits with banks | 991,734 | 1,034,477 | |
| Total illiquid debt assets | 13,964,441 | 19,034,491 | |
| Impairments carried to profit and loss (cumulative) (*) The fair value was calculated according to the contractual |
62,220 |
repayment date.

The tables below depict an analysis of the financial instruments presented at fair value. During the reporting periods there were no material transfers between Level 1 and Level 2.
| June 30, 2022 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liquid debt assets | 4,661,233 | 1,740,240 | - | 6,401,473 |
| Shares | 1,650,443 | 371,416 | 491,931 | 2,513,790 |
| Other | 670,203 | 347,871 | 3,453,113 | 4,471,187 |
| Total | 6,981,879 | 2,459,527 | 3,945,044 | 13,386,450 |
| June 30, 2021 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liquid debt assets | 5,841,444 | 1,421,324 | - | 7,262,768 |
| Shares | 1,955,956 | 292,369 | 440,727 | 2,689,052 |
| Other | 776,680 | 540,827 | 2,433,324 | 3,750,831 |
| Total | 8,574,080 | 2,254,520 | 2,874,051 | 13,702,651 |
| As of December 31, 2021 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Audited | ||||
| NIS thousand | ||||
| Liquid debt assets | 6,078,689 | 1,394,244 | - | 7,472,933 |
| Shares | 1,782,305 | 481,559 | 498,033 | 2,761,897 |
| Other | 1,020,779 | 615,128 | 2,863,064 | 4,498,971 |
| Total | 8,881,773 | 2,490,931 | 3,361,097 | 14,733,801 |

Assets measured at fair value - Level 3
| Fair value measurement at the reporting date | |||||||
|---|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss and available-for sale financial assets |
|||||||
| Liquid debt assets |
Illiquid debt assets |
Shares Unaudited |
Other financial investments |
Total | |||
| NIS thousand | |||||||
| Balance as of January 1, 2022 Total gains (losses) recognized: |
- | - | 498,033 | 2,863,064 | 3,361,097 | ||
| In profit and loss (*) In other |
- | - | (3,649) | 37,612 | 33,963 | ||
| comprehensive income Purchases Proceeds from |
- - |
- - |
26,345 87,481 |
331,780 463,217 |
358,125 550,698 |
||
| interest and dividend Redemptions / |
- | - | (55) | (71,305) | (71,360) | ||
| sales | - | - | - | (153,902) | (153,902) | ||
| Transfers from Level 3 (**) |
- | - | (116,224) | (17,353) | (133,577) | ||
| Balance on June 30, 2022 |
- | - | 491,931 | 3,453,113 | 3,945,044 | ||
| (*) Of which: Total unrealized gains (losses) for the period recognized in profit and loss in respect of assets held as of June 30, 2022 |
- | - | (3,699) | (42,895) | (46,594) |
Transfers into (from) Level 3:
Transfers from Level 3 stem mainly from securities whose rating changed and from securities issued for the first time

Assets measured at fair value - Level 3 (cont.)
| Fair value measurement at the reporting date | ||||||
|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss and available-for-sale financial assets |
||||||
| Liquid debt |
Illiquid debt |
Other financial |
||||
| assets | assets | Shares | investments | Total | ||
| Unaudited | ||||||
| NIS thousand | ||||||
| Balance as of January 1, 2021 | - | - | 330,008 | 2,037,817 | 2,367,825 | |
| Total profits recognized: | ||||||
| In profit and loss (*) | - | - | 16,265 | 62,180 | 78,445 | |
| In other comprehensive income | - | - | 81,985 | 175,925 | 257,910 | |
| Purchases | - | - | 54,172 | 395,560 | 449,732 | |
| Proceeds from interest and | ||||||
| dividend | - | - | (1,388) | (66,015) | (67,403) | |
| Redemptions / sales | - | - | (18,071) | (113,937) | (132,008) | |
| Transfers from Level 3 (**) | - | - | (22,244) | (58,206) | (80,450) | |
| Balance as of June 30, 2021 | - | - | 440,727 | 2,433,324 | 2,874,051 | |
| (*) Of which: Total unrealized | ||||||
| gains (losses) for the period | ||||||
| recognized in profit and loss in | ||||||
| respect of assets held as of | ||||||
| June 30, 2021 | - | - | (1,311) | (7,960) | (9,271) | |
Transfers into (from) Level 3:
Transfers from Level 3 stem primarily from securities issued for the first time.
| Fair value measurement at the reporting date | ||||||
|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss and available for-sale financial assets |
||||||
| Liquid debt assets |
Illiquid debt assets |
Shares | Other financial investments |
Total | ||
| Unaudited | ||||||
| NIS thousand | ||||||
| Balance as of April 1, 2022 Total gains (losses) |
- | - | 438,387 | 2,917,650 | 3,356,037 | |
| recognized: In profit and loss (*) In other comprehensive income Purchases Proceeds from interest and dividend Redemptions / sales Balance on June 30, 2022 |
- | - | (3,649) | (13,938) | (17,587) | |
| - - |
- - |
22,140 35,108 |
320,192 296,611 |
342,332 331,719 |
||
| - - |
- - |
(55) - |
(22,981) (44,421) |
(23,036) (44,421) |
||
| - | - | 491,931 | 3,453,113 | 3,945,044 | ||
| (*) Of which: Total unrealized gains (losses) for the period recognized in profit and loss in respect of assets held as of June 30, 2022 |
- | - | (3,699) | (34,401) | (38,100) |

Assets measured at fair value - Level 3 (cont.)
| Fair value measurement at the reporting date | |||||
|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss and available-for-sale financial assets |
|||||
| Liquid debt |
Illiquid debt |
Other financial |
|||
| assets | assets | Shares | investments | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Balance as of April 1, 2021 Total profits recognized: |
- | - | 328,816 | 2,186,140 | 2,514,956 |
| In profit and loss (*) | - | - | - | 24,122 | 24,122 |
| In other comprehensive income | - | - | 75,311 | 108,239 | 183,550 |
| Purchases | - | - | 36,600 | 203,076 | 239,676 |
| Proceeds from interest and | |||||
| dividend | - | - | - | (28,604) | (28,604) |
| Redemptions / sales | - | - | - | (59,649) | (59,649) |
| Balance as of June 30, 2021 | - | - | 440,727 | 2,433,324 | 2,874,051 |
| (*) Of which: Total unrealized gains (losses) for the period recognized in profit and loss in respect of assets held as of June |
|||||
| 30, 2021 | - | - | - | (5,646) | (5,646) |
| Fair value measurement at the reporting date | |||||
|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss and available-for-sale financial assets |
|||||
| Liquid | Illiquid | Other | |||
| debt | debt | financial | |||
| assets | assets | Shares | investments | Total | |
| Audited | |||||
| NIS thousand | |||||
| Balance as of January 1, 2021 | - | - | 330,008 | 2,037,817 | 2,367,825 |
| Total profits recognized: | |||||
| In profit and loss (*) | - | - | 18,658 | 120,906 | 139,564 |
| In other comprehensive income | - | - | 162,902 | 256,973 | 419,875 |
| Purchases | - | - | 121,831 | 907,353 | 1,029,184 |
| Proceeds from interest and | |||||
| dividend | - | - | (1,526) | (156,899) | (158,425) |
| Redemptions / sales | - | - | (29,189) | (244,880) | (274,069) |
| Transfers into Level 3 (**) | - | - | 96,224 | - | 96,224 |
| Transfers from Level 3 (**) | - | - | (200,875) | (58,206) | (259,081) |
| Balance as of December 31, 2021 | - | - | 498,033 | 2,863,064 | 3,361,097 |
| (*) Of which: Total unrealized | |||||
| losses for the period included in | |||||
| profit and loss in respect of | |||||
| assets - balance held as of | |||||
| December 31, 2021 | - | - | (339) | (46,271) | (46,610) |
| Transfers into (from) Level 3: |
Transfers into Level 3 stem mainly from securities that were classified from an investment as an associate. Transfers from Level 3 stem from securities issued for the first time.
| As of June 30 2022 Unaudited NIS thousand |
As of June 30 2021 Unaudited NIS thousand |
As of December 31 2021 Audited NIS thousand |
|
|---|---|---|---|
| Trade receivables and checks for collection |
1,096,544 | 726,917 | 845,079 |
| Credit vouchers | 19,601 | 17,807 | 14,984 |
| Loans and checks for collection | 830,736 | 380,072 | 608,405 |
| Credit vouchers for sale | 1,280,360 | 1,172,775 | 1,096,965 |
| Provision for doubtful debts | (18,919) | (14,040) | (15,041) |
| Total | 3,208,322 | 2,283,531 | 2,550,392 |
| June 30, 2022 | ||
|---|---|---|
| Carrying | ||
| amount | Fair value | |
| Unaudited | ||
| NIS thousand | ||
| Financial liabilities presented at amortized cost: | ||
| Short-term credit from banking corporations (4) | 530,921 | 530,921 |
| Loans from non-bank entities (see Note 8F) | 821,494 | 821,494 |
| Bonds (see Notes 8C, 8M and 8N) | 2,079,078 | 2,016,153 |
| Subordinated bonds (1) (see Note 8K) | 3,675,910 | 3,693,530 |
| Additional Tier 1 capital subordinated bond (1) | 206,145 | 191,479 |
| Trade receivables for credit cards | 1,472,492 | 1,472,492 |
| Other (2) | 34,612 | 34,612 |
| Total financial liabilities presented at amortized cost | 8,820,652 | 8,760,681 |
| Financial liabilities presented at fair value through profit and loss: | ||
| Derivatives (3) | 2,163,418 | 2,163,418 |
| Liability for short sale of liquid securities (4) | 2,319,030 | 2,319,030 |
| Total financial liabilities presented at fair value through profit and loss | 4,482,448 | 4,482,448 |
| Lease liabilities | 128,901 | |
| Total financial liabilities | 13,432,001 |
The bonds were issued for the purpose of complying with the capital requirements.
Mainly provision in respect of deferred consideration and an undertaking to acquire portfolios.
Including financial liabilities in respect of yield-dependent contracts totaling approximately NIS 1,635 million.
For information regarding spread transactions involving financial instruments, see Note 8O.

| June 30, 2021 | |||
|---|---|---|---|
| Carrying | |||
| amount | Fair value | ||
| Unaudited | |||
| NIS thousand | |||
| Financial liabilities presented at amortized cost: | |||
| Loans from banks and other corporations | 434,932 | 434,932 | |
| Bonds (1) | 1,868,831 | 1,933,050 | |
| Subordinated bonds (1) | 3,382,991 | 3,659,031 | |
| Liability for REPO | 392,549 | 392,549 | |
| Trade receivables for credit cards | 1,267,310 | 1,267,310 | |
| Other (2) | 24,628 | 24,628 | |
| Total financial liabilities presented at amortized cost | 7,371,241 | 7,711,500 | |
| Financial liabilities presented at fair value through profit and loss: | |||
| Derivatives (3) | 317,262 | 317,262 | |
| Liability for short sale of liquid securities | 1,004,495 | 1,004,495 | |
| Total financial liabilities presented at fair value through profit and | |||
| loss | 1,321,757 | 1,321,757 | |
| Lease liabilities | 120,752 | ||
| Total financial liabilities | 8,813,750 |
The bonds were issued for the purpose of complying with the capital requirements.
Mainly provision in respect of an option to acquire an investee.
Including financial liabilities in respect of yield-dependent contracts totaling approximately NIS 220 million.

| As of December 31, 2021 |
|||
|---|---|---|---|
| Carrying | |||
| amount | Fair value | ||
| Audited | |||
| NIS thousand | |||
| Financial liabilities presented at amortized cost: | |||
| Short-term credit from banking corporations | 159,195 | 159,195 | |
| Loans from non-bank entities | 587,500 | 587,500 | |
| Bonds | 1,705,853 | 1,787,052 | |
| Subordinated bonds (1) | 3,390,114 | 3,651,204 | |
| Subordinated bonds - Additional Tier 1 capital (1) | 199,810 | 216,995 | |
| Trade receivables for credit cards | 1,433,827 | 1,433,827 | |
| Other (2) | 23,428 | 23,428 | |
| Total financial liabilities presented at amortized cost | 7,499,727 | 7,859,201 | |
| Financial liabilities presented at fair value through profit and loss: | |||
| Derivatives (3) | 361,150 | 361,150 | |
| Liability for short sale of liquid securities | 828,576 | 828,576 | |
| Total financial liabilities presented at fair value through profit and | |||
| loss | 1,189,726 | 1,189,726 | |
| Lease liabilities | 123,229 | ||
| Total financial liabilities | 8,812,682 |
The bonds were issued for the purpose of complying with the capital requirements.
Mainly provision in respect of an option to acquire an investee and an undertaking to acquire portfolios.
Including financial liabilities in respect of yield-dependent contracts totaling approximately NIS 286 million.
| June 30, 2022 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liability for short sale of liquid securities | 2,319,030 | - | - | 2,319,030 |
| Derivatives | 314,073 | 1,849,345 | - | 2,163,418 |
| Financial liabilities presented at fair value | 2,633,103 | 1,849,345 | - | 4,482,448 |

| June 30, 2021 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liability for short sale of liquid securities | 1,004,495 | - | - | 1,004,495 |
| Derivatives | 176,262 | 135,251 | 5,749 | 317,262 |
| Financial liabilities presented at fair value | 1,180,757 | 135,251 | 5,749 | 1,321,757 |
| As of December 31, 2021 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Audited | ||||
| NIS thousand | ||||
| Liability for short sale of liquid securities | 834,576 | - | - | 834,576 |
| Derivatives | 143,941 | 211,209 | - | 355,150 |
| Financial liabilities presented at fair value | 978,517 | 211,209 | - | 1,189,726 |

The fair value of investments traded actively in regulated financial markets is determined based on market prices as of the reporting date. For investments where there is no active market, fair value is determined using valuation techniques. Such techniques include using transactions that were recently made at market terms, reference to the current market value of another instrument which is substantially the same, discounting of cash flows, or other valuation methods.
The fair value of illiquid debt assets, which are measured at fair value through profit and loss, and the fair value of illiquid financial debt assets, for which fair value information is provided solely for disclosure purposes, is determined by discounting the estimated future cash flows from those assets. The discount rates are based primarily on yields on government bonds and spreads of corporate bonds as measured on the TASE. The quoted prices and interest rates used for discounting purposes are determined by a company which won the tender, published by the Ministry of Finance, for the setting up and operating a database of quoted prices and interest rates for institutional entities.
The fair value of the investment in illiquid shares was estimated using the discounted cash flow model (DCF). The estimate requires management to make certain assumptions regarding the model's data, including expected cash flows, discount rates, credit risk and volatility. The probabilities in respect of the estimates in the range can be measured reliably, and management uses them to determine and evaluate the fair value of these investments in illiquid shares.
The Company enters into transactions involving derivative financial instruments with multiple parties, especially financial institutions. The derivatives were valued using valuation models with observable market inputs are mainly interest rate swap contracts and foreign currency forwards. The most frequently used valuation techniques include prices of forwards and swap models using present value calculations. The models combine a number of inputs, including the credit rating of the parties to the financial transaction, spot/forward exchange rates, prices of forward contracts and interest rate curves. All derivative contracts are fully back against cash; therefore, there is no counterparty credit risk and non-performance risk of the Company itself in respect thereof.

A. It is management's policy to maintain a strong capital base in order to retain Company's ability to continue its activities such that it will be able to generate returns to its shareholders and support future business activities. The Phoenix Insurance, the Excellence Group, pension and provident funds management companies and other institutional entities consolidated in the financial statements are subject to capital requirements set by the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner").
The Phoenix Insurance is subject to the Solvency II-based Economic Solvency Regime in accordance with implementation provisions as published in June 2017 and revised in October 2020 (hereinafter - the "Economic Solvency Regime").
The economic solvency ratio is calculated as the ratio between the insurance company's recognized economic equity and the capital required for solvency purposes.
The recognized economic equity is determined as the sum of the core tier 1 capital derived from the economic balance sheet and debt instruments that include loss absorption mechanisms (Additional Tier 1 capital and Tier 2 capital instrument).
Economic balance sheet items are calculated based on economic value, with insurance liabilities calculated on the basis of a best estimate of all expected future cash flows from existing businesses, without conservatism margins, and plus a risk margin.
The solvency capital requirement (SCR) is designed to estimate the economic equity's exposure to a series of scenarios set out in the Economic Solvency Regime provisions, and which reflect insurance risks, market risks and credit risks as well as operational risks.
The Economic Solvency Regime includes, among other things, transitional provisions in connection with compliance with capital requirements, and which allow increasing the economic capital by deducting from the insurance reserves an amount calculated in accordance with the Economic Solvency Regime provisions (hereinafter - the "Deduction"). The Deduction will decrease gradually until 2032 (hereinafter - the "Transitional Period"). In addition to a reduced capital requirements, that will increase gradually until 2023, in respect of certain investment types.
In accordance with the provisions of the Economic Solvency Regime, the economic solvency ratio report as of the December 31 and June 30 data of each year shall be included in the first periodic report published after the calculation date.
The Phoenix Insurance published its Solvency Ratio Report as of December 31, 2021, along with the publication of the consolidated interim financial statements as of March 31, 2022.
In accordance with the Solvency Ratio Report as of December 31, 2021, The Phoenix Insurance has surplus capital, both when calculation is made having no regard to the transitional provisions and when it is made taking into account the transition provisions.
The calculation made by The Phoenix Insurance as described above, was reviewed by The Phoenix Insurance's independent auditors, in accordance with International Standard on Assurance Engagements (ISAE 3400) - The Examination of Prospective Financial Information. This standard is relevant to audits of solvency calculations and does not constitute part of the auditing standards that apply to financial statements (hereinafter - "Audited for Solvency Purposes").

It should be emphasized that the projections and assumptions on the basis of which the economic solvency ratio report was prepared are based mainly on past experience as arising from actuarial studies conducted from time to time. In view of the reforms in the capital market, insurance and savings, and the changes in the economic environment, past data do not necessarily reflect future results. The calculation is sometimes based on assumptions regarding future events, steps taken by management, and the pattern of the future development of the risk margin, that will not necessarily materialize or will materialize in a manner different than the assumptions used in the calculation. Furthermore, actual results may materially vary from the calculation, since the combined scenarios of events may materialize in a manner that is materially different than the assumptions made in the calculation.
In their special report, the independent auditors noted that they did not review the appropriateness of the Deduction During the Transitional Period as of December 31, 2021, except for verifying that the Deduction amount does not exceed the expected discounted amount of the risk margin and the capital required for solvency in respect of life and health insurance risks arising from existing businesses during the Transitional Period in accordance with the pattern of future development of the required capital, which affects both the calculation of the expected capital release and the release of the expected risk margin as described in the provisions on calculation of risk margin. Furthermore, attention is drawn to what is stated in the economic solvency ratio report regarding the uncertainty derived from regulatory changes and exposure to contingent liabilities, the effect of which on the solvency ratio cannot be estimated.
For further details, please see Section 2.1 to the Report of the Board of Directors, and the Economic Solvency Ratio Report as of December 31, 2021, published on The Phoenix Insurance's website.
According to the letter published by the Commissioner, in October 2017, (hereinafter - the "Letter") an insurance company shall be entitled to distribute a dividend only if, following the distribution, the company has a solvency ratio - according to the provisions of the Economic Solvency Regime - of at least 100%, calculated without taking into account the transitional provisions and subject to the economic solvency ratio target set by the Company's Board of Directors. The aforesaid ratio shall be calculated without the relief granted in respect of the original difference attributed to the acquisition of the provident funds and management companies. In addition, the letter set out provisions for reporting to the Commissioner.
The Phoenix Insurance's Board of Directors has set a minimum economic solvency ratio target and target range based on Solvency II. The economic solvency ratio target range, within which the Company seeks to be during and at the end of the Transitional Period, taking into account the Deduction during the Transitional Period and its gradual reduction is 150%-170%. In addition, the minimum economic solvency ratio target, taking into account the transitional provisions, is set at 135%. In addition, on August 24, 2022, the Company's Board of Directors increased the minimum economic solvency ratio target by 3 percentage points without taking into account the provisions during the Transitional Period - from a rate of 108% to a rate of 111% beginning on June 30, 2022. This minimum economic solvency ratio target is expected to reach 135% at the end of the transitional period, in accordance with the Company's capital plan.
On October 27, 2020, The Phoenix Insurance's Board of Directors approval of the dividend distribution whereby, as from 2021, The Phoenix Insurance shall distribute an annual dividend at a rate of 30% to 50% of its distributable comprehensive income as per its audited annual consolidated financial statements for the relevant year, so long as The Phoenix Insurance meets the minimum economic solvency ratio targets in accordance with Solvency II, as described above.

On March 28, 2022, The Phoenix Insurance's Board of Directors approved a revision of the dividend distribution policy that will apply to future dividend distributions to be made in connection with The Phoenix Insurance's financial results for 2022 and thereafter. According to the update, the rate of dividend will not change, but The Phoenix Insurance will take steps to distribute a dividend twice a year:
It is hereby clarified that this policy should not be viewed as an undertaking by The Phoenix Insurance to distribute dividends, and that any actual distribution shall be individually subject to the Board of Directors' approval, at its sole discretion; the Board of Directors of The Phoenix Insurance may decide on actual distribution at different (higher or lower) rates, or not to distribute any dividend. Furthermore, the execution of any actual distribution shall be subject to compliance with the provisions of the law applicable to any dividend distribution, including, among other things, the provisions of the Companies Law, 1999, and to compliance with the financial covenants The Phoenix Insurance has undertaken or/or will undertake to comply with, to The Phoenix Insurance's having sufficient distributable profits on the relevant dates, to the condition that the distribution shall not adversely affect the terms of The Phoenix Insurance's bonds and/or its cash flows, and to the extent to which The Phoenix Insurance needs cash to finance its activities, including future investments, as shall be from time to time, and/or its expected and/or planned future activities.
The Board of Directors of The Phoenix Insurance may review the dividend distribution policy from time to time and decide, at any given time, taking into account business considerations and the legal and regulatory provisions applicable to The Phoenix Insurance, to change the dividend distribution policy, including the rate of dividend to be distributed.
On March 28, 2022, The Phoenix Insurance's Board of Directors approved the distribution of a NIS 500 million dividend based on the audited solvency ratio report as of December 31, 2020, and on the Company's estimate of the economic solvency ratio as of December 31, 2021. The dividend was paid in April 2022.
On August 24, 2022, The Phoenix Insurance's Board of Directors approved a dividend distribution in the amount of NIS 115 million in respect of the profits for the six-month period ended June 30, 2022, based on the audited solvency ratio report as of December 31, 2021, and an estimate of the economic solvency ratio as of March 31, 2022, as carried out by the Company. The dividend will be paid in September 2022.
These results, that were integrated into a revised capital management plan, indicated that the Company meets the minimum capital target set by the Board of Directors as described above. Therefore, the Company met the requirements of the letter published by the Commissioner in October 2017 regarding the restrictions on dividend distribution.
The solvency ratio as of December 31, 2021, does not include the effect of the business activity of The Phoenix Insurance subsequent to December 31, 2021, until the report publication date, changes in the mix and amounts of insurance investments and liabilities, exogenous effects - including changes in the risk-free interest rate curve, and regulatory changes affecting the business environment.

On January 5, 2022, the Commissioner published an Amendment to the Provisions of the Consolidated Circular - "Reporting to the Commissioner of Capital Market" - Own Risk and Solvency Assessment of an Insurance Company (ORSA) was published (hereinafter - the "Amendment"); the Amendment stipulates that an insurance company shall report to the Commissioner about Own Risk and Solvency Assessment of an Insurance Company (ORSA) once a year - in January. In accordance with the Amendment, the Company shall provide the Commissioner with a report that will include a summary of its results, status of its business and interactions, risk exposure, assessment of solvency and capital requirement, forward-looking valuation, scenarios and sensitivity analyses. The circular's effective date is January 1, 2023.

In recent years, there has been a significant increase in the number of petitions to approve class actions filed against the group and in the number of lawsuits recognized as class actions. This is part of an overall increase in petitions to approve class actions in general, including against companies engaged in the group's areas of activity, which stems mainly from the enactment of the Class Actions Law, 2006 (hereinafter - the "Class Actions Law"). This trend substantially increases the group's potential exposure to losses in the event of a ruling against the group companies in class actions.
Petitions to approve class actions are filed through the hearing procedure mechanism set forth in the Class Action Law. The hearings procedure for petitions to approve class actions is divided into two main stages: The first stage is the approval petition (hereinafter - the "approval petition" or the "approval stage", respectively). If the approval petition is rejected by the court, the hearing stage at the class action level ends. A ruling at the approval stage may be subject to a request for appeal to the appellate courts. In the second stage, if the approval petition is accepted, the class action will be heard (hereinafter - the "class action stage"). A judgment at the class action stage can be appealed to the appellate courts. Within the mechanism of the Class Actions Law, there are, inter alia, specific settlement agreements, both in the approval stage and in the class action stage, as well as arrangements with regard to the plaintiff's withdrawal of the approval petition or class action lawsuit.
In the State of Israel, filing class action lawsuits does not entail payment of a fee derived from the claim amount; therefore, the amounts of such claims may be significantly higher than the actual exposure for that claim.
Petitions to approve lawsuits as class actions (including lawsuits approved as class actions and the approval of which is under appeal) are set out in Sections 1-12, 16-24, 26, 28-34, 36-38, 40-45, 56 to the following table; for such lawsuits, which, in management's opinion - that is based, inter alia, on legal opinions whereby the group's defense claims are more likely than not to be accepted and the petitions to approve the lawsuit as class actions will be rejected - no provision was included in the financial statements, except for petitions to approve class actions in which the group is willing to reach a settlement. For petitions to approve lawsuits as class actions (including lawsuits approved as class actions and the approval of which is under appeal), in which the group's defense claims - in whole or in part - are more likely than not to be rejected, and in which the group is willing to reach a compromise, provisions were included in the financial statements to cover the exposure as assessed by the group or a provision in the amount for which the group is willing to settle, as the case may be.
Management's assessment, which is based, inter alia, on legal opinions received, is included in the financial statements under adequate provisions, where such provisions were required, to cover the exposure as assessed by the group or the amount for which the group is willing to settle, as the case may be.
Many of the petitions to approve lawsuits as class actions have been filed against the group on various matters related to insurance contracts and the group's ordinary course of business, for which the group has allocated insurance reserves.
In petitions to approve lawsuits as class actions as set out in Sections 13-15, 25, 27, 35, 39, 46-55, 57, 58 in the table below, at this preliminary stage, the chances of the petitions to approve lawsuits as class actions cannot be assessed and therefore no provision is included in respect thereof in the Financial Statements.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| January 2008 | Unlawful collection of | In May 2018, the Supreme Court granted the defendants' motion for leave to appeal and dismissed the | |
| 1. | payments known as | plaintiffs' appeal, such that the District Court's judgment was quashed and the motion for approval of the | |
| Tel Aviv District Court | "sub-annuals" for life | claim as a class action was denied. | |
| insurance policies, in an | |||
| The Phoenix Insurance and other | amount that exceeds | In July 2019, the Supreme Court upheld the plaintiffs' request for a further hearing on the question set | |
| insurance companies | the permitted one. | forth in the Judgment regarding the regulator's position filed with the court regarding its instructions, and | |
| on the question of de minimis defense in a monetary class action. | |||
| Approximately NIS 1.67 billion of all defendants, with about NIS 277 million |
|||
| attributed to The Phoenix Insurance.4 | On July 4, 2021, the Supreme Court handed down its judgment in respect of the further hearing by the Supreme Court (which was concluded at a 4 to 3 majority), whereby the Supreme Court's judgment will be canceled and the District Court's judgment will be reinstated, the approval petition will be allowed and the class action will be heard by the District Court, excluding the specific claims that were raised against The Phoenix Insurance (and another insurance company) regarding the collection of "sub-annuals" in an amount that exceeds the amount permitted by law - claims which were rejected by the court and therefore will not be discussed again by the District Court, and the legal proceedings in respect thereof has ended. |
||
| The class action continues to be heard in the district court. A pre-trial hearing is scheduled for January 5, 2023. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.
4 The amounts were assessed by the plaintiffs in the class action statement of claim. It should be noted that the amounts in the motion to approve the claim as a class action were different and higher; those amounts also referred to the claim of collecting handling fees on policies and interest on annual premium, which is paid in installments, at a rate higher than the rate permitted by law, which, as stated, has been rejected.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| February 2010 | The cause of the lawsuit, as approved | In November 2016, the District Court - in a parallel case filed against |
|
| 2. | by the District Court (in the |
several other insurance companies - partially approved motions to approve |
|
| Central District Court | corresponding case) was breach of | the claims as class actions. | |
| insurance policies due to unlawful | |||
| The Phoenix Insurance (and other insurance companies | collection of handling fees in a manner | The class action - both in the corresponding case and in the case heard |
|
| in a parallel case, in light of filing a consolidated class | that reduced the saving amount | against The Phoenix Insurance - continues to be heard jointly by the |
|
| action statement of claim) | accrued in favor of the policyholder for | District Court. At the same time, the parties conduct a mediation process. | |
| a period starting seven years before | |||
| Approximately NIS 1.47 billion of all defendants | the claim was filed. | ||
| (including the defendants in the corresponding case), | |||
| of which approximately NIS 238 million is attributed to | |||
| The Phoenix Insurance.4 |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.
4 The amounts are the amounts assessed by the plaintiffs in the consolidated class action statement of claim filed in March 2019 against the insurance companies sued in the corresponding case and against The Phoenix. It should be noted that the amounts in the motion for approval of the claim as a class action were different and higher.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 3. | April 2010 Central District Court The Phoenix Insurance and other insurance companies NIS 225.2 million from all the defendants. |
Non-refund of premium for the relative portion of the month in which the insurance ended (due to cancellation by the policyholder) and/or refund of premium (where the premium is refunded) at nominal values (without linkage differences and interest). |
In June 2015, the district court partially affirmed the motion to approve the action as a class action lawsuit. In September 2016, the parties filed with the District Court an application for approval of a settlement agreement, at amounts that are immaterial to The Phoenix Insurance, which includes: the appointment of an examining party who will review the collection amounts in respect of which the claim was approved as a class action; consent to a contribution of 80% of the amount of the refund to be determined by the examining party; provisions regarding future conduct in cases of cancellation of policies that are the subject matter of the lawsuit and a recommendation regarding the payment of compensation to the plaintiffs, legal fees, etc. The settlement agreement is subject to the Court's approval. In June 2017, the Court appointed a reviewer to review the settlement agreement; the reviewer filed the review on The Phoenix Insurance in December 2020. In July 2022, the parties filed an amended settlement agreement in accordance with the Court's clarifications. The Court has not yet approved the amended settlement agreement. |
| 4. | May 2013 Tel Aviv District Court The Phoenix Insurance Approximately NIS 220 million or alternatively NIS 90 million.4 |
Non-payment of interest in respect of insurance benefits from the date of the insurance event, or alternatively from the end of 30 days from the date on which the claim was filed and until actual payment date. |
In February 2021, the District Court handed down a partial judgment, according to which it has approved the class action, in respect of any entitled party (policyholder, beneficiary or third party), who - during the period starting three years prior to the filing of the lawsuit and ending on judgment date - received insurance benefits from The Phoenix Insurance (not in accordance with a judgment rendered in his case) without being duly paid interest thereon. It was also established that, for the purpose of implementing the judgment, calculation and manner of restitution, an expert will be appointed and that the class plaintiffs will be awarded legal expenses and legal fees. In May 2021, The Phoenix Insurance filed a motion to appeal with the Supreme Court against the judgment handed down by the District Court as well as a motion to stay the execution of the judgment. In June 2021 the Supreme Court issued a motion to stay the execution of the judgment and ruled that the motion to appeal requires a reply (the latter was submitted in September 2021). |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.
4 The amounts are those amounts that were estimated by the plaintiff in the class action statement of claim - NIS 220 million (if it was ruled that interest should be calculated from the date of occurrence of the insurance event) and NIS 90 million (if it is ruled that interest should be calculated starting 30 days from the delivery date of the claim). It should be noted that the amounts in the motion for approval of the class action lawsuit were different and higher and also related to the linkage claim, which was rejected as described above.

| No. | Date,1 court,2 defendants Main arguments and claim amount3 |
Details | ||
|---|---|---|---|---|
| 5. | July 2014 Central District Court The Phoenix Pension and Provident Fund Ltd. and management companies of additional pension funds. NIS 48 million from all defendants. |
Acting in bad faith when using the right - under the pension fund's rules and regulations - to increase management fees paid by pensioners from the accrual to the maximum amount allowed, as from the date they become pensioners. |
On March 18, 2022, the District Court approved the motion to approve the claim as a class action. As part of the approval process it was determined that the group on behalf of which the class action will be conducted will include any person who is a planholder in a new comprehensive pension fund, which is among the defendants, where such planholder is entitled to receive old-age pension; it was also determined that the questions for discussion are whether the defendants should have given planholders advance notice regarding the management fees that will be collected from them during the pension period, and if so - what is the damage caused as a result of not issuing such notice. |
|
| 6. | June 2015 Beer Sheva District Court The Phoenix Insurance Approximately NIS 125 million. |
The cause of action, as approved by the District Court, is a violation of the provisions of the policy regarding special compensation (reimbursement) for performing surgery in a private hospital funded by "additional insurance services" (SHABAN) and the questions common to the group members are: what is the value of the commitment form on behalf of a health maintenance organization in respect of a privately-owned hospital (Form 17), according to which the amount to be reimbursed to the policyholder is calculated; how The Phoenix Insurance in effect calculated the amount reimbursed to policyholders who underwent surgeries as part of SHABAN; and whether The Phoenix Insurance violated the provisions of the policy, and did not reimburse the full amount to the policyholders. |
The class action continues to be heard in the district court. In December 2019, the District Court approved the motion to approve the claim as a class action lawsuit. The group on whose behalf the class action will be conducted will include all policyholders who were insured under a health insurance policy with The Phoenix Insurance, which included a reimbursement arrangement for performing surgery at a private hospital funded by Shaban, based on a commitment form/Form 17, and in respect of whom an insurance event occurred from June 25, 2012 through June 25, 2015. The parties are in a mediation procedure. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 7. | September 2015 Tel Aviv District Court The Phoenix Pension (currently - The Phoenix Pension and Provident Fund Ltd.) and management companies of additional pension funds Approximately NIS 300 million per year since 2008 of all the defendants. |
The claim is that the defendants pay agents fees and commissions calculated as a percentage of the management fees charged by them, thus allegedly violating their fiduciary duties, and that, as a result, the management fees that planholders are charged are higher than the appropriate rate. |
The parties are awaiting the court's decision on the application for approval of the claim as a class action. |
| 8. | December 2015 Tel Aviv District Court The Phoenix Insurance and another insurance company Approximately NIS 100 million from all defendants, of which NIS 50 million is attributed to The Phoenix Insurance. |
Alleged unlawful collection of "sub-annuals" in life insurance at a rate that is higher than the permitted one. |
In May 2020, the court issued a ruling rejecting the motion for approval of the claim as a class action, on the grounds that the plaintiffs do not have a cause of action. In September 2020, the plaintiff filed an appeal with the Supreme Court. An appeal hearing is scheduled for December 8, 2022. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 9. | February 2016 Central District Court The Phoenix Insurance NIS 100 million. |
The plaintiffs argue that The Phoenix Insurance does not link the payments it must pay policyholders under life insurance policies (which it issued until July 19 1984) due to an insurance event or due to the redemption of the policy, to the correct basic CPI in accordance with the linkage terms and conditions set out in the policies; i.e., the latest CPI published before the first day of the month in which the insurance term begins; the plaintiffs argue that this has a significant effect on the benefits to which the policyholders will be entitled. |
The parties are in a mediation procedure. |
| 10. | February 2016 Tel Aviv Regional Labor Court (the hearing was transferred from the Central District Court due to substantive jurisdiction) The Phoenix Pension and Provident Fund Ltd. and management companies of additional pension funds. Approximately NIS 1 billion of all the defendants. |
The plaintiffs argue that the defendants are acting inappropriately by charging management fees in respect of disability and survivors benefits, and do not disclose that fact, and that the rate of management fees collected from such benefit recipients is the maximum permitted rate, taking advantage of the fact that benefit recipients cannot transfer their funds and/or entitlement to such benefits elsewhere. |
The parties are awaiting the court's decision on the application for approval of the claim as a class action. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details | |
|---|---|---|---|---|
| The motions to approve the lawsuits as class actions that appear in Sections 11-15 below were submitted on the grounds of unlawful collection of investment management expenses which are |
||||
| not sanctioned by the policies or bylaws. | ||||
| September 2016 | Collecting investment |
In May 2019, the District Court approved the motion to approve as a class action the claim filed against The Phoenix Insurance | ||
| 11. | Central District Court | management expenses in the individual saving |
and three other insurance companies (hereinafter - the "Defendants"), for breaching the provisions of the insurance policy due to unlawful collection of investment management expenses. The class on whose behalf the class action lawsuit against |
|
| The Phoenix Insurance | policy Excellence Invest | The Phoenix Insurance will be conducted includes all policyholders of the individual savings policy Excellence Invest issued by | ||
| NIS 14.7 million. | in addition to collecting management fees, |
The Phoenix Insurance at present and in the seven years prior to the date of submission of the motion for approval as class action. The remedies claimed are the reimbursement of the investment management expenses that were overcharged in addition to interest differentials; and an order directing the defendants to stop collecting such fees. |
||
| without a provision in the policy expressly |
In September 2019, The Phoenix Insurance (along with the other defendants) filed a motion for leave to appeal to the | |||
| permitting to do so. | Supreme Court against the decision approving the class action lawsuit. | |||
| At the request of the Supreme Court, on August 13, 2020, the Attorney General submitted his position on the proceedings and announced his attendance. According to the position, the Attorney General is of the opinion that the court should accept the motion for leave to appeal and the appeal itself and order the rejection of the motions for approval as class actions, for the reasons set out in the position. |
||||
| A hearing on the request for leave to appeal took place on February 11, 2021. | ||||
| In January 2022, the Attorney General submitted his position regarding the proceeding following a final report submitted by the advisory committee to the Capital Market, Insurance and Savings Authority, on the issue of direct expenses, as published in November 2021; the Attorney General noted that the request for leave to appeal and the appeal itself should be allowed, and in this respect, the motions for certification of the lawsuits as class actions must be rejected, and that there is nothing in the report that affects the decision made in the proceeding and it may even support his position. The other parties have also submitted their response to the position of the Attorney General and to the committee's report. The parties await the judgment. |
||||
| At this point, the hearing on the class action in the District Court was postponed. It should be noted that requests for approval of class actions regarding investment management expenses are also pending against Excellence Gemel (please see Section 12 in the table below), The Phoenix Insurance (see Section 13 in the table below) and Halman Aldubi Provident and Pension Funds Ltd. (see Sections 14 and 15 in the table below). |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 12. | November 2016 Jerusalem Regional Labor Court Excellence Nessuah Gemel Ltd. (currently: The Phoenix Pension and Provident Fund Ltd.) Approximately NIS 215 million. |
The plaintiffs argue that under the rules and regulations of the Excellence Gemel provident fund, which were in effect until January 1, 2016, and according to the rules and regulations of the Excellence Advanced Education fund, Excellence Gemel may not collect investment management expenses from planholders, since collection of such expenses had to stipulated clearly and expressly in the rules and regulations of the funds. |
The court approved the hearing arrangement filed by the parties, according to which the hearings to approve the claim as a class action will be postponed until a decision has been made in connection with the motion for leave to appeal against the May 2019 District Court decision to approve as class actions claims filed for similar causes of action against The Phoenix Insurance, among others (see Section 11 above in the table). |
| 13. | June 2019 Tel Aviv Regional Labor Court The Phoenix Insurance Approximately NIS 351 million. |
According to the plaintiff, The Phoenix Insurance charges policyholders of insurance policies which combine a life insurance component and a pension saving component (executive insurance) for investment management expenses without such charges being included in the terms and conditions of the policy. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. The Phoenix Insurance's application for stay of proceedings until a decision is made regarding the appeal motion described in Section 11 to the table above, has not been allowed. A hearing is scheduled for December 12, 2022. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 14. | June 2019 Jerusalem Regional Labor Court Halman Aldubi Provident and Pension Funds Ltd. (which was merged into The Phoenix Pension and Provident Fund Ltd.) NIS 17.5 million. |
The statement of claim alleges that IBI Provident and Study Fund Management Company Ltd. (which was merged with Halman Aldubi on July 1, 2018) charged the plaintiff and the other planholders of the advance education fund under its management, investment management expenses, in addition to the fund management fees, contrary to the fund's bylaws. |
Halman Aldubi has not yet submitted its response to the petition for approval of the claim as a class action lawsuit; in September 2019, it submitted a motion for a stay of proceedings until a final decision has been made on ten petitions for approval of claims as class action lawsuits which are being heard in Labor Court (including against Excellence Nessuah (see Section 12 above in the table) regarding the collection of management expenses in provident funds and advanced education funds. In March 2022, the Court stayed the proceedings until after a decision is made regarding the motion to appeal described in Section 11 in the table above. |
| 15. | July 2019 Jerusalem Regional Labor Court Halman Aldubi Provident and Pension Funds Ltd. (which was merged into The Phoenix Pension and Provident Fund Ltd.) No estimate was provided, but it was noted that the damage to all class members exceeds NIS 3 million. |
According to the statement of claim, Halman Aldubi charged the plaintiff and the other planholders of the Halman Aldubi comprehensive pension fund (hereinafter - the "Fund") investment management expenses, in addition to the management fees charged by the Fund, contrary to the Fund's bylaws; the practice continued until May 2017, at which time the Fund's bylaws were changed so as to include the specific provision for charging direct investment management expenses. |
Halman Aldubi has not yet submitted its response to the petition for approval of the claim as a class action lawsuit; in September 2019, it submitted a motion for a stay of proceedings until a final decision has been made on ten petitions for approval of claims as class action lawsuits which are being heard in Labor Court (including against Excellence Nessuah (see Section 12 above in the table) regarding the collection of management expenses in provident funds and advanced education funds. In March 2022, the Court stayed the proceedings as stated above. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 16. | January 2017 Central District Court |
According to the plaintiffs, insurance companies overcharge insurance premiums since they do not disclose to policyholders a "practice" in the motor insurance subsegment that allows updating the age of the young driver insured under the policy and/or the years |
On March 20, 2022, the Court stayed the proceedings in this case until a judgment is handed down in the appeal that has been filed in a similar class action lawsuit against |
| The Phoenix Insurance and other insurance companies At least approximately NIS 12.25 million in respect of each of the defendants. |
of driving experience when moving into another age bracket and/or years of driving experience bracket which can potentially result in a reduction of the insurance premium. |
another insurance company that was rejected (to which the plaintiffs referred in the certification motion). |
|
| It should be noted that the plaintiffs refer in their claim to a decision approving a motion for approval of a claim as a class action dealing with the same issue and filed against another insurance company, in which the said practice had allegedly been proven. |
|||
| 17. | April 2017 Tel Aviv Regional Labor Court (the hearing was transferred from the Tel Aviv District due to substantive |
According to the plaintiffs, until the regulator intervened and legislative changes were made in connection with this issue, managers of pension arrangements in general and the defendants in particular, provided employers with operating services involving |
In August 2020, the court issued a ruling rejecting the motion for approval of the claim as a class action. |
| jurisdiction) Shekel Insurance Agency (2008) Ltd. (hereinafter - |
preparing and managing pension insurance for employees without the employers paying any consideration in respect thereof to the pension arrangement managers, and that all costs pertaining to the |
In October 2020, the plaintiffs filed an appeal with the National Labor Court. |
|
| "Shekel"), Agam Liderim (Israel) Insurance Agency (2003) Ltd. (hereinafter - " Agam Liderim"), second-tier companies of The Phoenix Holdings, and other insurance agencies. |
operating services are paid by the employees through management fees they pay for the products marketed to them by the managers of the pension arrangement. |
In July 2021, a hearing on the appeal took place and the parties are awaiting the ruling of the National Court on the appeal. |
|
| Approximately NIS 357 million of all defendants, of which NIS 47.81 million is attributed to Agam Liderim and NIS 89.64 million to Shekel. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 18. | June 2017 Central District Court |
The lawsuit is concerned with a claim that service level agreements are marketed and sold, either directly or through agents on behalf of The Phoenix Insurance, in violation of the provisions of the law regarding the marketing and sale procedure of such |
In August 2021, the District Court issued a ruling approving the petition to approve the claim as a class action. |
| The Phoenix Insurance | agreements. | The group on behalf of which the class action will be conducted is anyone who had purchased from The Phoenix Insurance, whether directly or through its agents, service level |
|
| The amount of the claim was not estimated. |
agreements as part of the comprehensive car insurance policy, with The Phoenix Insurance violating the law regarding the marketing and sale of service level agreements, in the period ranging from June 30, 2016 until the date of the ruling. |
||
| The parties are in a mediation procedure. | |||
| 19. | June 2017 Central District Court (sitting as an Administrative Court). The National Insurance Institute (hereinafter - the "National Insurance Institute") |
According to the plaintiffs, the National Insurance Institute collects national insurance contributions and health insurance contributions illegally from the tax-exempt income of class members as defined below, in addition to collecting the minimum rate of health insurance contributions from class members' disability annuity. According to the plaintiffs, the National Insurance Institute overcharges class members for these contributions through the pension fund, the employer or any other third party. The plaintiffs point out that the Official Respondents are entities through which the insurance premiums were collected from the plaintiffs, and clarify that any employer and any entity paying an early pension and any entity paying a PHI benefit in Israel may be |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| The Phoenix Insurance and additional insurance companies (hereinafter, jointly: the "Official Respondents") The amount of the claim was not estimated. |
in a similar position to that of the Official Respondents. According to the plaintiffs, it is impossible to add all the parties as respondents and the court is asked to consider the Official Respondents that were added, and which are related to the plaintiffs' case as class action defendants. The plaintiffs also stated that no operative remedy is requested in the case of the Official Respondents in the framework of the above claim. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 20. | August 2017 | Increasing management fees in 2007 without sending prior notice as required by law. |
On March 20, 2022, the court approved the motion to approve the claim as a class action. |
| Tel Aviv Regional Labor Court (the hearing was transferred from the Central District Court due to substantive jurisdiction) Excellence Gemel & Hishtalmut Ltd. (currently: The Phoenix Pension and Provident Fund Ltd.) The claim amount was not estimated but it was stated as more than NIS 2.5 million. |
As part of the certification decision, it is decided that the group on behalf of which the class action will be conducted is as requested in the certification motion. On June 14, 2022, Excellence Gemel filed a motion for leave to appeal against the decision approving the lawsuit as class action to the National Labor Court. A hearing was scheduled for September 20, 2022. The hearing of the class action by the Regional Court was |
||
| delayed until a decision is made regarding the motion for leave to appeal. |
|||
| January 2018 | According to the plaintiff, The Phoenix Insurance unlawfully |
On January 4, 2022, the District Court issued a judgment | |
| 21. | Central District Court The Phoenix Insurance and other insurance companies Approximately NIS 82.2 million per year from all the defendants, of which approximately NIS 22.3 million per year is attributed to The Phoenix Insurance. |
refrains from paying its policyholders and third parties the VAT component applicable to the cost of damages when the damages have not been effectively repaired. |
rejecting the motion for approval of the claim as a class action lawsuit. In April 2022 the plaintiff filed an appeal to the Supreme Court. An appeal hearing is scheduled for March 13, 2023. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 22. | May 2018 Haifa Regional Labor Court The Phoenix Pension and Provident Fund Ltd.4 NIS 200 million. |
According to the plaintiffs, contrary to that which is stated in its rules and regulations, The Phoenix Pension has refrained from paying or from paying in full the partial contributions towards benefits to anyone who does not receive a full disability pension. In any case, The Phoenix Pension refrained from reporting to policyholders - either in pay slips or in annual statements - about the payments it made, to the extent that it did, indeed, make such payments. |
In August 2021, the Regional Labor Court issued a resolution approving the motion for approval of the claim as a class lawsuit. As part of the above resolution, the Court approved causes of action in connection with the failure to pay contributions towards benefits in respect of planholders receiving a partial disability pension during the period from May 1, 2012 through May 1, 2019; the Court ordered a remedy whereby the rules and regulations should be abided by and the planholders' accumulated balance should be credited with current monthly contributions towards benefits based on a value date as of the original entitlement date, plus the yield accrued on the fund as from the said date. The Court also ruled that no separate pecuniary damages has been proven in addition to what is stated above, and that no monetary damages should be paid. The class action continues to be heard in court. |
| 23. | June 2018 Jerusalem District Court The Phoenix Insurance and another insurance company The amount of the claim was not estimated. |
According to the plaintiff, the claim deals with the defendants' unjustified refusal to recognize a surgical procedure that had medical justification as an insurance event according to the health policies issued, by claiming that it is a "preventive surgical procedure". |
In January 2022, the District Court issued a ruling approving the petition to approve the claim as a class action. As part of the certification decision it was determined that the group on whose behalf the class action will be conducted will include any person who engaged in an health insurance contract with the defendants, including insurance coverage for surgical procedures, whose claim to have such procedure done was rejected for the reason that it is a preventative procedure which is not covered by the policy (even if the reason was presented differently in the letter rejecting the claim), and the joint questions for the group members are: Did the defendants breach the insurance contracts when they rejected the claims for insurance coverage by stating that the surgical procedure is a "preventative" one, and the remedies to which group members are entitled due to that. On May 24, The Phoenix Insurance filed a motion for leave to appeal to the Supreme Court against the decision approving the class action lawsuit. The Phoenix Insurance' motion for stay of proceedings until a decision is made regarding the motion for leave to appeal was not allowed by the Supreme Court, and therefore the class action is heard simultaneously by the District Court. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.
4 The petition for approval of the claim as a class action lawsuit was originally filed against The Phoenix Insurance. The plaintiffs filed an amended petition for approval of the claim as a class action lawsuit, in which they changed the identity of the defendant and also added to their previous allegations and to the definition of the class they seek to represent.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 24. | December 2018 Tel Aviv District Court The Phoenix Insurance, other insurance companies and banks NIS 280 million from all defendants. |
According to he plaintiffs, the claim deals with unlawful overcharging of insurance premiums for unnecessary building insurance policies issued to building owners (who took out a mortgage loan and were required to insure the building with a building policy in favor of the lending bank), despite the fact that at the time of issuance of such policies, there was already and insurance policy covering that building, regardless of whether that policy was taken out with the same insurance company or with another insurance company. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| 25. | March 2019 Central District Court The Phoenix Insurance Approximately NIS 2.6 million. |
According to the plaintiff, the claim deals with The Phoenix Insurance's practice to delay the repayment of the relative portion of insurance premiums upon cancellation of compulsory motor and property insurance policies rather than paying it within the period set by law; the plaintiff also claims that The Phoenix Insurance repays the said amount without adding linked interest. The plaintiff also claims that The Phoenix Insurance refrains from repaying full linkage when refunding the relative portion of the insurance premiums. |
The parties are in a mediation procedure. |
| 26. | May 2019 Tel Aviv District Court The Phoenix Insurance Approximately NIS 766.8 million. |
According to the plaintiff, the claim deals with The Phoenix Insurance's not paying policyholders in participating life insurance policies which include an Rm formula their full share of the profits and full payments to which they are entitled under the insurance contracts; the plaintiff also claims that The Phoenix Insurance does not fulfill its reporting and disclosure obligations towards policyholders regarding their policies and rights. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. A hearing was scheduled for September 6, 2022. It should be noted that the plaintiff stated that a similar motion for approval of a claim as class action, which was filed against another insurance company, had recently been approved. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 27. | July 2019 Tel Aviv District Court The Phoenix Insurance and other insurance companies Approximately NIS 264.5 million from all the defendants, of which approximately NIS 67.5 million is attributed to The Phoenix Insurance. |
The plaintiffs claim that the defendants do not pay their policyholders interest as required by law in respect of insurance benefits for the period starting 30 days after the date of delivery of the claim until the date of actual payment. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. It should be noted that according to the plaintiffs, this claim is based on the same cause of action as the class action described in Section 4 above in the table; however, it was nevertheless decided to file this claim for the sake of caution only, given the doubt as to whether the class of plaintiffs seeking the approval of this motion is included in the previous class action. In light of this, the proceedings in this claim were stayed until a judgment is rendered in the previous claim. |
| 28. | August 2019 Central District Court The Phoenix Insurance and other insurance companies The claim amount was not estimated, but it was stated that it was in the tens of millions of shekels or more. |
The plaintiffs claim that in case of vehicle theft or total loss as a result of an accident, the defendants refuse to reimburse policyholders for the proportionate share of the insurance premiums (the premium) paid for service contracts (road recovery services, windscreen repair, towing, etc.) in respect of the period subsequent to the theft or total loss, despite the fact that the service contract is canceled and the risk it covers no longer exists. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. In February 2020, the position of the Capital Market, Insurance and Savings Authority was submitted, which is not in line with the plaintiffs' position. |
| 29. | December 2019 Central District Court PassportCard Israel General Insurance Agency (2014) (hereinafter - "PassportCard") and The Phoenix Insurance The amount of the claim was not estimated. |
According to the plaintiff, the defendants sell travel insurance without informing their customers - at the time of issuing the insurance policy - about the fact that the "search and rescue" component can be excluded if it is not required by the customers; the plaintiff also claims that the defendants do not inform customers about price changes they make in insurance policies' components; furthermore, the defendants do not inform customers in a clear manner about the right to reimbursement of a proportionate share of the insurance premiums in the event that the actual trip is shorter than planned, and in the event that the insurance period is shortened for any reason whatsoever (including due to cancellation of the insurance policy). The plaintiff also claims that even when the defendants reimburse insurance premiums to policyholders who shortened their travel period and at the same time also shortened the insurance period for any reason whatsoever, they do not reimburse the full insurance premium for the shortened insurance period, contrary to law and the insurance policy. |
The parties are in a mediation procedure. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 30. | January 2020 Central District Court The Phoenix Insurance, other insurance companies and a road recovery and towing services company. The claim amount was not estimated but it was stated that it significantly exceeds NIS 2.5 |
The plaintiff claims that, in cases where vehicles' windscreens broke, the defendants had provided and still provide alternative windscreens, which do not meet Israeli standards and are not manufactured by the same maker as the car; by doing so, the defendants allegedly breach their obligations under the insurance policies and coverage contracts. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. A hearing was scheduled for September 7, 2022. |
| 31. | million. February 2020 Central District Court The Phoenix Insurance The claim amount was not estimated, but it was stated that it is in the millions of shekels or more. |
The plaintiff claims that starting in early 2016 or thereabouts, The Phoenix Insurance ceased to fulfill its obligation in health insurance policies marketed prior to February 1, 2016, in which it undertook to provide insurance coverage, at no additional cost, to all children born to the principal policyholder (starting with the fourth child), until they reach the age of 21. |
The parties are awaiting the court's decision on the application for approval of the claim as a class action. |
| 32. | February 2020 Tel Aviv Regional Labor Court (the hearing was transferred from the Tel Aviv District Court) Halman Aldubi Provident and Pension Funds Ltd. (which was merged into The Phoenix Pension and Provident Fund Ltd.) NIS 335 million (alternatively NIS 58 million, and alternatively 36 million). |
The claim is that Halman Aldubi allegedly violated its duty to the plaintiff and to all beneficiaries in the provident funds of Halman Aldubi, of deceased planholders, and any planholder of the Halman Aldubi provident funds with whom contact was lost, to locate and inform the said beneficiaries, as well as the planholders with whom contact was lost, that they are entitled to funds in the Halman Aldubi funds, on the dates set forth to that effect in the Supervision of Financial Services Regulations (Provident Funds) (Locating Planholders and Beneficiaries), 2012, in the period beginning on January 1, 2013 until the date of the ruling in the lawsuit. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| The petitions to approve claims as class actions listed in Sections 33 and 34 below were filed following the Covid-19 pandemic which broke out in March 2020. The petitions were submitted in the motor and home insurance subsegments; the plaintiffs argue in these motions that insurance companies in general and The Phoenix Insurance in particular should reimburse policyholders for premiums paid during the period in which restrictions were in place due to the Covid-19 pandemic in view of the reduced insurance risk in these fields during that period. |
|||
| 33. | April 2020 Tel Aviv District Court The Phoenix Insurance, other insurance companies and the managing corporation of the Compulsory Motor Insurance Pool (the "Pool") Ltd. Approximately NIS 1.2 billion of all the defendants, of which NIS 145 million is attributed to The Phoenix Insurance or, alternatively, NIS 719 million of all the defendants, of which NIS 113 million is attributed to The Phoenix Insurance. |
The subject matter of the lawsuit4 is that the defendants unjustly profited, allegedly, by failing to reduce car insurance premiums (for compulsory and/or comprehensive and/or third-party policies) during the mobility restrictions imposed due to the Covid-19 pandemic. This was done, argued the plaintiffs, despite a decrease in mileage traveled and the level of risk to which the defendants are exposed. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. A pre-trial hearing is scheduled for January 3, 2023. It should be noted that a petition to approve a similar claim as a class action, which was filed against The Phoenix Insurance and other insurance companies was rejected in August 2021. |
| 34. | April 2020 Tel Aviv District Court The Phoenix Insurance and other insurance companies Approximately NIS 18.14 million from all the defendants, of which approximately NIS 2.2 million is attributed to The Phoenix Insurance. |
The argument is that the defendants must reimburse premiums they overcharged policyholders in motor and home insurance, due to a decrease in the risk they are exposed to as a result of the restrictions imposed following the Covid-19 pandemic, which led to a decline in mileage traveled and a decline in bodily harm and damage to property. |
On February 2021, the court ruled that the petition to approve the claim as a class action in relation to motor insurance was dismissed and will continue to be heard in relation to home insurance only. The plaintiffs' appeal was dismissed in May 2022. The motion for approval of the claim as a class action lawsuit in relation to home insurance continues to be heard in the court. A pre-trial hearing is scheduled for January 3, 2023. It should be noted that a petition to approve a similar claim as a class action, which was filed against The Phoenix Insurance and other insurance companies, was rejected in August 2021. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.
4 The petition to approve the claim as a class action includes two petitions to approve claims as class actions filed against The Phoenix Insurance and other defendants, which were merged into a single claim in February 2021 by the Tel Aviv District Court (see Note 42(a)(1) in Sections 42 and 44 of the class actions table in the Company's financial statements as of December 31, 2020, published on March 25, 2021 (Ref. No. 2021-01-044709).

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 35. | May 2020 Tel Aviv District Court Phoenix Excellence Pension and Provident Funds Ltd. (currently - The Phoenix Pension and Provident Fund Ltd.), Halman Aldubi Provident and Pension Funds Ltd. (which was merged into The Phoenix Pension and Provident Fund Ltd.) and additional management companies The claim amount was not estimated, but it was stated that it is estimated, at a minimum, in the hundreds of millions of shekels. |
According to the plaintiffs, the claim deals with the defendants' classifying some of the contributions transferred to an advanced education fund on behalf of their customers as taxable provisions, even though they are not taxable. |
In accordance with the Court ruling, the government - the Israel Tax Authority, was added as a further defendant to the motion to approve the lawsuit as a class action. The petition for approval of the claim as a class action lawsuit continues to be heard in court. A hearing is scheduled for March 5, 2023. |
| 36. | June 2020 Tel Aviv District Court PassportCard Israel General Insurance Agency (2014) (hereinafter - "PassportCard") and The Phoenix Insurance At least NIS 10 million. |
According to the plaintiff, the claim deals with non-payment of insurance benefits in respect of cancellation of a trip due to a pandemic (the Covid-19 pandemic) under travel insurance that the plaintiff purchased through PassportCard. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court and a hearing was scheduled for September 8, 2022. At the same time, the parties are negotiating the plaintiff's withdrawal from the certification motion. |
| 37. | June 2020 Tel Aviv Regional Labor Court The Phoenix Insurance The amount of the claim was not estimated. |
According to the claim, after a policyholder passes away, The Phoenix Insurance links the funds accrued in the policy to the consumer price index, instead of linking them to the investment track selected by the policyholder, as it previously did. |
The parties are in a mediation procedure. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 38. | June 2020 Central District Court The Phoenix Insurance and another insurance company Approximately NIS 10.5 million for each defendant. |
According to the claim, the defendants overcharge customers in loan agreements they enter into with their customers; overcharging takes place due to a one-way linkage mechanism, which is in place under those agreements, whereby if the CPI increases above the base CPI, the defendants collect the linkage differences due to the increase; however, if the CPI decreases below the base index, they do not credit their customers for the said decrease. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| 39. | July 2020 Haifa Magistrate Court PassportCard Israel General Insurance Agency (2014) (hereinafter - "PassportCard") and The Phoenix Insurance NIS 1.84 million. |
According to the claim, when travel insurance benefits are paid late, the defendants do not pay interest in respect of the delay; the plaintiff also claims that the defendants usually pay the insurance benefits according to the exchange rate on the day of the insurance event rather than the exchange rate on repayment date. In addition, it was argued that the disclosure duty regarding the deductible and the limitation of the insurer's liability with regard to the "winter sports" component is violated as part of a representation made prior to entering into the insurance contract. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. The proceedings in this lawsuit were stayed until a final decision is made in connection with the class action outlined in Section 4 above in the table. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 40. | July 2020 Central District Court The Phoenix Insurance and other insurance companies About 1.9 billion of all defendants, with the share of each of the defendants being in accordance with its market segment; according to the plaintiffs, The Phoenix's share is approximately 19%. |
According to the claim, the defendants must charge reduced insurance premiums in cases of insurance policies with exclusions due to an existing medical condition compared to policies in which no such exclusion is present, since exclusions mitigate the defendants' insurance risk. |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. A hearing is scheduled for September 12, 2022. |
| 41. | September 2020 Tel Aviv District Court The Phoenix Insurance NIS 92.7 million. |
According to the claim, The Phoenix Insurance does not pay policyholders insured under long-term care policies the full amount due to them under their policies, since it offsets these amounts against proceeds received from the National Insurance Institute; it is also claimed that The Phoenix Insurance does not indemnify policyholders for certain medical treatments. |
The parties are awaiting the court's decision on the application for approval of the claim as a class action. |
| 42. | September 2020 Central District Court The Phoenix Insurance and another insurance company NIS 84 million from all the defendants, of which NIS 67.2 million is attributed to The Phoenix Insurance (a total of NIS 16.8 million in respect of critical illness insurance and a total of NIS 50.4 million in respect of permanent health insurance). |
According to the claim, the defendants acted in violation of the provisions of critical illness insurance policies when they continued to charge policyholders the full amount of the monthly premium even after the first insurance event had occurred. It was also alleged against The Phoenix Insurance that contrary to its obligations, it charges its policyholders a monthly PHI insurance premium, even after the period of insurance coverage has ended. |
The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A pre-trial hearing is scheduled for November 10, 2022. At the same time, the parties are negotiating to conclude the procedure. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 43. | December 2020 Central District Court |
According to the plaintiff, The Phoenix Insurance allegedly does not indemnify its policyholders in motor insurance policies relating to vehicles other than private and commercial cars weighing up to 3.5 tons (such as trucks, taxis, etc.), in respect of the |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| The Phoenix Insurance | damage caused to their vehicle due to the insurance event - which, the plaintiff claims, is in breach of the policy and the law. It is further claimed that The Phoenix Insurance does |
||
| The aggregate claim amount was not estimated but it was stated that it exceeds NIS 2.5 million. |
not provide its policyholders with an appraiser's report, which includes an estimate of the impairment to the vehicle's value due to the insurance event nor its manner of calculation. |
||
| 44. | February 2021 Central District Court |
According to the plaintiff, the claim deals with the increasing of insurance premiums by more than 75% than the agreed premiums in life, long-term care, and PHI insurance |
The petition for approval of the claim as a class action lawsuit continues to be heard in court. |
| The Phoenix Insurance | policies taken out as part of a special deal for members of the Israel Bar Association (and potentially in other insurance policies) in 2016, without informing policyholders, obtaining their consent and providing them with any explanations. |
||
| No estimate was provided for the claim amount, but it was stated that the damage exceeds NIS 2.5 million. |
|||
| 45. | March 2021 Tel Aviv District Court |
The subject matter of the claim, according to the plaintiffs, is that the defendants refuse to pay for the policyholders' expenses for the purchase of medical cannabis, contrary to the provisions of the policy to cover drugs excluded from the Healthcare Services Basket, |
The parties are in a mediation procedure. |
| The Phoenix Insurance and other insurance companies | and since medical cannabis is recognized for medical use in Western countries. | ||
| Approximately NIS 79 million from all defendants. | |||
| March 2021 | The subject matter of the claim, according to the plaintiff, is that The Phoenix Insurance | The petition for approval of the | |
| 46. | Central District Court | allegedly unlawfully rejects claims by its policyholders in "personal accident" policies to pay for hospitalization at a "non-general hospital", claiming that a "hospital", as defined in the |
claim as a class action lawsuit continues to be heard in court. |
| The Phoenix Insurance | policy, is a medical institution whose underlying meaning is a "general hospital only". | ||
| No estimate was provided for the claim amount, but it was stated that the damage exceeds NIS 2.5 million. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| April 2021 | According to the plaintiffs, when using the defendants' digital services |
The Phoenix Insurance filed its response to the | |
| 47. | Central District Court | (while browsing their personal accounts), customers' private, personal and confidential information is transferred to third parties |
motion to approve the claim as a class action. A pre-trial hearing is scheduled for November 6, |
| The Phoenix Insurance, banks, investment houses, | without the customers' consent, violating their privacy. | 2022. | |
| credit card companies and other insurance companies |
|||
| The claim amount was not estimated but it was | |||
| stated that it amounts to millions of shekels. | |||
| June 2021 | This lawsuit relies on the facts as presented in a petition to approve | The petition for approval of the claim as a class |
|
| 48. | Tel Aviv District Court | a derivative lawsuit that was filed against the Defendants, and which deals with events that took place at the beginning of the 1990s (see |
action lawsuit continues to be heard in court. A pre-trial hearing is scheduled for October 31, |
| The Phoenix Holdings, The Phoenix Insurance, the | Section 3 below in the Legal and Other Proceedings section). | 2022. | |
| Chairman of the Board of Directors of The Phoenix | |||
| Holdings and The Phoenix Insurance, serving board | According to the plaintiffs, the subject matter of the claim is an | ||
| members of The Phoenix Holdings and the Phoenix | alleged misleading report and non-disclosure by the Company of | ||
| Insurance and a long-serving manager in The Phoenix Insurance (hereinafter - the "Defendants"). |
material facts that caused damaged to buyers of the share. | ||
| According to the plaintiffs, at the beginning of the 1990s the Company |
|||
| NIS 137 million. | took steps, in which its managers were involved, to recruit customers |
||
| and help them to benefit from guaranteed return insurance policies; | |||
| such steps were allegedly carried out in breach of guidance. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 49. | July 2021 | According to the plaintiffs, the subject matter of the claim is that the defendants deduct interest at the rate of 2.5% (or any other |
The Phoenix Insurance filed its response to the motion to approve the claim as a class action. A |
| Tel Aviv District Court The Phoenix Insurance |
rate) from the monthly yield accrued for policyholders to whom a monthly benefit is paid under participating life insurance policies issued in 1991-2004; according to the plaintiffs, such a deduction is not established in the contractual terms of the relevant insurance policies. |
hearing was scheduled for September 6, 2022. | |
| The claim amount was not estimated, but it was stated that it exceeds NIS 2.5 million. |
|||
| 50. | August 2021 Tel Aviv District Court |
The subject matter of the lawsuit is the claim that the Partnership's filings posted on the Israel Securities Authority and |
On July 20, 2022, the Partnership filed a joint preliminary response on its behalf and on behalf of |
| Halman Aldubi I2P1, Limited Partnership (currently - The Phoenix Value P2P, Limited Partnership) (hereinafter - the "Partnership") NIS 7.5 million. |
the TASE's websites (the MAGNA and the MAYA, respectively) are not accessible to people with disabilities; accordingly, the plaintiff claims that the Partnership prevents or reduces disabled people's capability to obtain information from those reports. |
all the other defendants, against which a motion to approve the lawsuit as a class action was filed in connection with the said issue. A hearing date has not yet been scheduled. |
|
| 51. | November 2021 | According to the plaintiff, the lawsuit deals with The Phoenix | The Phoenix Insurance filed its response to the |
| Tel Aviv District Court | Insurance' refusal to fund the cost of a consultation in an ambulatory health insurance, stating as the reason for refusal the |
motion to approve the claim as a class action. A pre-trial hearing is scheduled for September 22, |
|
| The Phoenix Insurance | exclusions section in the general terms of health insurance plans, whereas the plaintiff claims that these exclusions are not included |
2022. | |
| NIS 4 million. | in the terms of the ambulatory insurance, and that The Phoenix Insurance did not provide fair disclosure of this matter. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 52. | December 2021 | The plaintiff claims that as part of the tender offer regarding the | ESOP has yet to submit its response to the petition to approve |
| Central District Court | shares of the Company in which he was employed and which he held by virtue of options awarded to him, ESOP allegedly breached |
the class action lawsuit. A pre-trial hearing is scheduled for December 13, 2022. |
|
| ESOP Management and Trust Services Ltd. |
various obligations as part of the operation of the sale of shares in the tender offer. |
||
| The claim amount was not estimated, | |||
| but it was stated that it may reach | |||
| many tens of millions of shekels. | |||
| 53. | December 2021 | The plaintiff argues that in claims pertaining to damages caused to | The Phoenix Insurance has yet to submit its response to the |
| Tel Aviv District Court | vehicles (of a policyholder or a third party), The Phoenix Insurance allegedly reduces the insurance benefits unlawfully due to failure to |
petition to approve the class action lawsuit. A pre-trial hearing is scheduled for January 19, 2023. |
|
| The Phoenix Insurance | fix the vehicles or transfer the damaged parts to The Phoenix Insurance. |
||
| The claim amount was not estimated, | |||
| but it was stated that it was in the | |||
| millions of shekels or more. | |||
| January 2022 | The plaintiff claims that in 2019 The Phoenix Insurance renewed a | The parties are in a mediation procedure. | |
| 54. | Central District Court | group health insurance policy to members of the Secondary Schools | |
| The Phoenix Insurance | and Colleges Teachers Union and their families, while making | ||
| changes, reducing the scope of the insurance coverage and | |||
| The claim amount was not estimated | increasing the premium, allegedly without informing policyholders | ||
| but it was stated as being more than NIS 2.5 million. |
and obtaining their consent. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| January 2022 | According to the plaintiffs, the defendants renewed a house insurance policy automatically | The parties are in a mediation procedure. | |
| 55. | Central District Court | while increasing the premium, allegedly without obtaining policyholders' consent. | |
| The Phoenix Insurance and another insurance | |||
| company The claim amount was not estimated but it |
|||
| was stated that it exceeds NIS 3 million. | |||
| April 2022 | The lawsuit deals with the claim that The Phoenix Insurance has collected and is still collecting | ||
| 56. | Tel Aviv District Court | from policyholders an additional premium for the expansion of insurance coverage in respect | The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A |
| The Phoenix Insurance | of preventative surgical procedures, despite the fact that those procedures are allegedly | pre-trial hearing is scheduled for January 11, 2023. | |
| The claim amount was not estimated but it | covered by the basic tier of The Phoenix Insurance's health insurance policies. | ||
| was stated as being (much) more than NIS 2.5 | According to the lawsuit, the plaintiff's claim is based on a decision of the Jerusalem District | ||
| million. | Court, to approve a lawsuit against The Phoenix Insurance and another insurance company | ||
| as a class action (see Section 24 in the table above). | |||
| May 2022 | The lawsuit deals with the claim that with regard to CPI-linked loans, the defendants adopted | The Phoenix Pension and Provident has yet to submit |
|
| 57. | Central District Court | a practice of a one-way linkage mechanism, whereby when the CPI increases compared with | its response to the petition to approve the class |
| The Phoenix Pension and Provident (formerly | the base index, the customer's monthly payment is increased accordingly, and when the CPI | action lawsuit. A pre-trial hearing is scheduled for | |
| - "The Phoenix Excellence Pension and |
decreases, the monthly payment does not change; the plaintiffs claim that this practice was | January 8, 2023. | |
| Provident Funds Ltd.") and another |
adopted despite the fact that this is not mentioned in the provisions of the agreement. | ||
| management company The claim amount was not estimated but it |
The plaintiffs noted that three motions to approve lawsuits as class actions are pending, which they claim give rise to joint issues against three other companies, including The |
||
| was stated that it exceeds NIS 3 million. | Phoenix Insurance (see Section 38 in the table above). | ||
| June 2022 | The subject matter of the lawsuit is the claim that The Phoenix Insurance breached its | ||
| 58. | contractual obligation with regard to the insurance period in a permanent health insurance, | The Phoenix Insurance has yet to submit its response to the petition to approve the class action lawsuit. A |
|
| Haifa Regional Labor Court | as reflected in the insurance offer, in contrast to the policy's provisions regarding "age for | pre-trial hearing is scheduled for December 28, | |
| insurance purposes"; the lawsuit also deals with the claim that as part of the engagement, | 2022. | ||
| The Phoenix Insurance | The Phoenix Insurance did not provide fair disclosure regarding the insurance end date. | ||
| NIS 5 million |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| September 2016 | Collection of premiums on health insurance policies, for unnecessary | In October 2020, the District Court ruled that the motion | |
| 1. | Tel Aviv District Court | coverages that the policyholders do not need, and alleged sale of | for approval of the claim as a class action was denied. |
| The Phoenix Insurance and other insurance | health insurance policies despite being aware that they include | In November 2020, the plaintiffs filed an appeal to the | |
| companies | coverages that the policyholders have no need for, since they have | Supreme Court. | |
| supplementary health insurance from the health maintenance | On March 28, 2022, the Supreme Court handed down a | ||
| NIS 4.45 billion from all defendants, of which | organization, they are a member of. In addition, according to the |
judgment dismissing the appeal filed by the plaintiffs |
|
| NIS 943 million is attributed to The Phoenix | defendants, they also tied services since customers were unable to | against the District Court's judgment. | |
| Insurance. | purchase a reduced-coverage policy that will include only coverages | ||
| that are not included in the supplementary health insurance of their | |||
| health maintenance organizations, thus creating "overlapping | |||
| insurance". | |||
| February 2020 | The claim is that The Phoenix Insurance refuses to pay its life | On April 19, 2022, the court issued a ruling confirming | |
| 2. | Tel Aviv Regional Labor Court | insurance policyholders the benefit they are entitled to in respect of | the plaintiff's withdrawal from the motion to approve the |
| The Phoenix Insurance | the first month after the end of the insurance period (the first month | claim as a class action. | |
| No less than NIS 25 million. | of their retirement). | ||
| According to the plaintiff, this claim deals with The Phoenix | On May 16, 2022, the Magistrates' Court granted the | ||
| 3. | May 2019 | Insurance's failure to pay in full insurance benefits under the | agreed motion for the plaintiff to withdraw from the |
| Nazareth Magistrate Court | insurance policy in respect of damage caused to a vehicle, on the | motion to approve the claim as a class action. | |
| The Phoenix Insurance | grounds that the ownership class of the vehicle is "leasing - sale of |
||
| The amount of the claim was not estimated. | a new vehicle with 0 km or formerly" even though the ownership of | ||
| the vehicle is not and/or never was of such ownership class, and the |
|||
| permanent owner of the vehicle's license as "Owner 00" was the first | |||
| purchaser, who is not the leasing company. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.
* For additional claims concluded between January 1, 2022, and March 29, 2022, please see Note 43A.2, Sections 11-16 of the table of concluded claims in the Company's financial statements as of December 31, 2021, published on March 29, 2022 (Ref. No. 2022-01-036997).

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 4. | February 2020 Central District Court PassportCard Israel General Insurance Agency (2014) (hereinafter - "PassportCard") and The Phoenix Insurance NIS 6.125 million. |
The claim is that the defendants violate the provisions of the travel insurance policy, since when an insurance event occurs to a policyholder and insurance benefits are claimed in respect of expenses of a person who traveled with the policyholder or accompanied him/her on their trip, the defendants deduct from the insurance benefits double the deductible - one for the policyholder and the other for another person covered by the insurance, i.e. the policyholder or person who traveled with the policyholder or the person who accompanied him/her. The plaintiff also claims that the defendants violate various provisions of insurance circulars regarding the claim filing form, the data included therein, receiving a copy thereof; the plaintiff further claims that the defendants refrain from informing policyholders who file claims of their right to obtain a copy of the decision made regarding their claim and/or appeal against the decision to various parties, nor do they inform policyholders of the period of time they have to do so. |
On May 17, 2022, the District Court granted the agreed motion for the plaintiff to withdraw from the motion to approve the claim as a class action. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.
* For additional claims concluded between January 1, 2022, and March 29, 2022, please see Note 43A.2, Sections 11-16 of the table of concluded claims in the Company's financial statements as of December 31, 2021, published on March 29, 2022 (Ref. No. 2022-01-036997).

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 5. | February 2018 Tel Aviv District Court Excellence Nessuah Gemel Ltd. (currently: The Phoenix Pension and Provident Fund Ltd.) and additional companies. NIS 21 million from all defendants, of which NIS 6 million is attributed to Excellence Gemel. |
According to the plaintiffs, the claim deals with the unlawful collection of handling fees /collection fees/operating fees/fees and commissions/early repayment fees or any other payment (whatever its name may be) collected by the defendants from planholders thereof to whom they extended loans. |
On June 16, 2022, the court rendered a judgment which approves the settlement agreement between the parties; as part of the settlement, The Phoenix Pension and Provident will refund 45% of the handling fees that were collected, as defined in the settlement agreement, plus interest and linkage differences; The Phoenix Pension and Provident will also pay compensation to the class action plaintiff and his/her attorneys, at amounts which are immaterial for The Phoenix Pension and Provident. It should be noted that similar motions for approval of claims as class actions filed against The Phoenix Pension (currently: The Phoenix Pension and Provident Fund Ltd.) and The Phoenix Insurance were concluded with a settlement agreement. |
| 6. | August 2019 Central District Court The Phoenix Insurance and other insurance companies The claim amount was not estimated, but it was stated that it was NIS 1 million or more. |
The claim is that in insurance polices covering mechanical engineering equipment the defendants determine the value of the equipment for the purpose of determining the premium according to the value of new equipment, disregarding the age of the equipment; however, in the event of total loss of equipment the defendants pay the policyholders insurance benefits in accordance with the equipment's actual value upon the occurrence of the insurance event, taking into consideration the age of the equipment. |
On August 11, 2022, the Court granted the agreed motion for the plaintiffs to withdraw from the motion to approve the claim as a class action. |
1 The date on which the petition for approval of the claim as a class action was originally filed.
2 The court with which the petition for approval of the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the claimant(s) in the petition for approval of the claim as a class action lawsuit.
* For additional claims concluded between January 1, 2022, and March 29, 2022, please see Note 43A.2, Sections 11-16 of the table of concluded claims in the Company's financial statements as of December 31, 2021, published on March 29, 2022 (Ref. No. 2022-01-036997).

Set forth below is a description of legal and other proceedings against the group. For proceedings where, in the opinion of management - which is based, among other things, on the legal opinion it has received - it is more likely than not that the group's defense claims will be allowed and the proceeding will be dismissed, no provision was included in the financial statements.
For proceedings where it is more likely than not that the group's defense claims will be dismissed, in whole or in part, the financial statements include provisions to cover the exposure estimated by the group. In management's opinion, which is based, among other things, on legal opinions it received, the financial statements include adequate provisions, where provisions were required, to cover the exposure estimated by the group.
In the statement of claim, the Court is requested to order the defendants, jointly and severally, to compensate the plaintiffs for the damage caused to them, according to the claim, due to the impairment of Pilat Group's value, in the total amount of NIS 35.9 million. The lawsuit continues to be heard in court.
According to the plaintiff, the subject matter of the claim is the alleged breach of duty towards the Company by the board members and officers, who allegedly allowed the Company to recruit customers and help them over more than three decades to benefit from guaranteed return insurance policies; such steps were allegedly carried out in breach of guidance prohibiting the marketing of such policies as from December 31 1990.

The claim amount, as claimed and estimated by the plaintiff, is NIS 124 million, which - according to the plaintiff - is the total direct damage caused to the Company as a result of El Al employees added to the guaranteed-return policies enjoying better conversion coefficients.1
In October 2021, the defendants filed a motion to dismiss the claim in limine. The court has not yet ruled in this dismissal in limine motion. The defendants' response to the motion to approve the lawsuit as a derivative lawsuit was also submitted. Further to a hearing held in June 2022, the parties are required to notify the court regarding the manner by which the proceedings will continue.
Complaints are filed against the group from time to time, including complaints to the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") in relation to policyholders' rights under insurance policies and/or the law. These complaints are handled on an ongoing basis by the group's Public Complaints Department. The Commissioner's decisions with regard to these complaints, to the extent that a decision has been made in respect thereof, are sometimes issued as sweeping decisions relating to a group of policyholders. Before issuing a final version of his decisions, the Commissioner usually issues a draft decision.
1 Since this is a derivative claim accompanied by a petition to approve the claim as a derivative claim, which, if approved, the Company will be entitled to funds thereunder, the total claimed amount does not appear in the following summary table.

Furthermore, as part of the Commissioner's inquiries with the group, following complaints and/or audits on his behalf, demands are made from time to time to receive various data regarding the group's handling of insurance policies in the past and/or a demand to reimburse funds to groups of policyholders and/or other guidelines. In addition, the Commissioner has the power, among other things, to impose monetary sanctions on the group in accordance with the data that was and/or will be transferred thereto following inquiries as described above. In addition to the petitions to approve lawsuits filed against the group as class actions.
and the legal and other proceedings, there is a general exposure, which cannot be assessed and/or quantified, due to, among other things, the complexity of the services provided by the group to its policyholders. The complexity of these services inevitably leads to interpretive claims and other claims due to information gaps between the group and third parties to the insurance contracts in connection with a long list of commercial and regulatory terms. This exposure is reflected, among other things, in the areas of pension savings and long-term insurance, including health and long-term care insurance, in which the group operates. Insurance policies in these areas of activity are assessed over many years in which policies, regulation and legislation change and new court rulings are issued. These changes are implemented by automated systems that undergo frequent changes and adjustments. The complexity of these changes and the application of the changes over many years lead to an increased operational exposure. In addition, allowing new interpretations for the provisions of insurance policies and long-term pension products sometimes affects the group's future profits in respect of its existing portfolio, in addition to the exposure embodied in claims for compensation for customers in respect of past activity.
It is impossible to anticipate the types of claims that will be raised in this area or the exposure arising from these and other claims in connection with insurance contracts - claims which are raised through, among other things, the procedural mechanism set forth in the Class Actions Law.
In addition, some of the group's products have long terms and are particularly complex in light of the various legislative arrangements both in the field of product management and in the field of taxation, attribution of contributions, investment management, the policyholder's employment status, his contributions and more.
The Wage Protection Law, 1958 imposes a liability on the group's institutional entities, in accordance with the circumstances specified in the law, in respect of employers' debts to the institutional bodies, where such debts have not been repaid on time. The group is in the process of improving the data on employers' debts and policyholders' rights, during the course of which lawsuits were filed against employers and the debts of other employers were rescheduled. Once this process is completed, the group will complete the handling of employers' debts in accordance with the provisions of the law.
The following table summarizes the amounts claimed in pending motions for approval of claims as class actions, claims approved as class actions and other material claims against the group, as noted by the plaintiffs in the statements of claim filed on their behalf. It is hereby clarified that the amounts claimed do not necessarily reflect the amounts of exposure assessed by the group, since these are assessments on behalf of the plaintiffs which will be resolved as part of the legal proceedings. It is further clarified that the table below does not include proceedings that have been concluded, including proceedings that concluded after a compromise agreement was approved in respect thereof.

| The claimed amount In NIS |
||
|---|---|---|
| Type | No. of claims |
thousand Unaudited |
| Claims approved as a class actions: | ||
| A specific amount was attributed to the Company |
6 | 1,074,743 |
| The claim pertains to several companies | ||
| and no specific amount was attributed to the Company |
2 | 273,200 |
| The amount of the claim was not specified |
3 | - |
| Pending petitions to approve lawsuits as class actions: |
||
| A specific amount was attributed to the Company |
22 | 3,043,417 |
| The claim pertains to several companies | ||
| and no specific amount was attributed to | 6 | 3,770,875 |
| the Company | ||
| The amount of the claim was not specified |
19 | - |
| Other material claims: | ||
| A specific amount was attributed to the Company |
- | - |
| The claim pertains to several companies | ||
| and no specific amount was attributed to | 1 | 35,900 |
| the Company | ||
| The amount of the claim was not specified |
- | - |
| Claims and other requirements | 24 | 41,740 |
The total provision amount in respect of class actions, legal proceedings and others, filed against the group as specified above as of June 30, 2022, and December 31, 2021, amounted to approximately NIS 279,475 thousand (of which a total of approximately NIS 4,335 thousand is in respect of concluded class actions) and approximately NIS 263,312 thousand, respectively.

A decrease (increase) in long-term interest rates may increase (decrease) the paid pension reserve and the supplementary retirement pension reserve is deferred due to the use of a lower (higher) discount rate, to the extent that a change in the discount rate is required due to changes in market interest rates.
In addition, the supplementary retirement pension reserve for deferred pensions is affected by future income expectations (using K factor), so that the decrease (increase) in interest rates may decrease (increase) the expected future income, and if according to the new projection it will be impossible to continue funding the provisions to the reserve, the Company will increase the reserve in order to reduce future provision amounts (or vice versa).
| June 30, | |||
|---|---|---|---|
| 2022 | 2021 | 31, 2021 |
|
| Unaudited | % | Audited | |
| In respect of yield-dependent insurance policies |
- | - | - |
| In respect of yield-dependent insurance policies |
0.85 | 0.85 | 0.85 |
The Company tests the adequacy of the reserves for life insurance and LTC and where necessary, increases the reserves. Testing is performed according to the regulatory guidelines and on the basis of actuarial assumptions and a risk-free yield curve plus an illiquidity premium. To the extent that there are changes in these assumptions, the supplement required according to the test will change. A decrease (increase) in the risk-free interest rate curve and/or in the rate of illiquidity premium will increase (decrease) the supplement for the reserves required according to the LAT test (to the extent that a supplement is required).
In June 2022, the Commissioner published the Circular "Amendment of the Provisions of the Consolidated Circular regarding Measurement of Liabilities - Updating the Demographic Assumptions System in Life Insurance and Pension Funds" (hereinafter - the "Circular"). The Circular lists updated default assumptions on the basis of which insurance companies will calculate the liabilities in respect of life insurance policies, which allow them to receive an annuity according to guaranteed conversion rates based on up-to-date demographic assumptions.
The Circular refers, among other things, to a change in life expectancy, including future improvements, and the resulting consequences for the level of reserves and how they are created. The circular includes a new life table for retirees of insurance companies, which is based, among other things, on past experience regarding mortality of retirees of insurance companies.

The Company has updated its estimates of pension liabilities based on the new life table and future life expectancy improvements included in the Circular.
As a result, the Company increased the provision for the supplementary pension reserve and paid pensions, and reduced the comprehensive income by NIS 364 million (pre-tax) and NIS 240 million (post-tax).
The said changes in the provisions also affected The Phoenix Insurance's economic solvency ratio; for more information, see Section 2.1 in the Report of the Board of Directors.
Further to Note 41, Section 5.1.5 to the annual financial statements, life insurance contracts containing a saving component, offered two tracks for funds withdrawal: equity track (one-off withdrawal), or an annuity track (with a secured annuity conversion factor), which also offers various tracks that can be selected (such as: life-long, policyholder and spouse, annuity secured for 10 years, and more). In some of the contracts, the policyholder may select the manner of receiving the funds at the time of their withdrawal. Since the insurance liability amount differs in each of these two tracks, the Company must determine the rate of policyholders opting for annuity, and the track that will be selected. This rate was determined based on Company's experience.
As of the report date, the Company completed a study on retirement age and pension take up rates (hereinafter - the "Study"), regarding retirees' tendency to take up an annuity at different rates in accordance with retirement age. Following the Study, the Company recorded in its financial statements as of June 30, 2022, a NIS 462 million gross pre-tax increase in comprehensive income, and a total post-tax increase of NIS 305 million. See Section 6 below.
The completion of the Study also affected The Phoenix Insurance's economic solvency ratio; for more information, see Section 2.1 in the Report of the Board of Directors.

A. Changes in estimates and principal assumptions used to calculate the insurance reserves: (cont.)
| For the 6 months ended on June 30 |
For the 3 months ended on June 30 |
For the year ended December 31 |
|||
|---|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | 2021 | |
| Unaudited NIS million |
Audited | ||||
| Life insurance segment: Effect of updating assumptions regarding rates of annuity uptake (see Section 5 above) |
(462) | - | (462) | - | (55) |
| Effect of updating other assumptions on the supplementary retirement pension reserve and paid pensions |
- | - | - | - | (12) |
| Effect of updating assumptions on the mortality and morbidity rates (see Section 4 above) |
364 | - | 364 | - | - |
| Effect of updating assumptions on the expense rates | - | (16) | - | (16) | (13) |
| Change in the discount rate used in the calculation of the supplementary retirement pension reserve and paid pensions |
(397) | 16 | (119) | 11 | 46 |
| Change in the supplementary retirement pension reserve following the application of the illiquidity premium circular (*) |
- | - | - | - | (66) |
| Total decrease in liabilities on retention in life insurance segment | (495) | - | (217) | (5) | (100) |
| Health insurance segment: Effect of updating of assumptions on the cancellation rates: LAT Other |
- - |
- - |
- - |
- - |
159 (21) |
| Effect of updating assumptions on the expense rates: LAT Other |
- - |
(198) 19 |
- - |
(198) 19 |
(204) (23) |
| Effect of updating assumptions on the mortality and morbidity rates: LAT Other |
- - |
293 (121) |
- - |
293 (121) |
293 (42) |
| Change in the LAT reserve following a change in the discount rate (**) | (753) | 54 | (133) | 30 | 429 |
| Change in the LAT reserve following application of the illiquidity premium circular (*) |
- | - | - | - | (298) |
| Total increase (decrease) in liabilities on retention in health insurance segment |
(753) | 47 | (133) | 23 | 293 |
| P&C insurance segment: Change in discount rate (**) |
(68) | (8)(* ) |
(70) | (7)(***) | (8)(***) |
| Total decrease in liabilities on retention in P&C insurance segment |
(68) | (8) | (70) | (7) | (8) |
| Total increase (decrease) in liabilities on retention before tax | (1,316) | 39 | (420) | 11 | 185 |
| Total increase (decrease) in liabilities on retention, after tax | (869) | 26 | (277) | 7 | 122 |
(*) For information about the Amendment to the Provisions of the Consolidated Circular regarding Measurement of Liabilities - Illiquidity Premium, see Note 41(5.1.10)D to the 2021 consolidated annual financial statements.
(**) This effect includes the change in the excess of value of illiquid assets, and the effect of the classification of NIS 80 million in excess of value of illiquid assets in the second quarter of 2022, from the health insurance and capital subsegments to the P&C insurance subsegment. As to the effect of the excess of value of illiquid assets in the health insurance subsegment, see also Note 1E above.
(***) Reclassified.

B. Fluctuations in financial markets and changes in the risk-free interest curves affect the group's results. During the reporting period, there were slumps in capital markets; those slumps intensified upon the breakout of the war between Russia and Ukraine. Consequently, the participating life insurance policies marketed through 2004 achieved negative real yields. Therefore, during the reporting period the Company did not record variable management fees; rather, it only recorded fixed management fees. So long as the policies do not achieve a positive real yield that will cover the investment losses accrued by the policyholder, the Company will not be able to collect variable management fees. As of June 30, 2022, management fees that were not collected due to the negative real return and until accumulative positive return is achieved amounted to NIS 507 million before tax. In addition, the slumps in capital markets also had an adverse effect on the Company's liquid nostro investments portfolio; on the other hand, there was an increase in the risk-free interest rate curve during the period, which caused a decrease in liabilities in respect of insurance contracts. The effect of the increase in interest rates has offset most of the impact of the slumps in capital markets. For further details about the impact of interest, please see Section A above.
For information concerning the effect of interest and the rise in financial markets subsequent to balance sheet date, see Note 9A below.
For further details, please see the Company's immediate reports of December 9, 2021, and January 6, 2022 (Ref. Nos.: 2021-01-107986, 2022-01-004077).
The outstanding balance of the bonds' principal bears a fixed annual interest rate of 1.94%. The interest payable on the outstanding balance of the bonds' principal shall be paid in semi-annual installments, on June 30 and December 31 of each of the years 2022 through 2032; the last interest installment will be paid on December 31, 2032. The Series 6 bonds were rated by Midroog at Aa3.il with a stable outlook, and by Maalot at ilAA-.
The issuance proceeds are designed to be used for early redemption of Series 3 bonds and for the Company's operating activities.
D. On January 17, 2022, Midroog reiterated the rating of the Series 3-6 bonds at Aa3.il, and changed the outlook from stable to positive.

E. On January 31, 2022, the Company's Board of Directors approved, after receiving the approval of Compensation Committee, to allocate the employees of the Company and its subsidiaries - some of whom are officers of the Company (including the Company's CEO) as well as some of the Company's service providers (hereinafter - the "Offerees") a total of up to 4,883,593 options, not listed for trading, offered at no cash monetary consideration (offered in consideration for work performed or service rendered to the Company by the Offerees) exercisable into up to 4,883,593 registered ordinary shares of NIS 1 par value each of the Company, out of the Company's reserved shares. Under the theoretical assumption of all allocatable options being exercised under the outline, immediately after exercise thereof and taking into account the issued and paid-up capital of the Company, the shares arising from the exercise of the options as of the Board of Directors' approval, shall constitute approximately 1.94% of the issued and paid-up capital of the Company and approximately 1.94% of its voting rights (and approximately 1.85% and 1.85%, respectively, fully diluted). In practice, no allotment will be made to the offerees who will realize the full stock options arising from them, but only shares in an amount that reflects the amount of the monetary benefit inherent in the options. In accordance with the Board of Directors' decision, out of the amount of 4,883,593 options offered to offerees a total of 90,000 options were allotted to the Company's CEO. The fair value at the Award Date is calculated based on an appraisal received from an external appraiser who used the binomial model.
The average value of one option was estimated at approximately NIS 4.18, and the total value of the options allotted was estimated at that date at approximately NIS 20 million. The award of options to the Company's CEO was approved in an extraordinary annual general meeting of the Company on March 8, 2022. For further details regarding the vesting terms and conditions, see Note 37B(4) to the annual financial statements. For more information, please see immediate reports dated February 1, 2022, and March 8, 2022 (Ref. Nos.: 2022-01-012510, 2022-01-023133 and 2022-01-023208, respectively).
Furthermore, the Company will not include in the amount of the dividend any amounts that were used for the execution of the share buyback plan. It is stipulated that the foregoing policy is not intended to derogate from the power of the Board of Directors to determine and approve the dividend to be distributed, as it deems appropriate at any given time.

On March 30, 2022, up to 3,761,841 options were offered to employees and officers of Gama (hereinafter - the "Offerees"), under the theoretical assumption of all allocatable options being exercised under the outline (see Gama's immediate report of April 1, 2022, Ref. No.: 2022-01-034830); immediately after exercise thereof and taking into account the issued and paid up capital of Gama as of the approval by Gama's Board of Directors, the shares arising from the exercise of the options shall constitute approximately 6.17% of the issued and paid up capital and voting rights of Gama. In practice, no allotment will be made to the offerees who will realize the full stock options arising from them, but only shares in an amount that reflects the amount of the monetary benefit inherent in the options.
For further details, see Gama's immediate reports dated April 1, 2022 (Ref. Nos.: 2022-01-034830 and 2022-01-034836).

N. On April 18, 2022, the Company issued NIS 283,010 par value of registered Series C bonds of NIS 1 par value each; the bonds, which are linked to the CPI, were issued pursuant to the Company's shelf offering report of May 30, 2021 (Ref. No. 2021-01-032896) in consideration for NIS 283,010 thousand. The bonds shall be repayable (principal) in three unequal annual installments; the first installment, constituting 30% of the principal amount, shall be made on October 18, 2024; the second installment, constituting 30% of the principal amount, shall be made on April 18, 2025, and the third and last installment, constituting 40% of the principal amount, shall be made on October 18, 2025. The outstanding balance of the bonds' principal shall bear variable annual interest at the rate of the Bank of Israel interest, plus a 1.35% spread; the interest on the outstanding balance of the bonds' principal will be paid in semi-annual installments, on April 18 and October 18 of each of the years 2022 through 2025. The first interest payment will be paid on October 18, 2022, and the last principal and interest payments will be paid on October 18, 2025. The bonds were rated by Midroog at Aa3.il with a stable outlook.
Excellence performs spread transactions involving financial instruments; the said transactions are presented at fair value through profit or loss. Those transactions are presented in the Company's books of account at their gross amount. Spread transactions include derivatives, underlying assets, credit and deposits, which are managed by the Company as a single financial transaction, whose purpose is to fix the spread with no exposure to market risk or third-party credit risk. These transactions are normally conducted with banking corporations with a maximum ILAAA rating, in dedicated accounts that the bank may offset against one another. As of the financial statements date, the income generated from the said spread transactions is immaterial.
In view of the increase in this activity, the Company is currently assessing the option of entering into an agreement with the bank in connection therewith; such an agreement will be in line with the transaction's characteristics as a single transaction settled on a net cash flow basis. As of June 30, 2022, the balance of deposits backing the financial liabilities due to short sale amounts to NIS 1.5 billion.
P. On June 9, 2022, the Company (through Excellence Investments) entered into an agreement with three partners, Mr. Eyal Greenbaum, Mr. Ehud Toibin, and Mr. Yoav Fogel (all of whom have background and experience in the field of underwriting) for the establishment of a new underwriting company (hereinafter - the "Underwriting Company"). In accordance with the terms of the agreement, the Company will hold (indirectly) 19.99% of the new Underwriting Company's issued and paid-up share capital and voting rights, and the remaining rights shall be held by the above-mentioned partners. The above-mentioned transaction is subject to conditions precedent, including the fulfillment of the requirements and conditions for obtaining an underwriter license and registering with the underwriters registry of the Israel Securities Authority in accordance with the Securities Regulations (Underwriting), 2007 (hereinafter - the "Underwriting Regulations").
Subject to the completion of the transaction as stated above, the Company will use its means of control to cause Excellence Nessuah Underwriting (1993) Ltd. to stop serving as an active underwriter, as this term is defined in the Underwriting Regulations. As of the report date, the conditions precedent have not yet been fulfilled.

These bonds shall be recognized as a Tier 2 capital instrument by The Phoenix Insurance, subject to the Commissioner's directives on restricting recognized capital.


| June 30, 2022 | ||||
|---|---|---|---|---|
| Presented at fair value through profit and |
Available | Loans and | ||
| loss | for-sale | receivables | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liquid debt assets (a1) | 380,954 | 5,931,293 | - | 6,312,247 |
| Illiquid debt assets | - | - | 14,106,324 | 14,106,324 |
| Shares (a2) | - | 2,144,175 | - | 2,144,175 |
| Other (a3) | 433,597 | 3,924,439 | - | 4,358,036 |
| Total | 814,551 | 11,999,907 | 14,106,324 | 26,920,782 |
| June 30, 2021 Presented |
||||
|---|---|---|---|---|
| at fair value through profit and |
Available | Loans and | ||
| loss | for-sale | receivables | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liquid debt assets (a1) | 157,315 | 7,010,047 | - | 7,167,362 |
| Illiquid debt assets | - | - | 12,248,364 | 12,248,364 |
| Shares (a2) | - | 2,570,777 | - | 2,570,777 |
| Other (a3) | 527,881 | 3,156,656 | - | 3,684,537 |
| As of December 31, 2021 | ||||
|---|---|---|---|---|
| Presented at fair value through profit and loss |
Available for-sale |
Loans and receivables |
Total | |
| Audited | ||||
| NIS thousand | ||||
| Liquid debt assets (a1) (*) | 236,367 | 7,136,770 | - | 7,373,137 |
| Illiquid debt assets | - | - | 12,346,143 | 12,346,143 |
| Shares (a2) | - | 2,602,173 | - | 2,602,173 |
| Other (a3) | 672,079 | 3,729,284 | - | 4,401,363 |
| Total | 908,446 | 13,468,227 | 12,346,143 | 26,722,816 |
| (*) Reclassified. |

| June 30, 2022 | ||
|---|---|---|
| Carrying amount |
Amortized cost Unaudited |
|
| NIS thousand | ||
| Government bonds | 2,717,777 | 2,805,869 |
| Other debt assets: | ||
| Other non-convertible debt assets | 3,213,516 | 3,230,546 |
| Other convertible debt assets | 380,954 | 410,952 |
| Total liquid debt assets | 6,312,247 | 6,447,367 |
| Impairments carried to profit and loss (cumulative) | 356,873 |
| June 30, 2021 | ||
|---|---|---|
| Carrying | Amortized | |
| amount | cost | |
| Unaudited | ||
| NIS thousand | ||
| Government bonds | 4,071,847 | 4,046,080 |
| Other debt assets: | ||
| Other non-convertible debt assets (*) | 2,938,200 | 2,661,023 |
| Other convertible debt assets (*) | 157,315 | 145,372 |
| Total liquid debt assets | 7,167,362 | 6,852,475 |
| Impairments carried to profit and loss (cumulative) | 86,162 | |
| (*) Reclassified. |
| As of December 31, 2021 |
|||
|---|---|---|---|
| Carrying amount |
Amortized cost Audited |
||
| NIS thousand | |||
| Government bonds | 3,925,232 | 3,738,712 | |
| Other debt assets: | |||
| Other non-convertible debt assets (*) | 3,211,538 | 2,960,183 | |
| Other convertible debt assets (*) | 236,367 | 231,789 | |
| Total liquid debt assets | 7,373,137 | 6,930,684 | |
| Impairments carried to profit and loss (cumulative) (*) Reclassified. |
81,553 |

| June 30, 2022 Carrying amount Unaudited |
Cost | |
|---|---|---|
| NIS thousand | ||
| Liquid shares | 1,671,274 | 1,365,837 |
| Illiquid shares | 472,901 | 288,885 |
| Total shares | 2,144,175 | 1,654,722 |
| Impairments carried to profit and loss (cumulative) | 280,643 |
| June 30, 2021 Carrying |
||
|---|---|---|
| amount Unaudited |
Cost | |
| NIS thousand | ||
| Liquid shares | 2,104,837 | 1,603,626 |
| Illiquid shares | 465,940 | 229,965 |
| Total shares | 2,570,777 | 1,833,591 |
| Impairments carried to profit and loss (cumulative) | 175,809 |
| As of December 31, 2021 |
||
|---|---|---|
| Carrying amount Audited |
Cost | |
| NIS thousand | ||
| Liquid shares | 2,120,169 | 1,513,615 |
| Illiquid shares | 482,004 | 354,577 |
| Total shares | 2,602,173 | 1,868,192 |
| Impairments carried to profit and loss (cumulative) | 216,277 |

| June 30, 2022 | ||
|---|---|---|
| Carrying | ||
| amount | Cost | |
| Unaudited | ||
| NIS thousand | ||
| Total liquid financial investments | 572,658 | 514,615 |
| Total illiquid financial investments | 3,785,378 | 2,651,937 |
| Total other financial investments | 4,358,036 | 3,166,552 |
| Impairments carried to profit and loss (cumulative) | 205,570 |
| June 30, 2021 Carrying amount |
Cost | |
|---|---|---|
| Unaudited | ||
| NIS thousand | ||
| Total liquid financial investments | 714,486 | 632,229 |
| Total illiquid financial investments | 2,970,051 | 2,258,378 |
| Total other financial investments | 3,684,537 | 2,890,607 |
| Impairments carried to profit and loss (cumulative) | 121,812 |
| As of December 31, 2021 |
|||
|---|---|---|---|
| Carrying amount |
Cost | ||
| Audited NIS thousand |
|||
| Total liquid financial investments Total illiquid financial investments Total other financial investments |
942,070 3,459,293 4,401,363 |
878,257 2,583,864 3,462,121 |
|
| Impairments carried to profit and loss (cumulative) | 153,113 |

Standalone Financial Data from the Consolidated Interim Financial Statements Attributed to the Company


| Independent Auditors' Review Report………………………………………………………………2 |
|---|
| Condensed Interim Data on Financial Position…………………………………………………….3 |
| Condensed Interim Data about Profit and Loss……………………………………………………4 |
| Condensed Interim Data about Comprehensive Income……………………………………….5 |
| Condensed Interim Data about Changes in Equity…………………………………………6-10 |
| Condensed Interim Data about Changes in Cash Flows………………………………….11-12 |
| Additional Information to the Condensed Interim Separate Financial Information….13 |

Kost Forer Gabbay & Kasierer Menachem Begin Road 144A, Tel Aviv 6492102 Tel. +972-3-6232525 Fax +972-3-5622555 ey.com
To The Shareholders of The Phoenix Holdings Ltd. Dear Madam/Sir,
We have reviewed the separate interim financial information disclosed in accordance with Regulation 38D to the Securities Regulations (Periodic and Immediate Reports), 1970 of The Phoenix Holdings Ltd. ("the Company") as of June 30, 2022, and for the six and three months periods then ended. The Company's board of directors and management are responsible for the separate interim financial information. Our responsibility is to express a conclusion regarding the separate interim financial information based on our review.
We did not audit the separate interim financial information taken from the interim information of investees, in which the total investment amounted to approximately NIS 860,273 thousand as of June 30, 2022, and the Company's share in of their earnings amounted to approximately NIS 16,204 thousand and NIS 16,862 thousand for the six and three months periods then ended, respectively. The separate interim financial information of those companies was reviewed by other auditors, whose review reports have been furnished to us, and our conclusion, insofar as it relates to the financial information in respect of those companies, is based on the review reports of the other auditors.
We conducted our review in accordance with Review Standard (Israel) 2410 of the Institute of Certified Public Accountants in Israel, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and of applying analytical and other review procedures. A review is substantially less in scope than an audit performed pursuant to Israeli GAAP and, as a result, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we are not express an audit opinion.
Based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the accompanying separate interim financial information is not prepared, in all material respects, in accordance with Regulation 38D to the Securities Regulations (Periodic and Immediate Reports), 1970.
Tel Aviv, Kost Forer Gabbay & Kasierer August 24, 2022 Certified Public Accountants

| Conde nsed Sepa rate Inte rim Fina ncial Information of Fina ncia l Position as of June 30, 2022 | As of | |||
|---|---|---|---|---|
| Jun. 30, 2022 | Jun. 30, 2021 | Dec. 31, 2021 | ||
| Unaudited | Audited | |||
| NIS thousand | ||||
| Assets | ||||
| Investments in investees | 9,381,481 | 8,757,186 | 9,353,800 | |
| Loans and capital notes to | ||||
| investees | 703,950 | 1,357,394 | 701,740 | |
| Total non-current assets | 10,085,431 | 10,114,580 | 10,055,540 | |
| Other financial investments | 982,081 | 20,152 | 946,470 | |
| Other receivables | 10,565 | 26 | 16,839 | |
| Current tax assets | 31 | 13,039 | 31 | |
| Cash and cash equivalents | 105,710 | 49,431 | 109,922 | |
| Total current assets | 1,098,387 | 82,648 | 1,073,262 | |
| Total assets | 11,183,818 | 10,197,228 | 11,128,802 | |
| Equity attributable to | ||||
| Company's shareholders | ||||
| Share capital | 310,514 | 310,059 | 310,323 | |
| Premium on shares and capital | ||||
| reserves | 845,296 | 839,186 | 849,309 | |
| Treasury shares | (155,628) | (93,271) | (99,769) | |
| Capital reserves | 934,615 | 1,139,769 | 1,261,509 | |
| Surplus | 7,773,062 | 6,489,114 | 7,331,992 | |
| Total equity | 9,707,859 | 8,684,857 | 9,653,364 | |
| Liabilities | ||||
| Non-current liabilities | - | - | - | |
| Bonds | 1,417,883 | 1,391,996 | 1,129,848 | |
| Current liabilities | ||||
| Payables and credit balances | 4,796 | 11,307 | 11,448 | |
| Liability in respect of deferred | ||||
| taxes | 18,600 | 22,399 | 18,479 | |
| Bonds | 34,680 | 86,669 | 315,663 | |
| Total current liabilities | 58,076 | 120,375 | 345,590 | |
| Total liabilities | 1,475,959 | 1,512,371 | 1,475,438 | |
| Total equity and liabilities | 11,183,818 | 10,197,228 | 11,128,802 | |
| Benjamin Gabbay | Eyal Ben Simon | Eli Schwartz |
|---|---|---|
| Chairman of the Board | CEO | Executive Vice President, CFO |
Date of approval of the financial statements - August 24, 2022

| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
|||
|---|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | 2021 | |
| Unaudited | Unaudited | Audited | |||
| NIS thousand | |||||
| Company's share in the profits of investees, net of tax | 840,839 | 919,745 | 172,613 | 611,574 | 1,900,306 |
| Investment income, net and finance income | 55,302 | 35,517 | 31,351 | 22,955 | 117,198 |
| Income from management fees of investees | 1,500 | 1,500 | 750 | 750 | 3,000 |
| Total income | 897,641 | 956,762 | 204,714 | 635,279 | 2,020,504 |
| General and administrative expenses | 5,437 | 9,352 | 2,415 | 7,355 | 8,703 |
| Finance expenses | 32,241 | 19,158 | 17,433 | 15,076 | 47,105 |
| Total expenses | 37,678 | 28,510 | 19,848 | 22,431 | 55,808 |
| Profit for the period attributed to the Company's owners | 859,963 | 928,252 | 184,866 | 612,848 | 1,964,696 |

| ended June 30 | For the six months | For the three months ended June 30 |
For the year ended December 31 |
||
|---|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | 2021 | |
| Unaudited | Audited | ||||
| NIS thousand | |||||
| Net income for the period | 859,963 | 928,252 | 184,866 | 612,848 | 1,964,696 |
| Other comprehensive income: | |||||
| Amounts that will be or that have been | |||||
| reclassified to profit or loss when specific | |||||
| conditions are met | |||||
| Net change in fair value of financial assets classified | |||||
| as available for sale, carried to capital reserves | (673) | 3,541 | (710) | 1,878 | 4,460 |
| Gains (losses) net from disposal of financial assets | |||||
| classified as available for sale, carried to the income | |||||
| statement | 87 | (1,008) | 9 | (1,008) | (4,495) |
| Impairment loss of financial assets classified as | |||||
| available for sale, carried to the income statement | 110 | - | 110 | - | - |
| The Group's share in other comprehensive income of | |||||
| equity-accounted investees | (323,030) | - | (323,623) | - | 24,282 |
| Taxes on income relating to components of other | |||||
| comprehensive income | (121) | - | 137 | - | - |
| Total components of income (loss) items, | |||||
| subsequently reclassified to profit or loss | (323,627) | 2,533 | (324,077) | 870 | 24,247 |
| Amount that will not be subsequently | |||||
| reclassified to profit or loss | |||||
| The Group's share in other comprehensive income of | 597 | 222,057 | 324,121 | 183,218 | 327,092 |
| equity-accounted investees Other comprehensive income (loss) for the |
|||||
| period, net | (323,030) | 224,590 | 44 | 184,088 | 351,339 |
| Total comprehensive income for the period | 536,933 | 1,152,842 | 184,910 | 796,936 | 2,316,035 |

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|---|---|---|---|---|---|---|---|---|---|---|
| 9,653,364 | ||||||||||
| 859,963 | ||||||||||
| (323,030) | ||||||||||
| - | - | - | 860,556 | - | - | - | - | 18,823 | (342,446) | 536,933 |
| - | (4,993) | - | - | - | - | 10,035 | - | - | - | 5,042 |
| (55,859) | ||||||||||
| - | ||||||||||
| - | - | - | 1,514 | - | - | - | (1,514) | - | - | - |
| (421,000) | ||||||||||
| 1,379 | ||||||||||
| - | - | - | - | (12,000) | - | - | - | - | - | (12,000) |
| 310,514 | 845,296 | (155,628) | 7,773,062 | (56,276) | 11,000 | 60,516 | 129,840 | (23,123) | 812,658 | 9,707,859 |
| 310,323 - - - 191 - - |
849,309 - - - 980 - - |
(99,769) - - (55,859) - - - |
7,331,992 859,963 593 - - (421,000) - |
(45,655) - - - - - 1,379 |
11,000 - - - - - - |
NIS thousand 51,652 - - - (1,171) - - |
131,354 - - - - - - |
(41,946) - 18,823 - - - - |
1,155,104 - (342,446) - - - - |
The Phoenix Holdings Ltd. 3-6
Condensed Separate Interim Financial Inform ation of Changes in Equity as of June 30, 2022


| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder NIS thousand |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as of January 1, | |||||||||||
| 2021 (audited) | 309,951 | 833,592 | (26,411) | 5,939,754 | (43,622) | 11,000 | 44,943 | 114,614 | (23,338) | 809,439 | 7,969,922 |
| Net income | - | - | - | 928,252 | - | - | - | - | - | - | 928,252 |
| Other comprehensive | |||||||||||
| income (loss) | - | - | - | - | - | - | - | - | (2,495) | 227,085 | 224,590 |
| Total comprehensive income | |||||||||||
| (loss) | - | - | - | 928,252 | - | - | - | - | (2,495) | 227,085 | 1,152,842 |
| Dividend | - | - | - | (380,000) | - | - | - | - | - | - | (380,000) |
| Transfer from revaluation | |||||||||||
| reserve in respect of revaluation of property, |
|||||||||||
| plant, and equipment, at the | |||||||||||
| depreciation amount | - | - | - | 1,108 | - | - | - | (1,108) | - | - | - |
| Share-based payment | 4,638 | - | - | - | - | 4,315 | - | - | - | 8,953 | |
| Acquisition of treasury | |||||||||||
| shares | - | - | (66,860) | - | - | - | - | - | - | - | (66,860) |
| Exercise of employee | |||||||||||
| options | 108 | 956 | - | - | - | - | (1,064) | - | - | - | - |
| Balance as of June 30, 2021 | 310,059 | 839,186 | (93,271) | 6,489,114 | (43,622) | 11,000 | 48,194 | 113,506 | (25,833) | 1,036,524 | 8,684,857 |
| (unaudited) |
The Phoenix Holdings Ltd. 3-7 The attached additional information is an integral part of the Company's separate interim financial information.

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder NIS thousand |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as of April 1, | |||||||||||
| 2022 (unaudited) Net income for the |
310,366 | 851,131 | (155,628) | 7,587,379 | (45,408) | 11,000 | 56,835 | 130,657 | (39,539) | 829,030 | 9,535,823 |
| period | - | - | - | 184,866 | - | - | - | - | - | - | 184,866 |
| Other comprehensive income (loss) |
- | - | - | - | - | - | - | - | 16,416 | (16,372) | 44 |
| Comprehensive | |||||||||||
| income (loss) | - | - | - | 184,866 | - | - | - | - | 16,416 | (16,372) | 184,910 |
| Share-based payment |
- | (6,568) | - | - | - | - | 4,562 | - | - | - | (2,006) |
| Exercise of employee | |||||||||||
| options Transfer from |
148 | 733 | - | - | - | - | (881) | - | - | - | - |
| revaluation reserve in respect of |
|||||||||||
| revaluation of | |||||||||||
| property, plant, and equipment, at the |
|||||||||||
| depreciation amount | - | - | - | 817 | - | - | - | (817) | - | - | - |
| Allocation of shares | |||||||||||
| of a consolidated subsidiary to |
|||||||||||
| minority interests | - | - | - | - | 1,132 | - | - | - | - | - | 1,132 |
| Acquisition of non | |||||||||||
| controlling interests Balance as of June |
- | - | - | - | (12,000) | - | - | - | - | - | (12,000) |
| 30, 2022 (unaudited) | 310,514 | 845,296 | (155,628) | 7,773,062 | (56,276) | 11,000 | 60,516 | 129,840 | (23,123) | 812,658 | 9,707,859 |
The Phoenix Holdings Ltd. 3-8

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder NIS thousand |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as of April 1, | |||||||||||
| 2021 (unaudited) Net income |
309,961 - |
837,324 - |
(26,411) - |
5,875,712 612,848 |
(43,622) - |
11,000 - |
47,150 - |
114,060 - |
(22,281) - |
848,884 - |
7,951,777 612,848 |
| Other comprehensive | |||||||||||
| income (loss) | - | - | - | - | - | - | - | - | (3,552) | 187,640 | 184,088 |
| Total comprehensive | |||||||||||
| income (loss) Transfer from |
- | - | - | 612,848 | - | - | - | - | (3,552) | 187,640 | 796,936 |
| revaluation reserve in | |||||||||||
| respect of revaluation | |||||||||||
| of property, plant, and equipment, at the |
|||||||||||
| depreciation amount | - | - | - | 554 | - | - | - | (554) | - | - | - |
| Share-based payment | - | 1,003 | - | - | - | - | 2,001 | - | - | - | 3,004 |
| Acquisition of treasury | |||||||||||
| shares | - | - | (66,860) | - | - | - | - | - | - | - | (66,860) |
| Exercise of employee options |
98 | 859 | - | - | - | - | (957) | - | - | - | - |
| Balance as of June 30, | |||||||||||
| 2021 (unaudited) | 310,059 | 839,186 | (93,271) | 6,489,114 | (43,622) | 11,000 | 48,194 | 113,506 | (25,833) | 1,036,524 | 8,684,857 |
The Phoenix Holdings Ltd. 3-9

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as of January 1, | NIS thousand | ||||||||||
| 2021 (audited) Net income for the year |
309,951 - |
833,592 - |
(26,411) - |
5,939,754 1,964,696 |
(43,622) - |
11,000 - |
44,943 - |
114,614 | (23,338) - |
809,439 - |
7,969,922 1,964,696 |
| Other comprehensive income (loss) |
- | - | - | (1,787) | - | - | - | 26,069 | (18,608) | 345,665 | 351,339 |
| Total comprehensive | |||||||||||
| income (loss) | - | - | - | 1,962,909 | - | - | - | 26,069 | (18,608) | 345,665 | 2,316,035 |
| Share-based payment | - | 13,083 | - | - | - | - | 9,715 | - | - | - | 22,798 |
| Acquisition of treasury | |||||||||||
| shares | - | - | (73,358) | - | - | - | - | - | - | - | (73,358) |
| Exercise of employee | |||||||||||
| options Transfer from revaluation reserve in respect of revaluation of property, plant, and equipment, at |
372 | 2,634 | - | - | - | - | (3,006) | - | - | - | - |
| the depreciation amount | - | - | - | 9,329 | - | - | - | (9,329) | - | - | - |
| Dividend | - | - | - | (580,000) | - | - | - | - | - | - | (580,000) |
| Transaction with minority interest Allocation of shares of a |
- | - | - | - | 1,223 | - | - | - | - | - | 1,223 |
| consolidated subsidiary to minority interests |
- | - | - | - | (3,256) | - | - | - | - | - | (3,256) |
| Balance on December 31, 2021 (audited) |
310,323 | 849,309 | (99,769) | 7,331,992 | (45,655) | 11,000 | 51,652 | 131,354 | (41,946) | 1,155,104 | 9,653,364 |
The Phoenix Holdings Ltd. 3-10 The attached additional information is an integral part of the Company's separate interim financial information.
| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
|||||
|---|---|---|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | 2021 | |||
| Appendix | Unaudited | Unaudited | |||||
| NIS thousand | |||||||
| Cash flows for operating activities | |||||||
| Gain | 859,963 | 928,252 | 184,866 | 612,848 | 1,964,696 | ||
| Adjustments required to present cash flows for | |||||||
| operating activities | (a) | (869,932) | (934,374) | (199,048) | (639,034) | (1,986,532) | |
| Net cash used for operating activities of the | |||||||
| Company | (9,969) | (6,122) | (14,182) | (26,186) | (21,836) | ||
| Cash flows from investing activities: | |||||||
| Loans and capital notes repaid by subsidiaries | 5,125 | - | 5,125 | - | 70,505 | ||
| Dividend from investees | 500,000 | 538,000 | 500,000 | 538,000 | 1,063,000 | ||
| Net sales of financial investments of the | |||||||
| Company | 10,627 | 7,319 | 3,622 | 14,244 | 19,888 | ||
| Investment in investees | (14,925) | (275,000) | (14,925) | - | (275,000) | ||
| Loans and capital notes provided to investees | - | (156,633) | - | (63,000) | (428,633) | ||
| Net cash from investing activities | 500,827 | 113,686 | 493,822 | 489,244 | 449,760 | ||
| Cash flows from financing activities | |||||||
| Dividend paid to shareholders | (421,000) | (380,000) | (421,000) | (380,000) | (580,000) | ||
| Share buyback by the Company | (55,859) | (66,860) | - | (66,860) | (73,358) | ||
| Repayment of bonds | (315,159) | - | (34,220) | - | (53,371) | ||
| Issuance of bonds (less issuance expenses) | 296,948 | 348,457 | - | - | 348,457 | ||
| Net cash used in financing activities | (495,070) | (98,403) | (455,220) | (446,860) | (358,272) | ||
| Increase (decrease) in cash and cash | |||||||
| equivalents | (4,212) | 9,161 | 24,420 | 16,198 | 69,652 | ||
| Balance of cash and cash equivalents at | |||||||
| beginning of period | 109,922 | 40,270 | 81,290 | 33,233 | 40,270 | ||
| Balance of cash and cash equivalents at end of period |
105,710 | 49,431 | 105,710 | 49,431 | 109,922 | ||
Condensed Separate Interim Financial Information of Cash Flow s of the Company as of June 30, 2022

| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
||||
|---|---|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | 2021 | ||
| Unaudited Audited |
||||||
| NIS thousand | ||||||
| Adjustments required to present | ||||||
| cash flows (for) from operating | ||||||
| (a) activities: |
||||||
| Items not involving cash flows: | ||||||
| Profits from financial investments, net Income and expenses not involving |
(46,714) | (1,952) | (26,294) | (1,670) | (62,354) | |
| cash flows: | ||||||
| Accrued interest and appreciation of | ||||||
| bonds | 25,263 | 11,670 | 12,534 | 11,015 | 31,887 | |
| Company's share in the profits of | ||||||
| investees, net | (840,839) | (919,745) | (172,613) | (611,574) | (1,900,306) | |
| Changes in other balance sheet line | ||||||
| items, net: | ||||||
| Change in other receivables | 6,318 | (6,721) | (6,647) | (11,592) | (10,456) | |
| Change in payables and credit balances | (6,652) | 5,352 | (1,658) | (2,561) | (13,490) | |
| Changes in loans to investees | (7,308) | (8,655) | (4,370) | (8,329) | (13,565) | |
| Cash paid and received during the | ||||||
| period for: | - | - | - | - | - | |
| Taxes paid, net | - | (14,323) | - | (14,323) | (18,248) | |
| Total cash flows for operating activities | (869,932) | (934,374) | (199,048) | (639,034) | (1,986,532) |

Additiona l Informa tion to the Condense d Interim F inancia l Informa tion
The Interim Separate Financial Information is presented in accordance with Regulation 38D of the Securities Regulations (Periodic and Immediate Reports), 1970 and does not include all the information required under Regulation 9C and the Tenth Addendum to the Securities Regulation (Periodic and Immediate Reports), 1970, "Separate Financial Information of the Corporation".
This separate financial information should be read in conjunction with the separate financial information as of the date and year ended December 31, 2021, and in conjunction with the consolidated condensed interim financial statements as of June 30, 2022 (hereinafter - the "Consolidated Financial Statements").
The "Company" - The Phoenix Holdings Ltd.
"Investee companies" - Consolidated companies and companies the Company's investment in which is included, whether directly or indirectly, in the financial statements based on the equity method.

August 24, 2022
Dear Madam/Sir,
We hereby inform you that we agree to the inclusion (including by way of reference) of our reports outlined below in a shelf offering based on the Shelf Prospectus:
Kost Forer Gabbay & Kasierer Certified Public Accountants

Report on the Effectiveness of Internal Control over Financial Reporting and Disclosure


Management, under the supervision of the Board of Directors of The Phoenix Holdings Ltd. (hereinafter: the "Corporation"), and the management of The Phoenix Insurance Company Ltd., are responsible for establishing and maintaining adequate internal control over financial reporting and disclosure in the Corporation. For that purpose, members of the Corporation and The Phoenix Insurance's managements are as follows:
The internal control over financial reporting and disclosure consists of the Corporation's existing controls and procedures that have been planned by the chief executive officer and the most senior financial officer or under their supervision, or by the equivalent acting officers, under the supervision of the Corporation's Board of Directors, designed to provide reasonable assurance about the reliability of financial reporting and the preparation of the financial statements in compliance with applicable laws, and ensure that all information that the Company is required to disclose in the financial statements its publishes pursuant to law is collected, processed, summated and reported in a timely manner and according to the format prescribed by law.

Among other things, internal controls include controls and procedures planned to ensure that all information that the Corporation is required to disclose as aforesaid is collected and transferred to the Corporation's management, including the chief executive officer and the most senior financial officer, or the equivalent acting officers, in order to allow decision making on a timely basis with respect to the disclosure requirements.
Due to its inherent limitations, internal control over financial reporting and disclosure is not designed to provide absolute assurance that misstatements or omissions of information in the financial statements shall be prevented or detected.
Management, under the supervision of the Corporation's Board of Directors, performed an examination and assessment of the Corporation's internal control over financial reporting and disclosure and their effectiveness; the assessment of the effectiveness of internal control over financial reporting and disclosure as performed by management under the supervision of the Board of Directors included the following:
Entity-level controls, controls on the process for compiling and closing the financial statements, general information technology controls (ITGC), and controls over processes which are highly material to financial reporting and disclosure (these processes are carried out within The Phoenix Insurance Company Ltd. and its subsidiaries, The Phoenix Pension and Provident Fund Ltd. - which are institutional entities to which the following provisions relating to institutional entities apply):
The Phoenix Insurance Ltd. and The Phoenix Pension and Provident Fund Ltd., subsidiaries of the Corporation, are institutional entities which are subject to the directives of the Commissioner of the Capital Market, Insurance and Savings in the Ministry of Finance regarding the assessment of the effectiveness of internal controls over financial reporting.
Regarding the said subsidiary, management - under the supervision of the Board of Directors - examined and assessed the internal control over financial reporting and the effectiveness thereof, based on Institutional Entities Circular 2009-9-10, "Management's Responsibility for Internal Control over Financial Reporting"; Institutional Entities Circular 2010-9-6, "Management's Responsibility for Internal Control over Financial Reporting - Amendment"; Circular 2010-9-7, "Internal Control over Financial Reporting - Statements, Reports and Disclosures".
In the quarterly report on the effectiveness of internal control over financial reporting and the disclosure attached to the quarterly report for the period ended March 31, 2022 (hereinafter - the "Last Quarterly Internal Control Report"), the internal control was found to be effective.
As of the report date, the Board of Directors and management have not been informed of any event or matter that may alter the assessment of the effectiveness of internal control, as presented in the Most Recent Annual Report Over Internal Control.
As of the report date, based on the Most Recent Quarterly Report over Internal Control and based on information brought to the attention of management and the Board of Directors as stated above, the internal control is effective.

I, Eyal Ben Simon, hereby certify that:
Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.
August 24, 2022 ___________________________________________
Eyal Ben Simon, CEO

Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.
August 24, 2022 ___________________________________________

Statements Regarding Controls and Procedures in respect of Disclosure in the Financial Statements of The Phoenix Insurance Company Ltd.


I, Eyal Ben Simon, hereby certify that:
Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.
______________________________________
August 24, 2022
Eyal Ben Simon, Chief Executive Officer

I, Eli Schwartz, hereby certify that:
Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.
______________________________________________
August 24, 2022
Eli Schwartz, EVP, CFO
1 As defined in the provisions of the institutional entities circular titled "Internal Controls over Financial Reporting - Statements, Reports and Disclosures".
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.